As filed with the U.S. Securities and Exchange Commission on November 20, 2026.

Registration No. 333-[          ]

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM F-1

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

 

Axonex AI Group Limited

(Exact name of registrant as specified in its charter)

 

British Virgin Islands   7389   Not Applicable
(State or other jurisdiction of
incorporation or organization)
  (Primary Standard Industrial
Classification Code Number)
  (IRS. Employer
Identification Number)

 

Unit 506-8, 5/F, Laford Centre

838 Lai Chi Kok Road

Lai Chi Kok, Kowloon, Hong Kong

Tel: +852 3565-1925

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Cogency Global Inc.

122 East 42nd Street, 18th Floor

New York, NY 10168

+1 (212) 947-7200

(Name, address, including zip code, and telephone number, including area code, of agent for service)

 

Copies to:

 

William S. Rosenstadt, Esq.

Mengyi “Jason” Ye, Esq.

Yarona L. Yieh, Esq.

Ortoli Rosenstadt LLP

366 Madison Avenue, 9th Floor

New York, NY 10017

Tel: +1 (212) 588-0022

 

Approximate date of commencement of proposed sale to the public: From time to time after this registration statement becomes effective.

 

If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, check the following box. ☒

 

If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act of 1933, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act of 1933, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act of 1933, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933.

 

Emerging growth company ☒

 

If an emerging growth company that prepares its financial statements in accordance with U.S. GAAP, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards† provided pursuant to Section 7(a)(2)(B) of the Securities Act. ☐

 

† The term “new or revised financial accounting standard” refers to any update issued by the Financial Accounting Standards Board to its Accounting Standards Codification after April 5, 2012.

 

The Registrant hereby files this registration statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933, as amended, or until the registration statement shall become effective on such date as the U.S. Securities and Exchange Commission, acting pursuant to said Section 8(a), may determine.

 

 

 

 

 

 

The information in this prospectus is not complete and may be changed. We may not sell the securities until the registration statement filed with the U.S. Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and it is not soliciting any offer to buy these securities in any jurisdiction where such offer or sale is not permitted.

 

PRELIMINARY PROSPECTUS SUBJECT TO COMPLETION, DATED NOVEMBER 20, 2026

 

Axonex AI Group Limited

 

Resale of up to 4,319,802 Class A Ordinary Shares by the Selling Shareholders

 

This prospectus relates to the resale, from time to time, by the selling shareholders identified herein (each a “Selling Shareholder”, and collectively, the “Selling Shareholders”), of up to 4,319,802 Class A ordinary shares of no par value (the “Class A Ordinary Shares”) of Axonex AI Group Limited (formerly known as Mint Incorporation Limited) (“we,” “us,” “our,” “Axonex BVI” or the “Company”) (the “Resale Shares”), consisting of (i) 4,255,786 Class A Ordinary Shares issued to the Selling Shareholders pursuant to the securities purchase agreements by and between the Company and the Selling Shareholders dated July 2, 2026 and July 30, 2026 (collectively, the “Original Securities Purchase Agreements”), as amended on August 26, 2026 and October 7, 2026 (as amended from time to time, the “Securities Purchase Agreements”); (ii) 64,000 Class A Ordinary Shares acquired by two of the Selling Shareholders from an existing shareholder of the Company in private transactions in January 2026; and (iii) additional shares issued to the Selling Shareholders in lieu of fractional shares in connection with the reverse stock split effected in October 2026, with the numbers in (i) and (ii) giving effect to that reverse stock split. We are registering the Resale Shares on behalf of the Selling Shareholders, to be offered and sold by them from time to time. We are not selling any securities under this prospectus, and will not receive any proceeds from the sale of the Resale Shares by the Selling Shareholders pursuant to this prospectus.

 

We are registering the Resale Shares pursuant to, or as an accommodation in addition to, the Selling Shareholders’ registration rights under the Securities Purchase Agreements. Our registration of the Resale Shares does not mean that the Selling Shareholders will sell any of the securities offered hereby. The Selling Shareholders may offer and sell the Resale Shares in a number of different ways and at varying prices. See the section titled “Plan of Distribution” beginning on page 48 of this prospectus for more information about how the Resale Shares may be sold.

 

We have a dual class structure consisting of Class A Ordinary Shares and Class B ordinary shares both of no par value (the “Class B Ordinary Shares”). Unless otherwise required by the BVI Business Companies Act, 2004 (as amended) (the “BVI Act”), holders of Class A Ordinary Shares and Class B Ordinary Shares shall at all times vote together as one class on all matters submitted to a vote by the shareholders at any general meeting of the Company. Each Class A Ordinary Share shall entitle the holder thereof to one (1) vote on all matters subject to vote at general meetings of our Company and each Class B Ordinary Share shall entitle the holder thereof to twenty (20) votes on all matters subject to vote at general meetings of our Company. Also, each Class B Ordinary Share is convertible into one (1) Class A Ordinary Share, subject to adjustments provided in the memorandum and articles of association of the Company, at any time at the option of the holder thereof, but in no event shall Class A Ordinary Shares be convertible into Class B Ordinary Shares.

 

Our Class A Ordinary Shares are listed on the Nasdaq Capital Market (“Nasdaq”) under the symbol “AXNX”. On November 18, 2026, the last reported sale price of our Class A Ordinary Shares on the Nasdaq Capital Market was $0.8930 per share, and as of the date of this prospectus, we had 6,076,338 Class A Ordinary Shares, including 4,319,802 Resale Shares, and 280,752 Class B Ordinary Shares issued and outstanding.

 

Investing in our Class A Ordinary Shares, including the Resale Shares, involves a high degree of risk, including the risk of losing your entire investment. Before buying our Class A Ordinary Shares, you should carefully read and consider the risk factors under the section titled “Risk Factors” beginning on page 28 of this prospectus and as set forth in our most recent annual report on Form 20-F for the fiscal year ended March 31, 2026 filed with the U.S. Securities and Exchange Commission (the “SEC”) on August 14, 2026 (the “2026 Annual Report”).

 

Unless the context otherwise requires, the terms “Axonex BVI”, the “Company” and “our Company” refer to Axonex AI Group Limited (formerly known as Mint Incorporation Limited), a business company incorporated in the British Virgin Islands (the “BVI”) with limited liability.

 

 

 

 

Axonex AI Group Limited, or Axonex BVI, is a holding company incorporated in the BVI. As a holding company with no material operations of its own, Axonex BVI conducts substantially all of its operations through its operating subsidiaries, including (i) Matter International Limited (“Matter International”), formerly known as Matter Interiors Limited, a company incorporated in Hong Kong engaged in the provision of interior design and fit-out services; (ii) Grand Engineering and Construction Limited (“Grand Engineering”), a company incorporated in Hong Kong engaged in engineering works; (iii) Spark Interiors Limited (“Spark Interiors”), a company incorporated in Hong Kong engaged in the provision of interior design and fit-out services; (iv) Axonex Intelligence Limited (“Axonex Intelligence HK”), a company incorporated in Hong Kong engaged in smart facility management, robotics, IoT, and AI solutions; (v) Axonex Intelligence Pte. Ltd. (“Axonex Intelligence Singapore”), a company incorporated in Singapore engaged in software and application development; (vi) Axonex Robotics Limited (“Axonex Robotics”), a company incorporated in Hong Kong focused on robotics design, in which Axonex BVI indirectly holds a 60% equity interest; and (vii) Rice Robotics AGI Holding Limited (“Rice JV”), a company incorporated in the BVI and headquartered in Hong Kong through Rice Robotics (Hong Kong) Limited (“Rice HK”, together with Rice JV, “Rice JV HK”) with a focus on the development and sales of AI companion robots, in which Axonex BVI indirectly holds 54% equity interest (collectively, the “Operating Subsidiaries”).

 

Investors in our Class A Ordinary Shares should be aware that they will not and may never directly hold equity interests in any of the Operating Subsidiaries, but rather purchase equity solely in Axonex BVI, our BVI holding company. This structure of holding Operating Subsidiaries in Hong Kong through our BVI holding company involves unique risks to investors, and the Mainland Chinese regulatory authorities could disallow this structure, which would likely result in a material change in our operations and/or a material change in the value of our Class A Ordinary Shares, including that such event could cause the value of our Class A Ordinary Shares to significantly decline or become worthless. Furthermore, shareholders may face difficulties enforcing their legal rights under the securities laws of the United States of America (“U.S.” or the “United States”) against our directors and officers who are located outside of the United States.

 

The majority of our operations are conducted by our Operating Subsidiaries in Hong Kong, which is a special administrative region of the People’s Republic of China (the “PRC”). We and our Hong Kong Operating Subsidiaries do not have any operations, maintain office or personnel, or have physical presence in Mainland China, nor currently do we have, nor intend to have, any contractual arrangements to establish a variable interest entity (“VIE”) structure with any entity in Mainland China. However, we are subject to certain legal and operational risks associated with our Hong Kong Operating Subsidiaries being based in Hong Kong and having substantially all of their operations in Hong Kong, and the legal and operational risks associated with operating in Mainland China may also apply to our operations in Hong Kong. We may be subject to unique risks due to uncertainty of interpretation and application of Mainland Chinese laws and regulations, including but not limited to those relating to data and cyberspace security, anti-monopoly concerns, and the oversight and control over overseas securities offerings by the Mainland Chinese government. We are also subject to the risks of uncertainty about any future actions the Mainland Chinese government or Hong Kong authorities may take. Should the Mainland Chinese government choose to exercise significant oversight and discretion over the conduct of our business in Hong Kong, or in the event that we or our Hong Kong Operating Subsidiaries were to become subject to Mainland Chinese laws and regulations, we could incur material costs to ensure compliance, and we or our Hong Kong Operating Subsidiaries might be subject to fines, experience devaluation of securities or delisting, no longer be permitted to conduct offerings to foreign investors, or no longer be permitted to continue business operations as presently conducted. These actions could result in a material change in our operations and/or the value of our Class A Ordinary Shares, including that it could cause the value of our Class A Ordinary Shares to significantly decline or become worthless. See “Item 3. Key Information — 3.D. Risk Factors – Risks Relating to Doing Business in the Jurisdictions in which the Operating Subsidiaries Operate – Substantially all of our operations are in Hong Kong. However, due to the long-arm application of the current Mainland Chinese laws and regulations, the Mainland Chinese government may exercise significant direct oversight and discretion over the conduct of our business and may intervene or influence our operations, which could result in a material change in our operations and/or the value of our Class A Ordinary Shares. Our Operating Subsidiaries in Hong Kong may be subject to certain Mainland Chinese laws and regulations, which may impair our ability to operate profitably and result in a material negative impact on our operations and/or the value of our Class A Ordinary Shares. Furthermore, the changes in the policies, laws, regulations, rules, and the enforcement of laws of Mainland China may also occur quickly with little advance notice and our assertions and beliefs of the risk imposed by the Mainland China legal and regulatory system cannot be certain” in our 2026 Annual Report.

 

We are aware that the Mainland Chinese government initiated a series of regulatory actions and statements to regulate business operations in certain areas in Mainland China with little advance notice, including cracking down on illegal activities in the securities market, enhancing supervision over Mainland China-based companies listed overseas using VIE structure, and adopting new measures to extend the scope of cybersecurity reviews. See “Prospectus Summary — Recent Regulatory Development in the PRC” on page 16 of this prospectus.

 

 

 

 

On August 20, 2021, the 30th meeting of the Standing Committee of the 13th National People’s Congress voted and passed the “Personal Information Protection Law of the People’s Republic of China” (the “PIPL”), which became effective on November 1, 2021. The PIPL applies to the processing of personal information of natural persons within the territory of Mainland China that is carried out outside of Mainland China where (i) such processing is for the purpose of providing products or services for natural persons within Mainland China, (ii) such processing is to analyze or evaluate the behavior of natural persons within Mainland China, or (iii) there are any other circumstances stipulated by related laws and administrative regulations.

 

On December 24, 2021, the China Securities Regulatory Commission (the “CSRC”), together with other relevant government authorities in Mainland China, issued the Provisions of the State Council on the Administration of Overseas Securities Offering and Listing by Domestic Companies (Draft for Comments), and the Measures for the Filing of Overseas Securities Offering and Listing by Domestic Companies (Draft for Comments) (collectively, the “Draft Overseas Listing Regulations”). The Draft Overseas Listing Regulations require that overseas issuance and listing, which shall include direct and indirect overseas issuance and listing, shall complete the filing procedures and submit the relevant information to the CSRC. Where an enterprise whose principal business activities are conducted in Mainland China seeks to issue and list its shares in the name of an overseas issuer on the basis of the equity, assets, income, or other similar rights and interests of the relevant Mainland China domestic enterprise, such activities shall be deemed an indirect overseas issuance and listing under the Draft Overseas Listing Regulations.

 

On December 28, 2021, the Cyberspace Administration of China (the “CAC”), jointly with the relevant authorities, formally published the Measures for Cybersecurity Review (2021), which took effect on February 15, 2022 and replaced the former Measures for Cybersecurity Review (2020) issued on July 10, 2021 (collectively, the “Cybersecurity Review Measures”). The Cybersecurity Review Measures provide that operators of critical information infrastructure purchasing network products and services, and online platform operators carrying out data processing activities that affect or may affect national security (together with the operators of critical information infrastructure, the “Operators”), shall conduct a cybersecurity review, and that any online platform operator who controls more than one million users’ personal information must go through a cybersecurity review by the cybersecurity review office if it seeks to be listed in a foreign country.

 

On February 17, 2023, the CSRC published the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies and five supporting guidelines, which came into effect on March 31, 2023 (collectively, the “Trial Administrative Measures”). Among others, the Trial Administrative Measures provide that Mainland Chinese domestic companies seeking to offer and list securities (which, for the purposes of the Trial Administrative Measures, are defined thereunder as equity shares, depository receipts, corporate bonds convertible to equity shares, and other equity securities that are offered and listed overseas, either directly or indirectly, by Mainland Chinese domestic companies) in overseas markets, either via direct or indirect means, must file with the CSRC within three working days after their application for an overseas listing is submitted. According to the Trial Administrative Measures, any overseas securities offering and listing made by an issuer that meets both the following conditions will be determined as indirect overseas securities offering and listing by a Mainland Chinese domestic company: (i) 50% or more of the issuer’s operating revenue, total profit, total assets or net assets as documented in its audited consolidated financial statements for the most recent fiscal year is accounted for by domestic companies; and (ii) the main parts of the issuer’s business activities are conducted in Mainland China, or its main places of business are located in Mainland China, or the majority of senior management in charge of its business operations and management are Mainland Chinese citizens or domiciled in Mainland China. In addition, if a company is subject to the filing requirement with the CSRC, such company’s future securities offerings in the same overseas market or subsequent securities offering and listing in other overseas markets shall also be subject to the filing requirement with the CSRC, which shall be completed within three working days after the offering is completed or after the relevant application is submitted to the relevant overseas authorities, respectively.

 

 

 

 

Based on our understanding of the current PRC laws and regulations, we believe that neither we nor our Hong Kong Operating Subsidiaries are currently required to obtain any permissions or approvals from Mainland Chinese authorities, including the CAC and the CSRC, to operate our business and issue our Class A Ordinary Shares to foreign investors because: (i) our Hong Kong Operating Subsidiaries were established and operate in Hong Kong, which is not within the definition of a “domestic company” for the purposes of the Trial Administrative Measures; (ii) we do not own or control any Mainland Chinese entity, including any subsidiary or VIE structure in Mainland China, and we do not have any operations in Mainland China; (iii) businesses conducted by our Hong Kong Operating Subsidiaries are not included in the categories of industries and companies whose foreign securities offerings are subject to review by the CAC or the CSRC; and (iv) although our Hong Kong Operating Subsidiaries may collect and store data (including certain personal information) from their customers, some of whom may be individuals in Mainland China, in connection with our business and operations and for “Know Your Customers” purposes (to combat money laundering), we believe that we and our Hong Kong Operating Subsidiaries will not be deemed an “Operator” that is required to file for cybersecurity review before listing in the United States, given that, as of date of this prospectus, (a) our Hong Kong Operating Subsidiaries have in aggregate collected and stored personal information of less than one million users; (b) all of the data our Hong Kong Operating Subsidiaries have collected is stored in servers located in Hong Kong; and (c) neither the Company nor our Hong Kong Operating Subsidiaries have been informed by any PRC governmental authority of any requirement that we should file for a cybersecurity review with the CAC. Moreover, according to Article 18 of the Basic Law, Mainland Chinese laws and regulations shall not be applied in Hong Kong except for those listed in Annex III of the Basic Law, which is confined to laws relating to national defense, foreign affairs and other matters that are not within the scope of autonomy, such as the laws relating to the national flag, national anthem, and diplomatic privileges and immunities. As of the date of this prospectus, neither the CAC, the CSRC nor any other PRC regulatory body or administration has contacted the Company in connection with the Group’s operations in Hong Kong and the offering and listing of the Class A Ordinary Shares on Nasdaq. Therefore, the Company and its subsidiaries are not currently required to obtain permissions or approvals from PRC authorities for their operations and the offer and sale of the Class A Ordinary Shares registered herein, and accordingly, no permissions or approvals have been denied as of the date of this prospectus.

 

However, given the uncertainties arising from the legal system in Mainland China and Hong Kong, including uncertainties regarding the interpretation and enforcement of Mainland Chinese laws and the significant authority of the Mainland Chinese government to intervene or influence offshore holding companies headquartered in Hong Kong, and that laws, regulations and policies in the PRC could change rapidly in the future, we believe that there remains significant uncertainty in the interpretation and enforcement of relevant Mainland Chinese laws and regulations. If the applicable laws, regulations, or interpretations change or if we inadvertently conclude that such laws and regulations are not applicable to us, and we become subject to CAC or CSRC review, we cannot assure you that we and our subsidiaries will be able to comply with the regulatory requirements in all respects. If we were required to obtain such permissions or approvals in the future in connection with the listing or continued listing of our securities on a stock exchange outside of the PRC, it is uncertain how long it will take for us to obtain such approval. Any failure to obtain or a delay in obtaining the necessary permissions from the PRC authorities to conduct offerings or list outside of the PRC may subject us to sanctions imposed by the PRC regulatory authorities, which could include fines and penalties, proceedings against us, and other forms of sanctions, and restrict or completely hinder our ability to conduct our business, invest into Mainland China as foreign investments or accept foreign investments, offer or continue to offer Class A Ordinary Shares to investors or list on U.S. or other overseas exchanges, and the value of our Class A Ordinary Shares may significantly decline or be worthless. See “Item 3. Key Information — 3.D. Risk Factors – Risks Relating to Doing Business in the Jurisdictions in which the Operating Subsidiaries Operate – There remain some uncertainties as to whether we will be required to obtain approvals from the PRC authorities to list on the U.S. exchanges and offer securities in the future, and if required, we cannot assure you that we will be able to obtain such approval. We may become subject to a variety of Mainland Chinese laws and other obligations regarding data security in relation to offerings that are conducted overseas, and any failure to comply with applicable laws and obligations could have a material and adverse effect on our business, financial condition and results of operations and may hinder our ability to offer or continue to offer Class A Ordinary Shares to investors and cause the value of our Class A Ordinary Shares to significantly decline or be worthless” and “Item 3. Key Information — 3.D. Risk Factors — Risks Relating to Doing Business in the Jurisdictions in which the Operating Subsidiaries Operate — If the Mainland Chinese government chooses to extend the oversight and control over offerings that are conducted overseas and/or foreign investment in Mainland China-based issuers to Hong Kong-based issuers, such action may significantly limit or completely hinder our ability to offer or continue to offer Class A Ordinary Shares to investors and cause the value of our Class A Ordinary Shares to significantly decline or be worthless” in our 2026 Annual Report.

 

 

 

 

Furthermore, our Class A Ordinary Shares may be prohibited from trading if the Public Company Accounting Oversight Board (the “PCAOB”) determines that it is unable to inspect or investigate completely our auditor. Pursuant to the Holding Foreign Companies Accountable Act (the “HFCA Act”) enacted in 2020, if the auditor of a U.S. listed company’s financial statements is not subject to PCAOB inspections for three consecutive “non-inspection” years, the SEC is required to prohibit the securities of such issuer from being traded on a U.S. national securities exchange, such as NYSE and Nasdaq, or in U.S. over-the-counter markets. On June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act (the “AHFCA Act”), which was signed into law on December 29, 2022, amending the HFCA Act and requiring the SEC to prohibit an issuer’s securities from trading on any U.S. stock exchange if its auditor is not subject to PCAOB inspections for two, instead of three, consecutive “non-inspection” years. Pursuant to the HFCA Act, the PCAOB issued a Determination Report on December 16, 2021 (the “2021 Determination Report”) which found that the PCAOB is unable to inspect or investigate completely registered public accounting firms headquartered in: (1) Mainland China because of a position taken by one or more authorities in Mainland China; and (2) Hong Kong, a special administrative region and dependency of the PRC, because of a position taken by one or more authorities in Hong Kong. In addition, the 2021 Determination Report identified specific registered public accounting firms that were subject to these determinations. On August 26, 2022, the CSRC, the Ministry of Finance of the PRC (the “MOF”) and the PCAOB signed a Statement of Protocol (the “Protocol”) governing inspections and investigations of accounting firms based in Mainland China and Hong Kong. On December 15, 2022, the PCAOB announced that it was able to inspect and investigate registered public accounting firms headquartered in Mainland China and Hong Kong, and as a result, the PCAOB vacated its previous 2021 Determination Report.

 

Our auditor, WWC, P.C., is an independent registered public accounting firm headquartered in California and registered with the PCAOB and is subject to the laws in the United States pursuant to which the PCAOB conducts regular inspections to assess our auditor’s compliance with the applicable professional standards with the last inspection having occurred in December 2025. As of the date of this prospectus, our auditor is not affected by and is not subject to the 2021 Determination Report (which was vacated by the PCAOB on December 15, 2022) and the trading prohibitions of the HFCA Act. However, whether the PCAOB will continue to be able to satisfactorily conduct inspections of PCAOB-registered public accounting firms like our auditor is subject to uncertainty and depends on a number of factors out of our, and our auditor’s, control. We cannot assure you whether Nasdaq or regulatory authorities would apply additional and more stringent criteria to us after considering the effectiveness of our auditor’s audit procedures and quality control procedures, adequacy of personnel and training, or sufficiency of resources, geographic reach or experience as it relates to the audit of our financial statements. In the event it is later determined that the PCAOB is unable to inspect or investigate our auditor because of a position taken by an authority in a foreign jurisdiction, such as the PRC authorities, such could cause trading in our Class A Ordinary Shares to be prohibited under the HFCA Act, and ultimately result in a determination to delist our Class A Ordinary Shares. Such uncertainty could cause the market price of our Class A Ordinary Shares to be materially and adversely affected. See “Risk Factors — Risks Relating to our Class A Ordinary Shares and This Resale Offering — Our Class A Ordinary Shares may be delisted or prohibited from being traded on a national exchange under the Holding Foreign Companies Accountable Act if the PCAOB is unable to inspect our auditors” on page 31 of this prospectus.

 

Axonex BVI is a BVI holding company and has no operations of its own. It conducts substantially all of its operations in Hong Kong through the Operating Subsidiaries. Axonex BVI may rely on dividends or payments to be paid by the Operating Subsidiaries to fund its cash and financing requirements, including the funds necessary to pay dividends and other cash distributions to our shareholders and U.S. investors, to service any debt we may incur, and to pay our operating expenses. If our Operating Subsidiaries incur debt on their own behalf in the future, the instruments governing the debt may restrict their ability to pay dividends or make other distributions to us. Cash is transferred through our organization in the following manner: (i) funds are transferred from Axonex BVI, our holding company incorporated in the BVI, to our Operating Subsidiaries through CKL Holding Limited (“CKL”), Axonex AI Limited (“Axonex AI”) and/or Aspiration X Limited (“Aspiration X”), our intermediate holding companies incorporated in the BVI (collectively, the “Intermediate Holding Companies”), in the form of capital contributions or loans, as the case may be; and (ii) dividends or other distributions may be paid by our Operating Subsidiaries to Axonex BVI through our Intermediate Holding Companies. If Axonex BVI intends to distribute dividends to its shareholders, it will depend on the payment of dividends from the Operating Subsidiaries to Axonex BVI through the Intermediate Holding Companies in accordance with the laws and regulations of the relevant jurisdiction, and the dividends will be distributed by Axonex BVI to all shareholders in proportion to the shares they hold, regardless of whether the shareholders are U.S. investors or investors in other countries or regions.

 

 

 

 

There is no restriction under the BVI Act on the amount of funding that Axonex BVI may provide to its subsidiaries through loans, provided that such provision of funds is in the best interests of, and of commercial benefit to, Axonex BVI. Our Hong Kong Operating Subsidiaries are also permitted under the laws of Hong Kong to provide funding to Axonex BVI through dividend distributions or payments without any restrictions on the amount of the funds, subject to the applicable provisions under the Companies Ordinance (Chapter 622 of the Laws of Hong Kong). According to the Companies Ordinance (Chapter 622 of the Laws of Hong Kong), a Hong Kong company may only make a distribution out of profits available for distribution.

 

We can distribute accumulated and realized profits (so far as not previously utilized by distribution or capitalization) available for distribution less our accumulated loss (to the extent that they have not been previously written off in a reduction or reorganization of capital) by dividends from our Operating Subsidiaries in Hong Kong to Axonex BVI, and in turn to our shareholders and U.S. investors, provided that Axonex BVI remains solvent after such distribution. Subject to the BVI Act and our memorandum and articles of association, our board of directors may, by resolutions of directors, authorize, and declare a dividend to shareholders from time to time and of an amount they deem fit if they are satisfied, on reasonable grounds, that immediately after the distribution, the value of our assets will exceed our liabilities, and we will be able to pay our debts as they fall due in the ordinary course of business. Other than the above, we have not adopted, nor do we maintain any cash management policies and procedures as of the date of this prospectus.

 

Furthermore, as of the date of this prospectus, there are no restrictions or limitations under the laws of Hong Kong imposed on the conversion of Hong Kong dollars into foreign currencies and the remittance of currencies out of Hong Kong, or foreign exchange transferring cash between Axonex BVI and its subsidiaries in Hong Kong, across borders and to U.S. investors, nor are there any restrictions or limitations on the distribution of earnings from our business and subsidiaries in Hong Kong to Axonex BVI and U.S. investors or on the payment of amounts owed. While based on our understanding, the current laws and regulations of Mainland China have no impact on our ability to transfer cash or assets among Axonex BVI, our Intermediate Holding Companies and our Hong Kong Operating Subsidiaries or to U.S. investors, if certain Mainland Chinese laws and regulations, including existing laws and regulations and those to be enacted or promulgated in the future, were to become applicable to us, and to the extent our cash or assets are in Hong Kong or with a Hong Kong entity (such as our Operating Subsidiaries incorporated in Hong Kong), such cash or assets may not be available to fund operations or for other use outside of Hong Kong due to the Mainland Chinese government’s interventions in, or imposition of restrictions or limitations on, the ability of Axonex BVI, our Intermediate Holding Companies, or our Hong Kong Operating Subsidiaries to transfer cash and/or assets. In addition, we cannot assure you that the Mainland Chinese government will not intervene or impose restrictions on Axonex BVI, our Intermediate Holding Companies, or our Hong Kong Operating Subsidiaries to transfer or distribute cash or assets within the organization, which could result in an inability of, or prohibition on, making transfers or distributions to entities outside of Hong Kong.

 

Any limitation, if imposed in the future, on the ability of our subsidiaries to make payments to us could have a material adverse effect on our ability to conduct our business and could materially decrease the value of our Class A Ordinary Shares or cause them to be worthless. The promulgation of new laws or regulations, or the new interpretation of existing laws and regulations, in each case, that restrict or otherwise unfavorably impact the ability or way we conduct our business, could require us to change certain aspects of our business to ensure compliance, which could decrease demand for our services, reduce revenues, increase costs, require us to obtain more licenses, permits, approvals or certificates, or subject us to additional liabilities. To the extent any new or more stringent measures are required to be implemented, our business, financial condition and results of operations could be adversely affected, and such measures could materially decrease the value of our Class A Ordinary Shares, potentially rendering them worthless. See “Risk Factors — Risks Relating to Our Corporate Structure — We rely on dividends and other distributions on equity paid by our subsidiaries to fund any cash and financing requirements we may have. In the future, to the extent funds or assets in the business are in Hong Kong or a Hong Kong entity, the funds or assets may not be available to fund operations or for other uses outside of Hong Kong, due to interventions in, or the imposition of restrictions and limitations on, our or our Hong Kong Operating Subsidiaries’ ability by the Mainland Chinese government to transfer cash or assets. Any limitation on the ability of our subsidiaries to make payments to us could have a material adverse effect on our ability to conduct our business and might materially decrease the value of our Class A Ordinary Shares or cause them to be worthless” on page 28 of this prospectus for further details.

 

 

 

 

For the fiscal years ended March 31, 2026, 2025 and 2024, the cash flows and transfers of assets between Axonex BVI and its subsidiaries, and among its subsidiaries, were as follows:

 

During the fiscal year ended March 31, 2026,

 

  (i) Axonex BVI transferred approximately HK$3,000,000 (US$384,615.38) to Matter International for repayment of intercompany balance; HK$5,000,000 (US$641,025.64) to Axonex Intelligence HK as intercompany loan; and HK$200,000 (US$25,641.03) to Grand Engineering as intercompany loan;

 

  (ii) Matter International transferred approximately HK$20,000 (US$2,564.10) to Axonex BVI for operating expenses;

 

  (iii) Axonex Intelligence HK transferred approximately HK$51,239.44 (US$6,569.16) to Matter International for settlement of expense paid;

 

  (iv) Matter International transferred approximately HK$600,000 (US$76,923.08) to Grand Engineering for initial operating expenses;

 

During the fiscal year ended March 31, 2025,

 

  (i) Axonex BVI transferred approximately HK$24,000,000 (US$3,080,872.91) to Matter International for payment of expenses;

 

  (ii) Matter International transferred approximately HK$790,000 (US$101,412.07) to Axonex BVI for expenses related to our initial public offering.

 

These transfers were made as intercompany loans, for the repayment thereof, or for payment of expenses and not as dividend payments or distributions. Neither Axonex BVI nor its subsidiaries have declared or made any dividend payment or distribution to their respective shareholder(s) for the fiscal years ended March 31, 2026, 2025 and 2024.

 

As of the date of this prospectus, we do not have any plans to declare or pay any dividends on our Ordinary Shares in the foreseeable future. We currently intend to keep all available funds and future earnings, if any, for the operation and expansion of our business. Any future determination related to our dividend policy will be made at the discretion of our board of directors after considering our financial condition, results of operations, capital requirements, contractual requirements, business prospects and other factors the board of directors deems relevant, and subject to the restrictions contained in any future financing instruments. For a more detailed discussion of how cash is transferred among Axonex BVI and its subsidiaries, see “Prospectus Summary — Transfers of Cash to and from Our Subsidiaries” on page 12 of this prospectus.

 

We are an “emerging growth company” under the federal securities laws and will be subject to reduced public company reporting requirements. See “Prospectus Summary — Implications of Being an Emerging Growth Company” on page 15 of this prospectus for additional information.

 

Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

 

The date of this prospectus is             , 2026.

 

 

 

 

TABLE OF CONTENTS

 

    Page
ABOUT THIS PROSPECTUS   ii
CONVENTIONS THAT APPLY TO THIS PROSPECTUS   iii
SPECIAL NOTES REGARDING FORWARD-LOOKING STATEMENTS   vi
PROSPECTUS SUMMARY   1
THE OFFERING   27
RISK FACTORS   28
USE OF PROCEEDS   42
DIVIDEND POLICY   43
PRINCIPAL SHAREHOLDERS   44
SELLING SHAREHOLDERS   46
PLAN OF DISTRIBUTION   48
DESCRIPTION OF SHARE CAPITAL   50
TAXATION   59
ENFORCEABILITY OF CIVIL LIABILITIES   66
LEGAL MATTERS   67
EXPERTS   67
WHERE YOU CAN FIND ADDITIONAL INFORMATION   67
INCORPORATION OF CERTAIN INFORMATION BY REFERENCE   68

 

You should rely only on the information contained in this prospectus and the documents we incorporate by reference in this prospectus. We have not authorized anyone to provide you with different information, and if given, the information must not be relied upon as having been authorized by us. We do not take any responsibility for, and cannot provide any assurance as to the reliability of, any other information that others may give you. We are not making an offer to sell the securities in any jurisdiction where the offer or sale thereof is not permitted or where the person making the offer or sale is not qualified to do so or to any person to whom it is not permitted to make such offer or sale. The information contained in this prospectus is accurate only as of the respective date of such information, regardless of the time of delivery of this prospectus or of any sale or offer to sell hereunder. You should not assume that the information appearing in this prospectus and the registration statement to which this prospectus is a part is accurate as of any date other than the date on the front cover of this prospectus. Our business, financial condition, results of operations, and prospects may have changed since that date.

 

i

 

 

ABOUT THIS PROSPECTUS

 

This prospectus is part of a registration statement on Form F-1 that we file with the SEC using a continuous offering process. Under this continuous offering process, the Selling Shareholders may, from time to time, offer and sell up to an aggregate of 4,319,802 Class A Ordinary Shares in the manner as described in the section titled “Plan of Distribution” beginning on page 48 of this prospectus.

 

Except as otherwise set forth in this prospectus, we have not taken any action to permit a public offering of these securities outside the United States or to permit the possession or distribution of this prospectus outside the United States. Persons outside the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of these securities and the distribution of this prospectus outside the United States.

 

For investors outside of the United States, we have not done anything that would permit this resale offering or the possession or distribution of this prospectus in any jurisdiction, other than the United States, where action for that purpose is required. Persons outside of the United States who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of our Class A Ordinary Shares and the distribution of this prospectus outside of the United States.

 

To the extent this prospectus and the documents incorporated by reference into this prospectus contain summaries of the documents referred to herein or therein, you are directed to the actual documents for complete information. All of the summaries are qualified in their entirety by the actual documents. Copies of some of the documents referred to herein have been filed, or will be filed, as exhibits to the registration statement of which this prospectus forms a part, and you may obtain copies of such documents as described below in the section titled “Where You Can Find Additional Information” on page 67 of this prospectus.

 

Certain market data and forecasts used throughout this prospectus and the documents incorporated by reference into this prospectus were obtained from internal company surveys, market research, consultant surveys, reports of governmental and international agencies and industry publications and surveys, as well as estimates by our management based on such data. Industry publications and third-party research, surveys and reports generally indicate that their information has been obtained from sources believed to be reliable. While we believe that these data are reliable, we have not independently verified the data, and the accuracy and completeness of such data is not guaranteed. Such data and estimates involve several assumptions and limitations, and you are cautioned not to give undue weight to such data and estimates. Forecasts and other forward-looking information obtained from these sources are subject to the same qualifications and uncertainties as the other forward-looking statements in this prospectus and the documents incorporated by reference into this prospectus, and are subject to risks due to a variety of factors, including those described under the section titled “Risk Factors” beginning on page 28 of this prospectus. These and other factors could cause results to differ materially from those expressed in the estimates made by the independent parties and by us.

 

This prospectus and the documents incorporated by reference into this prospectus contain trademarks, service marks and trade names of others. All trademarks, service marks and trade names appearing in this prospectus are, to our knowledge, the property of their respective owners. We do not intend our use or display other companies’ trademarks, service marks or trade names to imply a relationship with, or endorsement or sponsorship of us by, any other person.

 

ii

 

 

CONVENTIONS THAT APPLY TO THIS PROSPECTUS

 

Unless otherwise indicated or the context otherwise requires, references in this prospectus to:

 

  ● “2026 Annual Report” refers to the Company’s most recent annual report on Form 20-F for the fiscal year ended March 31, 2026 filed with the SEC on August 14, 2026;
     
  ● “Amended and Restated Memorandum and Articles of Association” refers to the Sixth Amended and Restated Memorandum and Articles of Association of Axonex BVI, adopted by a resolution of directors passed on November 3, 2026 and filed with the Registry of Corporate Affairs of the BVI on November 4, 2026;
     
  ● “Axonex AI” refers to Axonex AI Limited (formerly known as Aspiration Group Limited), a company incorporated in the BVI with limited liability, which is a direct wholly owned subsidiary of Axonex BVI and serves as the intermediate holding company for Axonex Intelligence HK, Axonex Intelligence Singapore, Axonex Robotics, and 25% equity interest in YAS JV;  
     
  ● “Aspiration X” refers to Aspiration X Limited, a company incorporated in the BVI with limited liability, which is a direct wholly owned subsidiary of Axonex BVI and serves as the intermediate holding company for 54% equity interest in Rice JV;  
     
  ● “Axonex Automation” refers to Axonex Automation Limited, a company incorporated in Hong Kong with limited liability, and an indirect wholly owned subsidiary of Axonex BVI through Axonex AI and Axonex Intelligence HK. As of the date of this prospectus, it has not yet commenced business;  
     
  ● “Axonex Intelligence HK” refers to Axonex Intelligence Limited, a company incorporated in Hong Kong with limited liability, and an indirect wholly owned subsidiary of Axonex BVI through Axonex AI;  
     
  ● “Axonex Intelligence Singapore” refers to Axonex Intelligence Pte. Ltd., a company incorporated in Singapore with limited liability, and an indirect wholly owned subsidiary of Axonex BVI through Axonex AI;  
     
  ● “Axonex Robotics” refers to Axonex Robotics Limited, a company incorporated in Hong Kong with limited liability, in which Axonex BVI indirectly holds a 60% equity interest through Axonex AI;  
     
  ● “BVI” refers to the British Virgin Islands;
     
  ● “BVI Act” refers to the BVI Business Companies Act, 2004 (as amended) of the BVI;  
     
  ● “China” or the “PRC” refers to the People’s Republic of China, including Taiwan, Hong Kong and the Macau Special Administrative Region of the People’s Republic of China for the purposes of this prospectus only;
     
  ● “CKL Holding” refers to CKL Holding Limited, a company incorporated in the BVI with limited liability, which is a direct wholly owned subsidiary of Axonex BVI and serves as the intermediate holding company for Matter International, Grand Engineering, and Spark Interiors;  
     
  ● “Class A Ordinary Shares” refers to the Class A ordinary shares of Axonex BVI, with no par value, each carrying one (1) vote per share;  
     
  ● “Class B Ordinary Shares” refers to the Class B ordinary shares of Axonex BVI, with no par value, each carrying twenty (20) votes per share;  
     
  ● “Company”, “our Company” or “Axonex BVI” refers to Axonex AI Group Limited (formerly known as Mint Incorporation Limited), a BVI business company incorporated in the BVI with limited liability;  
     
  ● “Exchange Act” refers to the U.S. Securities Exchange Act of 1934, as amended;  

 

iii

 

 

  ● “Grand Engineering” refers to Grand Engineering and Construction Limited, a company incorporated in Hong Kong with limited liability, and an indirect wholly owned subsidiary of Axonex BVI through CKL Holding;  
     
  ● “HK$” or “Hong Kong dollars” refers to Hong Kong dollars, the lawful currency of Hong Kong;

 

  ●“Hong Kong” refers to the Hong Kong Special Administrative Region of the PRC;

 

●“Interior Design and Fit-Out Subsidiaries” refers collectively to Matter International, Grand Engineering, and Spark Interiors, being subsidiaries of the Company principally engaged in interior design and fit-out business activities;

 

  ● “Intermediate Holding Companies” refers collectively to CKL Holding, Axonex AI, and Aspiration X;  
     
  ● “Joint Venture Entities” refers collectively to Axonex Robotics, the Rice JV Group, and YAS JV, being the joint venture entities of the Group;

 

  ● “Mainland China” refers to the mainland of China, excluding Taiwan, Hong Kong and the Macau Special Administrative Region of the People’s Republic of China for the purposes of this prospectus only;
     
  ● “Matter International” refers to Matter International Limited (formerly known as Matter Interiors Limited), a company incorporated in Hong Kong with limited liability, and an indirect wholly owned subsidiary of Axonex BVI through CKL Holding;  
     
  ● “Operating Subsidiaries” refers collectively to the Matter International, Grand Engineering, Spark Interiors, Axonex Intelligence HK, Axonex Intelligence Singapore, Axonex Robotics, and Rice JV HK, being operating subsidiaries of the Company;  
     
  ● “Ordinary Shares” refers collectively to the Class A Ordinary Shares and the Class B Ordinary Shares;  
     
  ● “Rice HK” refers to Rice Robotics (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability, in which Axonex BVI indirectly holds a 54% equity interest through Aspiration X and Rice JV;  
     
  ● “Rice JV” refers to Rice Robotics AGI Holding Limited, a company incorporated in the BVI with limited liability, in which Axonex BVI indirectly holds a 54% equity interest through Aspiration X;  
     
  ● “Rice JV Group” refers collectively to Rice JV and its direct wholly owned subsidiaries, namely, (i) Rice HK; (ii) Rice Robotics KK, a joint stock corporation (Kabushiki Kaisha) organized under the laws of Japan; and (iii) Rice AI Holding Limited, a company incorporated in the BVI with limited liability;  
     
  ● “Rice JV HK” refers collectively to Rice JV and Rice HK;
     
  ● “Robotics and AI Subsidiaries” refers collectively to Axonex Intelligence HK, Axonex Intelligence Singapore, Axonex Automation (which has not commenced business), Axonex Robotics, and the Rice JV Group, being subsidiaries of the Company principally engaged in robotics and artificial intelligence business activities;  
     
  ● “SEC” or the “Commission” refers to the U.S. Securities and Exchange Commission;  
     
  ● “Securities Act” refers to the U.S. Securities Act of 1933, as amended;  
     
  ● “Spark Interiors” refers to Spark Interiors Limited, a company incorporated in Hong Kong with limited liability, and an indirect wholly owned subsidiary of Axonex BVI through CKL Holding;
     
  ● “US$”, “$” or “U.S. dollars” refers to United States dollars, the lawful currency of the United States;  
     
  ● “U.S.” or the “United States” refers to the United States of America;

 

iv

 

 

  ● “we”, “us”, “our”, “our Group” or the “Group” refers to Axonex AI Group Limited and its subsidiaries, taken as a whole, except where the context otherwise requires; and
     
  ●

“YAS JV” refers to YAS Robotics Limited, a company incorporated in Hong Kong with limited liability, in which Axonex BVI indirectly holds a 25% equity interest through Axonex AI and YAS Digital Group Limited holds the remaining 75% equity interest. The Group’s equity interest in YAS JV is accounted for as investment, and the financial results of YAS JV are not consolidated with those of the Group.

 

Axonex BVI is a holding company and conducts substantially all of its operations in Hong Kong through its Operating Subsidiaries in Hong Kong. Axonex BVI’s reporting currency is the United States dollar (“US$” or “$”). The functional currency of Axonex BVI’s Operating Subsidiaries in Hong Kong is the Hong Kong dollar (“HK$”). This prospectus contains translations of certain foreign currency amounts into U.S. dollars at specified rates solely for the convenience of the reader. Assets and liabilities denominated in foreign currencies are translated at year-end exchange rates, income statement accounts are translated at average rates of exchange for the year and equity is translated at historical exchange rates. Any translation gains or losses are recorded in other comprehensive income (loss). Gains or losses resulting from foreign currency transactions are included in net income. The conversion of Hong Kong dollars into U.S. dollars is based on the exchange rates set forth in the H.10 statistical release of the Board of Governors of the Federal Reserve System. Unless otherwise noted, all translations from Hong Kong dollars to U.S. dollars and from U.S. dollars to Hong Kong dollars in this prospectus were made at the following rates:

 

   For the years ended
March 31,
 
   2026   2025   2024 
Average rate   7.80    7.79    7.82 

 

   As of
March 31,
 
   2026   2025   2024 
Year-end spot rate   7.84    7.78    7.83 

 

No representation is made that the HK$ amounts could have been, or could be, converted, realized or settled into US$ at such rate, or at any other rate.

 

We have made rounding adjustments to some of the figures included in this prospectus. Accordingly, numerical figures shown as totals in some tables may not be an arithmetic aggregation of the figures that precede them.

 

v

 

 

SPECIAL NOTES REGARDING FORWARD-LOOKING STATEMENTS

 

This prospectus and the documents incorporated by reference into this prospectus may contain forward-looking statements that involve risks and uncertainties, including statements based on our current or then current expectations, intent, belief, assumptions, estimates and projections about us and our industry. Forward-looking statements are based on our management’s beliefs and assumptions and on information currently available to our management. These statements involve known and unknown risks, uncertainties and other factors that may cause our actual results, performance or achievements to be materially different from those expressed or implied by the forward-looking statements. In some cases, these forward-looking statements can be identified by words or phrases such as “may,” “will,” “expect,” “anticipate,” “aim,” “estimate,” “intend,” “plan,” “believe,” “potential,” “continue,” “is/are likely to” or other similar expressions. These risks and uncertainties include factors that relate to, among others:

 

●future financial and operating results, including revenues, income, expenditures, cash balances and other financial items;

 

●our ability to execute our growth, expansion and acquisition strategies, including our ability to meet our goals;

 

●current and future economic and political conditions;

 

●our expectations regarding demand for and market acceptance of our subsidiaries’ services;

 

●our expectations regarding the expansion of our subsidiaries’ customer base;

 

●our subsidiaries’ relationships with their business partners;

 

●competition in our industries;

 

●relevant government policies and regulations relating to our industries;

 

●our ability to obtain and maintain all necessary government certifications, approvals, and/or licenses to conduct our business;

 

●ability to managing our growth effectively;

 

●our capital requirements and our ability to raise any additional financing which we may require;

 

●our subsidiaries’ ability to protect their intellectual property rights and secure the right to use other intellectual property that they deem to be essential or desirable to the conduct of their business;

 

●the dependence on our senior management and key employees;

 

●our ability to hire and retain qualified management personnel and key employees in order to develop our subsidiaries’ business;

 

●overall industry and market performance; and

 

●other assumptions described in this prospectus underlying or relating to any forward-looking statements.

 

You should refer to the section titled “Risk Factors” beginning on page 28 of this prospectus for a discussion of the important factors that may cause our actual results to differ materially from those expressed or implied by our forward-looking statements. These risks are not exhaustive. We operate in an evolving environment. New risks may emerge from time to time, and it is impossible for our management to predict all risk factors, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ from those contained in any forward-looking statement.

 

As a result of these factors, we cannot assure you that the forward-looking statements in this prospectus will prove to be accurate. Furthermore, if our forward-looking statements prove to be inaccurate, the inaccuracy may be material. In light of the significant uncertainties in these forward-looking statements, you should not regard these statements as representations or warranties by us or any other person that we will achieve our objectives and plans in any specified time frame, or at all. Forward-looking statements speak only as of the date they are made, and we do not undertake any obligation to update them in light of new information or future developments or to release publicly any revisions to these statements in order to reflect later events or circumstances or to reflect the occurrence of unanticipated events.

 

You should read this prospectus and the documents incorporated by reference into this prospectus completely and with the understanding that our actual future results may be materially different from what we expect. We qualify all of our forward-looking statements by these cautionary statements.

 

vi

 

 

PROSPECTUS SUMMARY

 

This summary highlights selected information that is presented in greater detail elsewhere, or is incorporated by reference, in this prospectus. It does not contain all of the information that may be important to you and your investment decision. Before investing in our Class A Ordinary Shares, you should carefully read this entire prospectus, including the matters set forth under the sections titled “Risk Factors”, “Special Notes Regarding Forward-Looking Statements” and the financial statements and related notes and other information that we incorporate by reference herein, including, but not limited to, our 2026 Annual Report and other SEC reports.

 

Business Overview

 

Axonex AI Group Limited is a holding company incorporated in the British Virgin Islands on October 18, 2023. Through our Operating Subsidiaries, we conduct two principal lines of business in Hong Kong and Singapore, with majority of the business operations in Hong Kong: (i) interior design and fit-out services (“Interior Design and Fit-out Services”), and (ii) robotics, artificial intelligence (AI), and technology solutions (“Robotics and AI Solutions”).

 

Since mid-September 2025, the Group has been executing a strategic transition to position itself as a multi-sectoral enterprise that applies robotics, AI, and Internet of Things (IoT) technologies to facility management, automation, and consumer robotics applications. This expansion has been pursued through a combination of newly established wholly owned subsidiaries, joint ventures with technology and robotics partners, and product development initiatives. As of the date of this prospectus, our Robotics and AI Solutions business lines are still at an early stage of development. These business lines contributed approximately 16.78% of our total revenue for the fiscal year ended March 31, 2026, and we have a limited operating history on which to evaluate their prospects. Revenue from these business lines may not grow at the rate we anticipate, may fluctuate significantly between periods as a result of the timing and size of individual engagements, and may not prove sustainable or profitable. Accordingly, our historical results in these business lines are not necessarily indicative of future performance. For a discussion of the risks associated with this business transition, see “Item 3. Key Information — 3.D. Risk Factors — Risks Relating to Our Business and Operations - We may not be able to implement our business strategies and expansion plans, including our strategic expansion into robotics and AI, effectively to achieve future growth” and “Item 3. Key Information — 3.D. Risk Factors — Risks Relating to Our Business and Operations - We may not be successful in integrating newly established or acquired businesses with our existing operations” in our 2026 Annual Report.

 

Interior Design and Fit-out Services

 

We provide interior design and fit-out services principally through our operating subsidiary, Matter International Limited (“Matter International”), which was founded in 2018 and provides integrated interior design and fit-out services to commercial and residential customers in Hong Kong. Matter International has a strategic focus on industry-specific interior design and fit-out works for commercial properties. Its commercial portfolio encompasses offices across a range of industries and various categories of retail stores, with each project designed to reflect the customer’s corporate values and brand identity. Matter International has completed projects for internationally recognized retail brands, food and beverage chains, corporate offices, and premises of a leading charitable organization in Hong Kong. It also undertakes bespoke interior design and fit-out works for luxury residential properties.

 

Our interior design and fit-out projects can be broadly categorized into: (i) design-only services, in which we develop tailor-made interior design proposals; and (ii) design and fit-out services, in which we undertake overall project management, coordination, and quality control, and supervise fit-out works carried out by our subcontractors, complemented by ancillary services such as repair and maintenance works and procurement of furniture and fit-out materials.

 

Robotics and AI Solutions

 

Our Robotics ad AI Solutions segment is conducted principally through Axonex Intelligence Limited (“Axonex Intelligence HK”), Axonex Intelligence Pte. Ltd. (“Axonex Intelligence Singapore”), Axonex Automation Limited (“Axonex Automation”, which has not commenced business), together with several joint venture entities of the Group, namely, Axonex Robotics Limited (“Axonex Robotics”) and Rice Robotics AGI Holding Limited and its subsidiaries (collectively, the “Rice JV Group”, together with Axonex Intelligence HK, Axonex Intelligence Singapore, Axonex Automation and Axonex Robotics, the “Robotics and AI Subsidiaries”).

 

1

 

 

Through the Robotics and AI Subsidiaries, we intend to provide total solutions for smart facility management, integrating advanced technologies designed to improve efficiency, safety, and user experience across different property types. The intended capabilities of the Robotics and AI Subsidiaries include:

 

●robotic solutions to automate routine facility management tasks, improve efficiency, and reduce manpower requirements;

 

●object identification and human posture recognition for enhanced security and operational monitoring;

 

●digital twin solutions enabling real-time visualization and management of facilities; and

 

●AI-powered analytics intended to optimize maintenance, space utilization, and resource allocation.

 

In furtherance of these capabilities, through the Robotics and AI Subsidiaries, we are developing a portfolio of AI-enabled hardware products targeting both consumer and enterprise applications. These include but are not limited to: (i) R300, a consumer robotic companion product intended to provide conversational and interactive functionality for personal and household use; (ii) NEX, a humanoid service robot being designed for commercial and industrial productivity applications, including picking, stocking, material handling, and scene-adaptive actions enabled by large language model-based intent recognition and spatial awareness; (iii) the Patrol Series (Autonomous Security & Facility Management Robots), a line of mobile robots designed for security, patrol, and facility management applications across commercial, industrial, and public-space environments, which can provide 24/7 autonomous monitoring with advanced capabilities including facial recognition, illegal parking detection, loitering and unattended object alerts, thermal imaging, smoke/fire detection, and environmental hygiene monitoring (e.g., overflowing bins, faulty lights); and (iv) FLOKI Minibot M1, an AI companion robot with functions such as smart reminders, concierge services and educational tutoring, developed in collaboration with Rice Robotics Holdings Limited, the joint venture partner holding a 12.50% equity interest in Rice JV.

 

The target client base of the Robotics and AI Subsidiaries includes shopping malls, government premises, residential complexes, and warehouses. By leveraging the Group’s design background together with its new technological focus, we intend to offer a holistic approach to property and facility management through the Robotics and AI Subsidiaries.

 

Because our Robotics and AI Solutions business is still at the early stage of commercialization, there can be no assurance the Robotics and AI Subsidiaries will successfully develop or commercialize its product or service offerings, generate meaningful revenue, or achieve profitability. In addition, because Axonex Robotics and the Rice JV Group are partially owned by the Group, our ability to direct their business strategy, financial decisions and operations is subject to the rights of our joint venture partners and the terms of the applicable joint venture arrangements. See “Item 3. Key Information — 3.D. Risk Factors — Risks Relating to Our Business and Operations - We may not be able to implement our business strategies and expansion plans, including our strategic expansion into robotics and AI, effectively to achieve future growth” and “Item 3. Key Information — 3.D. Risk Factors — Risks Relating to Our Business and Operations - The Group’s robotics, AI, and technology business lines are at an early stage of development and may not achieve commercial viability” in our 2026 Annual Report.

 

For the fiscal year ended March 31, 2026, our total revenue was approximately $2.3 million, of which 1.0%, 82.2% and 16.8% were generated from our design only services, design and fit-out services and sales of robotic products, respectively. For the fiscal year ended March 31, 2025, our total revenue was approximately $3.3 million, of which 8.6% and 91.4% were generated from our design only services and design and fit-out services, respectively. For the fiscal year ended March 31, 2024, our total revenue was approximately $4.4 million, of which 17.8% and 82.2% were generated from our design only services and design and fit-out services, respectively.

 

2

 

 

Our Services

 

A brief description of each of our two major types of services for the three fiscal years ended March 31, 2026 is as follows:

 

1. Design Only Services

 

For design only services, our in-house designers understand the needs of individual customers and the industries they are engaged in, conceptualize customers’ design ideas with layout plans and sketches, create tailor-made interior design proposals to cater for individual customers’ industry needs and produce project documentation.

 

The design proposals are first presented to our customers in the form of a two-dimensional drawing executed by software, namely Adobe and AutoCAD, for their consideration. The drawing generally includes proposed layout, concept sketches, materials, colors, and textures to vividly showcase our creation.

 

After several rounds of interactive discussions with our customers and modifications of our interior design proposal, we produce a final design proposal in the form of a three-dimensional (“3D”) technical drawing with the assistance of computer-aided design (“CAD”) systems. A 3D CAD system produces the geometry of the site on which individual parts, including rooms, fixtures and furniture can be assembled to represent our final design.

 

2. Design and Fit-out Services

 

Design and fit-out services comprise both the abovementioned design services and our fit-out services. It constitutes a majority of our projects for the fiscal years ended March 31, 2026, 2025 and 2024.

 

For fit-out services, our project managers observe the progress of their responsible projects and closely supervise the work of subcontractors through regular on-site visits and quality inspections. Their work extends from the commencement of our services, the delivery of the certificate of completion and until the follow-up rectification of defects during the defects liability period of six to twelve months.

 

Our interior fit-out services typically involve: (i) overall project management of the interior fit-out works, which involves design implementation, planning, coordination, monitoring and on-site supervision throughout the project and during the defects liability period for rectification of defects; (ii) supervision of the construction and installation of interior fit-out works carried out by our subcontractors; (iii) procurement and supply of carpentry/joinery and integral furniture, fixtures and accessories; and (iv) maintenance of the interior fit-out works during the defects liability period for the projects which we undertake on an ad-hoc basis. To a lesser extent, we also provide other services, including repair and maintenance works and procurement of furniture and fit-out materials etc., to our customers.

 

Our Robotics and AI Solutions business is still at an early stage of development. For the fiscal year ended March 31, 2026, we recognized revenue of $384,429 from our Robotics and AI Solutions business, representing 16.8% of our total revenue for the same period. For the fiscal years ended March 31, 2025 and 2024, we did not recognize any revenue from this segment. See “Business Overview - Robotics and AI Solutions” on page 1 of this prospectus for further information.

 

Our Competitive Strengths

 

We believe the following competitive strengths differentiate us from our competitors and support our long-term growth:

 

●Experienced management with cross-sector expertise – We are led by a dedicated management team with extensive industry experience and have a strong and experienced in-house design team. Our management team brings experience across interior design, project management, and technology, positioning the Group to execute its strategy of building complementary businesses that share a common foundation in the built environment. The entrepreneurial approach of our senior leadership underpins the Group’s ability to identify and act on strategic opportunities in a dynamic market environment.

 

●Established operating track record and customer relationships in the Hong Kong interior design and fit-out market – Our interior design and fit-out business has built a portfolio of completed commercial and residential projects across a broad range of industries. Our customer relationships, which are sustained principally through repeat engagements and referrals, reflect the quality and reliability of our project delivery.

 

3

 

 

●Integrated service capability spanning design and execution – We offer customers both standalone design services and end-to-end design and fit-out solutions, giving us flexibility to serve customers at different stages of a project and to capture value across the full project lifecycle. Our in-house design professionals work alongside a network of approved subcontractors, enabling us to scale project delivery without bearing permanent labor overhead.

 

●Joint venture network providing complementary technology and market access – We have formed strategic joint ventures with established technology and robotics partners whose capabilities complement our own, giving the Group access to proprietary technology platforms, specialized technical expertise, and established market relationships that would take significant time and capital to develop independently. These partnerships support accelerated product development and commercialization across multiple technology verticals.

 

Our Business Strategies

 

We intend to execute the following key strategies:

 

●Stabilize and grow the interior design and fit-out operations – We intend to continue investing in our interior design capabilities, including strengthening our in-house design team, broadening our customer base, and improving customer retention. Our interior design and fit-out business has an operating history dating to 2018 and serves as the revenue foundation of the Group. We aim to pursue higher-value commercial and residential projects that offer better margin profits, and to reduce our dependence on a small number of major customers by broadening our pipeline of new client engagements.

 

●Expand our geographic reach on a selective basis – While our operations are currently centered in Hong Kong, we have begun to establish a presence in Singapore, where (i) in October 2025, we incorporated Axonex Intelligence Singapore as an indirect wholly owned subsidiary engaged in software and application development; and (ii) in June 2026, we entered into a non-binding memorandum of understanding (the “Ascendze MOU”) with Ascendze Pte. Ltd. (“Ascendze”), a Singapore-based semiconductor and industrial automation company, expressing our intent to acquire a controlling or majority equity interest. At the time of our initial public offering, we contemplated growing our presence in overseas markets, including by establishing branch offices in New York and London and other cities in the United States and the United Kingdom, subject to the availability of sufficient manpower, business opportunities, and development. We have continued to evaluate expansion into the United States and the United Kingdom, but during the fiscal year ended March 31, 2026, we prioritized the development of our technology business lines and our presence in Singapore, and we have not established any branch office in the United States or the United Kingdom as of the date of this prospectus. Other than as described above, as of the date of this prospectus, we do not have committed plans or timelines for expansion into any other specific new market, and there can be no assurance that the transactions contemplated by the Ascendze MOU will be consummated or that any geographic expansion will be realized.

 

●Expand and deepen Robotics and AI commercialization – Since mid-2025, we have been developing a portfolio of AI, robotics, and smart facility management businesses that we believe address a growing demand for technology-driven solutions in property operations and building management across Hong Kong and the Asia Pacific region. We intend to invest in commercializing these capabilities, growing the customer base for our technology products, and expanding deployments in Hong Kong and other markets in the region. The pace and scale of this expansion will depend on the commercial performance of our technology products and our ability to secure the necessary resources, and there can be no assurance that our technology businesses will achieve commercial viability or generate meaningful revenue within any particular timeframe.

 

●Pursue strategic partnerships and joint ventures to accelerate capability development – We have formed a number of joint ventures with technology and robotics partners to access their capabilities in areas including robotics design, digital twin technology, drone automation, and consumer AI applications. We intend to continue evaluating strategic partnership opportunities that can accelerate product development, provide access to proprietary technology, and extend our geographic reach, where we believe such partnerships are consistent with the Group’s strategic direction and offer a reasonable prospect of commercial return. We will approach such opportunities with discipline, prioritizing partnerships where the Group’s contribution and the terms of arrangement are clearly defined. There can be no assurance that our existing or future joint ventures will achieve their intended objectives or generate commercial returns.

 

4

 

 

●Pursue selective acquisitions – We may pursue acquisitions of businesses or assets that are complementary to our existing operations across interior design, construction, and technology. Any such acquisitions will be evaluated on the basis of strategic fit, financial return, and integration risk. In June 2026, we entered into the Ascendze MOU with Ascendze expressing our intent to acquire a controlling or majority equity interest in Ascendze. Other than as described above, as of the date of this prospectus, we have not identified any specific acquisition opportunities, and there can be no assurance that the transactions contemplated by the Ascendze MOU or any other acquisitions will be completed on the contemplated terms, or at all.

 

Corporate History and Structure

 

The following diagram illustrates our corporate structure as of the date of this prospectus:

 

 

 

Axonex AI Group Limited was incorporated on October 18, 2023, as a BVI business company with limited liability under the laws of the BVI. As of the date of this prospectus, the Company is authorized to issue an unlimited number of shares of no par value each divided into unlimited class A ordinary shares of no par value each and unlimited class B ordinary shares of no par value each, of which 6,076,338 Class A Ordinary Shares and 280,752 Class B Ordinary Shares are issued and outstanding as of the date of this prospectus. Axonex BVI is an investment holding company and is currently not actively engaging in any business.

 

CKL Holding Limited was incorporated on October 27, 2023, as a BVI business company with limited liability under the laws of the BVI. CKL Holding is a direct wholly owned subsidiary of Axonex BVI and an investment holding company with no active operations of its own. CKL Holding serves as the intermediate holding company for Matter International, Grand Engineering, and Spark Interiors.

 

Matter International Limited (formerly known as Matter Interiors Limited) was incorporated on November 16, 2018, as a private company limited by shares under the laws of Hong Kong. It is the Group’s principal interior design and fit-out operating subsidiary and is held indirectly through CKL Holding. On September 15, 2025, Matter Interiors Limited changed its name to Matter International Limited.

 

Axonex AI Limited (formerly known as Aspiration Group Limited) was incorporated on March 5, 2025, as a BVI business company with limited liability under the laws of the BVI. Axonex AI is a direct wholly owned subsidiary of Axonex BVI and an investment holding company with no active operations of its own. Axonex AI serves as the intermediate holding company for Axonex Intelligence HK, Axonex Intelligence Singapore, Axonex Robotics, and 25% equity interest in YAS JV.

 

5

 

 

Grand Engineering and Construction Limited was incorporated on February 10, 2025, as a private company limited by shares under the laws of Hong Kong. It was transferred into the Group as an indirect wholly owned subsidiary through CKL Holding on August 7, 2025, for administrative purposes and nominal consideration. Grand Engineering is principally engaged in the provision of building works and related construction services in Hong Kong.

 

Axonex Intelligence Limited (formerly known as Smartland Capital Limited) was incorporated on January 10, 2025, as a private company limited by shares under the laws of Hong Kong. It was transferred into the Group as an indirect wholly owned subsidiary through Axonex AI on August 7, 2025, for administrative purposes and nominal consideration. On August 6, 2025, Smartland Capital Limited was renamed Axonex Intelligence Limited. Axonex Intelligence HK is principally engaged in the provision of smart facility management solutions integrating robotics, IoT, and AI technologies, serving enterprises, real estate operators, shopping centers, and government agencies in Hong Kong and across the Asia Pacific region.

 

Aspiration X Limited was incorporated on October 3, 2025, as a BVI business company with limited liability under the laws of the BVI. Aspiration X is a direct wholly owned subsidiary of Axonex BVI and an investment holding company with no active operations of its own. Aspiration X serves as the intermediate holding company for 54% equity interest in Rice JV and is the vehicle through which the Group pursues its robotics and physical AI partnerships.

 

Axonex Intelligence Pte. Ltd. was incorporated on October 24, 2025, as a private company limited by shares under the laws of Singapore. Axonex Intelligence Singapore is an indirect wholly owned subsidiary of Axonex BVI through Axonex AI, and is principally engaged in software and application development.

 

Axonex Robotics Limited was incorporated on October 30, 2025, as a private company limited by shares under the laws of Hong Kong. Axonex BVI indirectly holds 60% of its issued share capital through Axonex AI. Axonex Robotics focuses principally on robotics design.

 

Spark Interiors Limited was incorporated on December 23, 2025, as a private company limited by shares under the laws of Hong Kong. Spark Interiors is an indirect wholly owned subsidiary of Axonex BVI through CKL Holding, and is principally engaged in the provision of interior design and fit-out services with a focus on residential customers.

 

Axonex Automation Limited was incorporated on March 3, 2026, as a private company limited by shares under the laws of Hong Kong. Axonex Automation is an indirect wholly owned subsidiary of Axonex BVI through Axonex Intelligence HK. As of the date of this prospectus, it is not actively engaging in any business.

 

Rice Robotics AGI Holding Limited was incorporated on May 20, 2026, as a BVI business company with limited liability under the laws of the BVI. Axonex BVI indirectly holds 54% of its issued share capital through Aspiration X. Rice JV in turn owns the entire issued share capital of (i) Rice Robotics (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability; (ii) Rice Robotics KK, a joint stock corporation (Kabushiki Kaisha) organized under the laws of Japan; and (iii) Rice AI Holding Limited, a company incorporated in the BVI with limited liability. The Rice JV Group focuses principally on the development and sales of AI companion robots.

 

YAS Robotics Limited was incorporated on September 28, 2022, as a private company limited by shares under the laws of Hong Kong and a wholly owned subsidiary of YAS Digital Group Limited (“YAS Digital”). On June 9, 2026, Axonex BVI and Axonex AI entered into a joint venture agreement with YAS Digital in respect of YAS JV (the “YAS JV Agreement”). Pursuant to the YAS JV Agreement, on June 29, 2026, YAS Digital transferred 25% of the issued and outstanding shares of YAS JV to Axonex AI, following which YAS JV became a joint venture entity of the Group in which we hold a 25% equity interest and YAS Digital holds the remaining 75%. YAS JV focuses principally on the development, marketing, and distribution of robotics and AI-related insurance products.

 

6

 

 

Recent Developments

 

Initial Public Offering (References to share and per share data described in this subsection have not been adjusted to give effect to the May 2026 Reverse Stock Split or the October 2026 Reverse Stock Split)

 

On January 8, 2025, the Company entered into an underwriting agreement (the “Underwriting Agreement”) with Benjamin Securities, Inc., as the representative of the underwriters named therein (the “Underwriters”), pursuant to which the Company agreed to sell to the Underwriters in a firm commitment initial public offering (the “IPO”) an aggregate of 1,750,000 Class A Ordinary Shares at an offering price of $4.00 per share. The Company received $8.05 million in gross proceeds from the IPO and the full exercise of the over-allotment option in connection therewith (the “Over-Allotment Option”), before deducting underwriting discounts and other estimated expenses payable by the Company.

 

Exercise of the Over-allotment Option (References to share and per share data described in this subsection have not been adjusted to give effect to the May 2026 Reverse Stock Split or the October 2026 Reverse Stock Split)

 

On January 10, 2025, the Underwriters exercised the Over-Allotment Option in full to purchase an additional 262,500 Class A Ordinary Shares. On January 13, 2025, the Company closed the IPO and the Over-Allotment Option.

 

The 2025 Stock Incentive Plan (References to share and per share data described in this subsection have not been adjusted to give effect to the May 2026 Reverse Stock Split or the October 2026 Reverse Stock Split)

 

In March 2025, the Company adopted the 2025 Stock Incentive Plan (the “2025 Incentive Plan”), for the purpose of granting share-based compensation awards to employees, directors and consultants to incentivize their performance and align their interests with ours. Under the 2025 Incentive Plan, we are authorized to issue an aggregate of 2,400,000 Class A Ordinary Shares. As of the date of this prospectus, the Company issued a total of 2,000,000 Class A Ordinary Shares to consultants of the Company as compensation for their continued service to the Company, and 400,000 Class A Ordinary Shares to an employee of the Company as performance bonus under the 2025 Incentive Plan.

 

Nasdaq Listing Rule 5550(a)(2) Deficiency and Reverse Stock Split, May 2026 (References to share and per share data described in this subsection have not been adjusted to give effect to the October 2026 Reverse Stock Split)

 

The Company received a written notification on December 19, 2025 from the Listing Qualifications Department of Nasdaq stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of US$1.00 per share for at least 30 consecutive business days (the “Minimum Bid Price Requirement”). The Company was granted a 180-calendar-day compliance period, through June 17, 2026, to regain compliance with the Minimum Bid Price Requirement, that is the closing bid price for our Class A Ordinary Shares must be at least $1.00 for a minimum of 10 consecutive business days. In the event the Company does not regain compliance by June 17, 2026, we are eligible for an additional 180-calendar-day period to regain compliance with the Minimum Bid Price Requirement.

 

On March 31, 2026, the board of directors of the Company approved a reverse stock split of all of the Company’s authorised shares, including the Class A Ordinary Shares and Class B Ordinary Shares, at a consolidation ratio of one (1) share for ten (10) shares (the “May 2026 Reverse Stock Split”). The May 2026 Reverse Stock Split was intended for the Company to regain compliance with the Minimum Bid Price Requirement. The May 2026 Reverse Stock Split took effect on April 8, 2026 upon completion of the necessary filing with the Registrar of Corporate Affairs of the British Virgin Islands. On May 6, 2026, our Class A Ordinary Shares began trading on Nasdaq on a post- May 2026 Reverse Stock Split basis under the then existing ticker symbol “MIMI”. On May 20, 2026, we received formal notification from Nasdaq indicating that the Company has regained compliance with the Minimum Bid Price Requirement.

 

Issuance of Class B Ordinary Shares, May 2026 (References to share and per share data described in this subsection have not been adjusted to give effect to the October 2026 Reverse Stock Split)

 

On May 18, 2026, the Company entered into a share purchase agreement (the “May 2026 Share Purchase Agreement”) with Deep Vision Enterprise Limited (“Deep Vision”), pursuant to which the Company issued and sold to Deep Vision 211,879 Class B Ordinary Shares (the “May 2026 Class B Shares”) at a purchase price of US$3.01 per share for an aggregate gross proceeds of HK$5,000,000 (equivalent to US$637,755.10 based on the exchange rate of HK$7.84 to US$1.00 agreed by the parties in the May 2026 Share Purchase Agreement) (the “May 2026 Class B Share Issuance”).

 

As of the date of the May 2026 Share Purchase Agreement and this prospectus, Deep Vision is a principal shareholder of the Company and is wholly owned by Mr. Hoi Lung CHAN, the Chairman of the Board and Chief Executive Officer of the Company. The transactions contemplated in the May 2026 Share Purchase Agreement constituted related party transactions of the Company and were approved by the board of directors and the audit committee of the Company, who each determined that the terms thereof were fair to, and in the best interests of, the Company and its shareholders.

 

On May 26, 2026, the Company issued the May 2026 Class B Shares to Deep Vision.

 

No placement agents were involved in the May 2026 Class B Share Issuance. The securities issued in the May 2026 Class B Share Issuance were exempt from the registration requirements of the Securities Act pursuant to Regulation S promulgated thereunder or Section 4(a)(2) thereof.

 

7

 

 

Private Placement of Class A Ordinary Shares, July 2026 (References to share and per share data described in this subsection have not been adjusted to give effect to the October 2026 Reverse Stock Split)

 

On July 2, 2026, the Company entered into securities purchase agreements (collectively, the “July 2026 PIPE Agreements”) with certain new investors and existing shareholders of the Company (each a “PIPE Investor”, and collectively, the “PIPE Investors”), pursuant to which the Company agreed to issue and sell to the PIPE Investors an aggregate of 4,310,350 Class A Ordinary Shares (the “July 2026 PIPE Shares”) at a purchase price of US$ 0.464 per share, representing 20% of the closing price of the Class A Ordinary Shares on the Nasdaq Capital Market on July 1, 2026, for an aggregate purchase price of US$2,000,000 (the “July 2026 PIPE”). On July 8, 2026, the Company issued the July 2026 PIPE Shares to the PIPE Investors.

 

The Company received a total of $2,000,000 in gross proceeds from the July 2026 PIPE. The Company intends to use the proceeds from the July 2026 PIPE for working capital and general corporate purposes.

 

Pursuant to the July 2026 PIPE Agreements, the Company has agreed to file a registration statement with the SEC registering the resale of the July 2026 PIPE Shares by the PIPE Investors within 60 calendar days following the closing of the July 2026 PIPE on July 8, 2026, and to use its reasonable best efforts to cause such registration statement to be declared effective by the SEC as promptly as practicable thereafter (the “Registration Requirement”).

 

On August 26, 2026, the Company entered into Amendment No. 1 to the July 2026 PIPE Agreement with each of the PIPE Investors (collectively, the “Amendments No. 1”). Pursuant to the Amendments No. 1, the Registration Requirement was amended to require the Company to file a registration statement with the SEC registering the resale of the July 2026 PIPE Shares by the PIPE Investors within 60 calendar days following the closing of the August 2026 PIPE (as defined below) on August 11, 2026. The Amendments No. 1 further provide that such resale registration statement may cover the resale of the Class A Ordinary Shares issued by the Company to other investors in one or more separate transactions. On October 7, 2026, the Company entered into an amendment to the July 2026 PIPE Agreements and the August 2026 PIPE Agreements with each of the PIPE Investors, which constitutes Amendment No. 2 to the July 2026 PIPE Agreements and Amendment No. 1 to the August 2026 PIPE Agreements (collectively, the “Amendments No. 2”). Pursuant to Amendments No. 2, the deadline by which the Company was required to file such resale registration statement was extended to March 31, 2027. Amendments No. 2 further provide that such resale registration statement may cover the resale of the Class A Ordinary Shares issued by the Company to other investors in one or more separate transactions. Except as amended by Amendments No. 1 and No. 2, the July 2026 PIPE Agreements remain in full force and effect in accordance with their original terms.

 

This prospectus forms a part of such registration statement. For the avoidance of doubt, the PIPE Investors are the Selling Shareholders named in this prospectus. Such registration statement also covers 64,000 Class A Ordinary Shares (after giving effect to the October 2026 Reverse Stock Split) that two of the Selling Shareholders acquired from an existing shareholder of the Company in private transactions in January 2026, which we have elected to include. See the section titled “Selling Shareholders” on page 46 of this prospectus for details.

 

No placement agents were involved in the July 2026 PIPE. The July 2026 PIPE Shares issued in the July 2026 PIPE were exempt from the registration requirements of the Securities Act pursuant to Regulation S promulgated thereunder or Section 4(a)(2) thereof.

 

Private Placement of Class A Ordinary Shares, August 2026 (References to share and per share data described in this subsection have not been adjusted to give effect to the October 2026 Reverse Stock Split)

 

On July 30, 2026, the Company entered into securities purchase agreements (collectively, the “August 2026 PIPE Agreements”) with the PIPE Investors, all being existing shareholders of the Company at the time, pursuant to which the Company agreed to issue and sell to the PIPE Investors an aggregate of 6,329,115 Class A Ordinary Shares (the “August 2026 PIPE Shares”) at a purchase price of US$0.316 per share, representing 20% of the closing price of the Class A Ordinary Shares on the Nasdaq Capital Market on July 29, 2026, for an aggregate purchase price of US$2,000,000 (the “August 2026 PIPE”). On August 11, 2026, the Company issued the August 2026 PIPE Shares to the PIPE Investors.

 

The Company received a total of $2,000,000 in gross proceeds from the August 2026 PIPE. The Company intends to use the proceeds from the August 2026 PIPE for working capital and general corporate purposes.

 

Pursuant to the August 2026 PIPE Agreements, the Company has agreed to file a registration statement with the SEC registering the resale of the August 2026 PIPE Shares by the PIPE Investors within 60 calendar days following the closing of the August 2026 PIPE on August 11, 2026, and to use its reasonable best efforts to cause such registration statement to be declared effective by the SEC as promptly as practicable thereafter. On October 7, 2026, pursuant to Amendments No. 2, the deadline by which the Company was required to file such resale registration statement was extended to March 31, 2027. Please refer to “Prospectus Summary – Recent Developments – Private Placement of Class A Ordinary Shares, July 2026” above for further information. Except as amended by Amendments No. 2, the August 2026 PIPE Agreements remain in full force and effect in accordance with their original terms.

 

This prospectus forms a part of such registration statement. For the avoidance of doubt, the PIPE Investors in the August 2026 PIPE are also the PIPE Investors in the July 2026 PIPE and the Selling Shareholders named in this prospectus. See the section titled “Selling Shareholders” on page 46 of this prospectus for details.

 

No placement agents were involved in the August 2026 PIPE. The August 2026 PIPE Shares issued in the August 2026 PIPE were exempt from the registration requirements of the Securities Act pursuant to Regulation S promulgated thereunder or Section 4(a)(2) thereof.

 

Class A Meeting and EGM, August 2026

 

On July 8, 2026, the Company, by written resolution of directors (the “July Board Resolution”), approved the increase of maximum number of authorised shares from 28,000,000 shares divided into 25,200,000 class A ordinary shares and 2,800,000 class B ordinary shares to 280,000,000 shares divided into 252,000,000 class A ordinary shares and 28,000,000 class B ordinary shares, by the addition of 226,800,000 class A ordinary shares and 25,200,000 class B ordinary shares (the “Authorised Share Increase”), with effect upon completion of the necessary filings with the Registrar of Corporate Affairs of the British Virgin Islands.

 

8

 

  

On the same day, holders of class B ordinary shares of the Company (the “Class B Shareholders”), by written resolutions, consents to (the “Class B Consent”), among other things, the increase in the voting rights attaching to each class B ordinary share from twenty (20) votes to two hundred (200) votes on all matters subject to vote at a general meeting (the “Class Rights Variation”), subject to class consent from holders of class A ordinary shares of the Company.

 

On August 18, 2026, the Company held a meeting of the holders of the Class A Ordinary Shares (the “Class A Meeting”), and immediately following the Class A Meeting, an extraordinary general meeting of shareholders (the “EGM”, together with the Class A Meeting, the “Meetings”). Pursuant to the Meetings, each of the proposals relating to Class Rights Variation and the adoption of the third amended and restated memorandum and articles of association of the Company reflecting both the Class Rights Variation and the Authorised Share Increase (the “Third Amended M&A”) was approved, both with effect upon completion of the necessary filings with the Registrar of Corporate Affairs of the British Virgin Islands.

 

On August 24, 2026, prior to the filings with the Registrar of Corporate Affairs of the British Virgin Islands relating to the Authorised Share Increase and the adoption of Third Amended M&A, the Class B Shareholders withdrew and rescinded the Class B Consent in its entirety. On the same day, the board of directors, by written resolution (the “August 24 Board Resolution”), also resolved that the July Board Resolution authorizing the filings with the Registrar of Corporate Affairs of the British Virgin Islands relating to the Authorized Shares Increase and the Third Amended M&A, and as the conditions to the approved proposals at the Meetings and the requirements for Class Rights Variation provided in the memorandum of association are no longer satisfied, the Class Rights Variation and the Third Amended M&A in the form approved at the EGM will not be implemented and no filings with the Registrar of Corporate Affairs of the British Virgin Islands will be made in this regard. Each then Class B Ordinary Share continues to carry twenty (20) votes.

 

Increase in Authorized Share Capital

 

Furthermore, the board of directors of the Company, by the August 24 Board Resolution as a new and standalone resolution aside from the July 8 Board Resolution, approved the Authorised Share Increase (in each case, without giving effect to the October 2026 Reverse Stock Split, following which our authorized share capital is 112,000,000 shares of no par value, divided into 100,800,000 Class A Ordinary Shares and 11,200,000 Class B Ordinary Shares), and the revised form of Third Amended M&A reflecting the Authorised Share Increase (without the Class Rights Variation). Both the Authorised Share Increase and Third Amended M&A took effect on August 25, 2026 upon completion of the filings with the Registrar of Corporate Affairs of the British Virgin Islands.

 

Registered Direct Offering of Class A Ordinary Shares and Pre-Funded Warrants, August 2026 (References to share and per share data described in this subsection have not been adjusted to give effect to the October 2026 Reverse Stock Split)

 

On August 27, 2026, the Company entered into a securities purchase agreement with certain institutional investors, pursuant to which the Company agreed to issue and sell in a registered direct offering (the “August 2026 Offering”): (i) 1,400,000 Class A Ordinary Shares (the “Sale Shares”), at a purchase price of $1.00 per Sale Share; and (ii) pre-funded warrants (the “Pre-Funded Warrants”) to purchase up to 1,100,000 Class A Ordinary Shares, at a purchase price of $0.999 per Pre-Funded Warrant (equal to the $1.00 purchase price per Sale Share, less the $0.001 per share exercise price of the Pre-Funded Warrants). On August 28, 2026, the August 2026 Offering was closed.

 

The Pre-Funded Warrants were sold to the purchasers in the August 2026 Offering whose purchase of the Sale Shares would otherwise have resulted in them, together with their affiliates and certain related parties, beneficially owning more than 4.99% or 9.99% (as applicable to the relevant purchaser) of all outstanding Class A Ordinary Shares of the Company immediately following the consummation of the August 2026 Offering. Each Pre-Funded Warrant represents the right to purchase one Class A Ordinary Share at an exercise price of $0.001 per share. The Pre-Funded Warrants are exercisable immediately and may be exercised at any time until exercised in full (subject to the beneficial ownership limitation described above). As of the date of this prospectus, the Pre-Funded Warrants have been fully exercised.

 

The Company received approximately $2.5 million in gross proceeds from the August 2026 Offering, before deducting placement agent fees and estimated offering expenses. The Company intends to use the net proceeds from the August 2026 Offering for working capital and general corporate purposes.

 

In connection with the August 2026 Offering, the Company engaged Maxim Group LLC as exclusive placement agent pursuant to a placement agency agreement dated August 27, 2026. Under the placement agency agreement, the placement agent will receive a cash fee equal to 7.0% of the aggregate gross proceeds raised in the August 2026 Offering, and the Company will reimburse certain offering-related legal fees, costs, and expenses in an amount not exceeding $50,000.

 

The Sale Shares, the Pre-Funded Warrants and the Class A Ordinary Shares underlying the Pre-Funded Warrants were offered by the Company pursuant to the 2026 Shelf Registration Statement, the base prospectus filed as part of the 2026 Shelf Registration Statement, and the prospectus supplement dated August 27, 2026.

 

Proposed Tokenization of Certain Class A Ordinary Shares

 

On September 3, 2026, the Company entered into a consulting agreement (the “CURRENC Consulting Agreement”) with CURRENC Capital Inc. (“CURRENC Capital”), a wholly owned subsidiary of Currenc Group Inc. (Nasdaq: CURR), to support the issuer-sponsored tokenization of a portion of the Company’s issued and outstanding Class A Ordinary Shares on the Ethereum and Solana blockchains. Under the CURRENC Consulting Agreement, CURRENC Capital will provide end-to-end advisory and facilitation support in connection with the proposed tokenization.

 

9

 

 

As of the date of this prospectus, the proposed tokenization has not been completed. Completion of the tokenization remains subject to, among other things, applicable regulatory requirements, and there can be no assurance that it will be completed on the timetable contemplated, or at all.

 

If and when the proposed tokenization is completed, the Company’s Class A Ordinary Shares will continue to trade on the Nasdaq Capital Market and settle in accordance with the ordinary settlement arrangements applicable to Nasdaq-listed securities. The rights attaching to the tokenized Class A Ordinary Shares will remain unchanged and will be governed by the Company’s Amended and Restated Memorandum and Articles of Association together with the tokenization arrangements (without limiting or reducing existing shareholder entitlements). No trading market for the proposed tokens currently exists, or is expected to exist, and there can be no assurance that any such trading market will develop or be permitted.

 

Name and Ticker Change

 

On September 28, 2026, the name of the Company was changed to “Axonex AI Group Limited” upon the issuance of a certificate of change of name by the Registrar of Corporate Affairs of the British Virgin Islands. In connection with the change of name, the Company amended and restated its memorandum and articles of association to reflect the new name.

 

Effective as of the open of market trading on October 13, 2026, the Company’s Class A Ordinary Shares began trading on the Nasdaq Capital Market under the new name and the new ticker symbol “AXNX” (formerly “MIMI”).

 

The name and ticker change reflects the Company’s intended strategic focus on expanding its Robotics and AI Solutions business.

 

Reverse Stock Split, October 2026

 

On October 2, 2026, the board of directors of the Company approved a reverse stock split of all of the Company’s authorised shares, including the Class A Ordinary Shares and Class B Ordinary Shares, at a consolidation ratio of two and a half (2.5) shares-to-one (1) share (the “October 2026 Reverse Stock Split”). Pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iv), if the Company’s Class A Ordinary Shares fail to meet the continued listing requirement for minimum bid price of US$1.00 per share and the Company has effected a reverse stock split over the prior one-year period; or has effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one, then the Company shall not be eligible for any compliance period specified in Rule 5810(c)(3)(A) and the Listing Qualifications Department shall issue a Staff Delisting Determination under Rule 5810 with respect to the Company’s security. Because the Company had already effected a one (1)-for-ten (10) reverse stock split that took effect on April 8, 2026, with our Class A Ordinary Shares beginning to trade on Nasdaq on a post-split basis on May 6, 2026, it would not have been eligible for any compliance period had its Class A Ordinary Shares failed to meet the Minimum Bid Price Requirement. The October 2026 Reverse Stock Split was therefore effected preemptively, to increase the bid price of our Class A Ordinary Shares above US$1.00 before any such failure persisted for 30 consecutive business days. The October 2026 Reverse Stock Split and the relevant fifth amended and restated memorandum and articles of association both took effect on October 9, 2026. The Company will not be provided any compliance period to regain compliance with the Minimum Bid Price Requirement and will receive a Staff Delisting Determination if the closing bid price of our Class A Ordinary Shares is below US$1.00 for 30 consecutive business days, upon which the Company would be entitled to appeal Nasdaq’s determination to a Nasdaq Hearings Panel and request a hearing, in each case until at least October 22, 2027, being one year after our Class A Ordinary Shares began trading on Nasdaq on a post-October 2026 Reverse Stock Split basis. On October 22, 2026, our Class A Ordinary Shares began trading on Nasdaq on a post-October 2026 Reverse Stock Split basis under the current ticker symbol “AXNX”.

 

Change of Authorized Shares, November 2026

 

On November 3, 2026, the Board of Directors of the Company approved, by unanimous written resolutions of directors, a change of the maximum number of shares the Company is authorized to issue. The maximum changes from 112,000,000 shares of no par value, divided into 100,800,000 Class A ordinary shares and 11,200,000 Class B ordinary shares, to an unlimited number of shares of no par value, divided into an unlimited number of Class A ordinary shares and an unlimited number of Class B ordinary shares. The board also adopted a sixth amended and restated memorandum and articles of association of the Company reflecting only this change (the “Sixth Amended M&A”). The Sixth Amended M&A was filed with the Registrar of Corporate Affairs of the British Virgin Islands and became effective on November 4, 2026.

 

Change of Directors and Management

 

On June 11, 2025, Mr. Ving Lung MA notified the Company of his resignation as an independent director, the chair of the Audit Committee, and a member of the Nominating Committee and the Compensation Committee, effective June 11, 2025.

 

On June 13, 2025, Mr. Ka Wai (Taniel) WONG was appointed as an independent director, the chair of the Audit Committee, and a member of the Nominating Committee and the Compensation Committee, effective June 13, 2025.

 

On January 23, 2026, Mr. Cheong Shing KU notified the Company of his resignation as the Chairman of the Board of the Company, effective January 26, 2026. Mr. Ku continues to serve as a director of the Company.

 

10

 

 

On January 26, 2026, Mr. Hoi Lung CHAN was appointed as the Chairman of the Board of the Company, effective January 26, 2026.

 

On January 26, 2026, Mr. Xunze (Tyler) XIU was appointed as an independent director, a member of the Audit Committee, the Nominating Committee and the Compensation Committee, effective January 26, 2026.

 

On April 30, 2026, Ms. Lo Chanii KAM notified the Company of her resignation as an independent director, the chair of the Compensation Committee, and a member of the Audit Committee and the Nominating Committee, effective May 31, 2026.

 

On May 18, 2026, Mr. Xunze (Tyler) XIU was appointed as the chair of the Compensation Committee, effective June 1, 2026.

 

Recent Business Developments

 

Formation of JV with AIMO (HK) Limited

 

On October 30, 2025, Axonex Intelligence Limited, a wholly owned subsidiary of the Company, formed a joint venture, Axonex Robotics Limited (“Axonex Robotics”), with AIMO (HK) Limited (“AIMO”). On July 2, 2026, Axonex Intelligence HK transferred its entire equity interest in Axonex Robotics to Axonex AI Limited, a wholly owned subsidiary of the Company and the intermediate holding company of Axonex Intelligence HK. Axonex Robotics is a private company limited by shares incorporated under the laws of Hong Kong and is indirectly owned as to 60% by the Company through Axonex AI and 40% by AIMO. The Company’s Chairman of the Board and Chief Executive Officer, Mr. Hoi Lung CHAN, serves as the sole director of Axonex Robotics. Axonex Robotics focuses on robotics design.

 

Formation and Discontinuation of JV with Synergy Technology Group Limited

 

On March 2, 2026, Axonex Intelligence Limited, a wholly owned subsidiary of the Company, entered into a joint venture agreement (the “STG JV Agreement”) with Synergy Technology Group Limited (“Synergy”) to establish a joint venture company to be named “Axonex Automation Limited” as a private company limited by shares incorporated under the laws of Hong Kong. Pursuant to the STG JV Agreement, Axonex Automation Limited shall focus on the commercialization and overseas expansion of digital twin and drone flight control technologies, and was expected to be owned as to 80% by Axonex Intelligence HK and 20% by Synergy. On March 3, 2026, Axonex Automation Limited (“Axonex Automation”) was incorporated under the laws of Hong Kong. As of the date of this prospectus, Axonex Automation is 100% owned by Axonex Intelligence HK and has not commenced active business operations. The parties to the STG JV Agreement have mutually agreed to discontinue the joint venture contemplated thereunder.

 

Formation of JV with Rice Robotics Holdings Limited

 

On May 22, 2026, Aspiration X Limited, a wholly owned subsidiary of the Company, entered into a joint venture agreement (the “Rice JV Agreement”) with Rice Robotics Holdings Limited (“Rice Robotics”), pursuant to which the parties agreed to form and operate a joint venture through a BVI business company incorporated under the laws of the BVI named “Rice Robotics AGI Holding Limited”. On May 20, 2026, Rice Robotics AGI Holding Limited (“Rice JV”) was incorporated under the laws of the BVI. Rice JV is owned as to 54% by Aspiration X and 12.5% by Rice Robotics. The board of directors of Rice JV currently consists of two members, one of whom is our Chairman of the Board and Chief Executive Officer, Mr. Hoi Lung CHAN. Rice JV in turn owns the entire issued share capital of (i) Rice Robotics (Hong Kong) Limited, a company incorporated in Hong Kong with limited liability; (ii) Rice Robotics KK, a joint stock corporation (Kabushiki Kaisha) organized under the laws of Japan; and (iii) Rice AI Holding Limited, a company incorporated in the BVI with limited liability (Rice JV together with its subsidiaries, the “Rice JV Group”). The Rice JV Group focuses on the development and sales of the next generation of AI companion robots, and may be expanded or changed from time to time in accordance with the Rice JV Agreement.

 

Formation of JV with YAS Digital Group Limited

 

On September 28, 2022, YAS Robotics Limited (“YAS JV”) was incorporated as a private company limited by shares under the laws of Hong Kong and a wholly owned subsidiary of YAS Digital Group Limited (“YAS Digital”). On June 9, 2026, the Company and Axonex AI Limited, a wholly owned subsidiary of the Company, entered into a joint venture agreement with YAS Digital in respect of YAS JV (the “YAS JV Agreement”). Pursuant to the YAS JV Agreement, on June 29, 2026, YAS Digital transferred 25% of the issued and outstanding shares of YAS JV to Axonex AI, following which YAS JV became a joint venture entity of the Group in which we hold a 25% equity interest and YAS Digital holds the remaining 75%. YAS JV focuses principally on the development, marketing, and distribution of robotics and AI-related insurance products.

 

Non-Binding Memorandum of Understanding with Ascendze Pte. Ltd.

 

On June 30, 2026, the Company entered into a non-binding memorandum of understanding (the “Ascendze MOU”) with Ascendze Pte. Ltd. (“Ascendze”), a Singapore-based company engaged in semiconductor and industrial automation solutions, pursuant to which the Company expressed its intent to acquire a controlling or majority equity interest in Ascendze. The Ascendze MOU contemplates that the parties will negotiate and enter into definitive agreements within 90 days, and the proposed transaction remains subject to, among other things, completion of due diligence, negotiation and execution of definitive agreements, and receipt of all requisite corporate and regulatory approvals. The Ascendze MOU is non-binding, and there can be no assurance that definitive agreements will be entered into or that the proposed transaction will be consummated on the contemplated terms, or at all. As of the date of this prospectus, no definitive agreement has been entered into by the parties.

 

11

 

 

Transfers of Cash to and from Our Subsidiaries

 

Axonex BVI is a BVI holding company and has no operations of its own. It conducts substantially all of its operations in Hong Kong through the Operating Subsidiaries. Axonex BVI may rely on dividends or payments to be paid by the Operating Subsidiaries to fund its cash and financing requirements, including the funds necessary to pay dividends and other cash distributions to our shareholders and U.S. investors, to service any debt we may incur, and to pay our operating expenses. If our Operating Subsidiaries incur debt on their own behalf in the future, the instruments governing the debt may restrict their ability to pay dividends or make other distributions to us. Cash is transferred through our organization in the following manner: (i) funds are transferred from Axonex BVI, our holding company incorporated in the BVI, to our Operating Subsidiaries through CKL Holding Limited (“CKL”), Axonex AI Limited (“Axonex AI”) and/or Aspiration X Limited (“Aspiration X”), our intermediate holding companies incorporated in the BVI (collectively, the “Intermediate Holding Companies”), in the form of capital contributions or loans, as the case may be; and (ii) dividends or other distributions may be paid by our Operating Subsidiaries to Axonex BVI through our Intermediate Holding Companies. If Axonex BVI intends to distribute dividends to its shareholders, it will depend on the payment of dividends from the Operating Subsidiaries to Axonex BVI through the Intermediate Holding Companies in accordance with the applicable laws and regulations of the relevant jurisdictions, and the dividends will be distributed by Axonex BVI to all shareholders in proportion to the shares they hold, regardless of whether the shareholders are U.S. investors or investors in other countries or regions.

 

There is no restriction under the BVI Act on the amount of funding that Axonex BVI may provide to its subsidiaries through loans, provided that such provision of funds is in the best interests of, and of commercial benefit to, Axonex BVI. Our Operating Subsidiaries incorporated in Hong Kong are also permitted under the laws of Hong Kong to provide funding to Axonex BVI through dividend distributions or payments without restrictions on the amount of funds, subject to the applicable provisions under the Companies Ordinance (Chapter 622 of the Laws of Hong Kong). According to the Companies Ordinance (Chapter 622 of the Laws of Hong Kong), a Hong Kong company may only make a distribution out of profits available for distribution.

 

We can distribute accumulated and realized profits (so far as not previously utilized by distribution or capitalization) available for distribution less its accumulated loss (to the extent that they have not been previously written off in a reduction or reorganization of capital) by dividends from our Operating Subsidiaries incorporated in Hong Kong to Axonex BVI, and in turn to our shareholders and U.S. investors, provided that Axonex BVI remains solvent after such distribution. Subject to the BVI Act and our Amended and Restated Memorandum and Articles of Association, our board of directors may, by resolutions of directors, authorize and declare a dividend to shareholders from time to time and of an amount they deem fit if they are satisfied, on reasonable grounds, that immediately after the distribution, the value of our assets will exceed our liabilities, and Axonex BVI will be able to pay its debts as they fall due in the ordinary course of business. Other than the above, we have not adopted, nor do we maintain any cash management policies and procedures as of the date of this prospectus.

 

Under the current practice of the Inland Revenue Department of Hong Kong, no tax is payable in Hong Kong in respect of dividends paid by us.

 

Furthermore, as of the date of this prospectus, there are no restrictions or limitations under the laws of Hong Kong imposed on the conversion of Hong Kong dollars into foreign currencies and the remittance of currencies out of Hong Kong, or foreign exchange transferring cash between Axonex BVI and its subsidiaries in Hong Kong, across borders and to U.S. investors, nor are there any restrictions or limitations under the laws of Hong Kong on the distribution of earnings from our business and subsidiaries in Hong Kong to Axonex BVI and U.S. investors or on the payment of amounts owed. While based on our understanding, the current laws and regulations of Mainland China have no impact on our ability to transfer cash or assets among Axonex BVI, our Intermediate Holding Companies and our Hong Kong Operating Subsidiaries, or to U.S. investors, if certain Mainland Chinese laws and regulations, including existing laws and regulations and those to be enacted or promulgated in the future, were to become applicable to us, and to the extent our cash or assets are in Hong Kong or with a Hong Kong entity (such as our Operating Subsidiaries incorporated in Hong Kong), such cash or assets may not be available to fund operations or for other use outside of Hong Kong due to the Mainland Chinese government’s interventions in, or imposition of restrictions or limitations on, the ability of Axonex BVI, our Intermediate Holding Companies, or our Hong Kong Operating Subsidiaries to transfer cash and/or assets. In addition, we cannot assure you that the Mainland Chinese government will not intervene or impose restrictions on the ability of Axonex BVI, our Intermediate Holding Companies, or our Hong Kong Operating Subsidiaries to transfer or distribute cash or assets within the organization, which could result in an inability of, or prohibition on, making transfers or distributions to entities outside of Hong Kong.

 

12

 

 

Any limitation, if imposed in the future, on the ability of our subsidiaries to make payments to us could have a material adverse effect on our ability to conduct our business and could materially decrease the value of our Class A Ordinary Shares or cause them to be worthless. The promulgation of new laws or regulations, or the new interpretation of existing laws and regulations, in each case, that restrict or otherwise unfavorably impact the ability or way we conduct our business, could require us to change certain aspects of our business to ensure compliance, which could decrease demand for our services, reduce revenues, increase costs, require us to obtain more licenses, permits, approvals or certificates, or subject us to additional liabilities. To the extent any new or more stringent measures are required to be implemented, our business, financial condition and results of operations could be adversely affected, and such measures could materially decrease the value of our Class A Ordinary Shares, potentially rendering them worthless. See “Risk Factors — Risks Relating to Our Corporate Structure — We rely on dividends and other distributions on equity paid by our subsidiaries to fund any cash and financing requirements we may have. In the future, to the extent funds or assets in the business are in Hong Kong or a Hong Kong entity, the funds or assets may not be available to fund operations or for other uses outside of Hong Kong, due to interventions in, or the imposition of restrictions and limitations on, our or our Hong Kong Operating Subsidiaries’ ability by the Mainland Chinese government to transfer cash or assets. Any limitation on the ability of our subsidiaries to make payments to us could have a material adverse effect on our ability to conduct our business and might materially decrease the value of our Class A Ordinary Shares or cause them to be worthless” on page 28 of this prospectus for further details.

 

For the fiscal years ended March 31, 2026, 2025 and 2024, the cash flows and transfers of assets between Axonex BVI and its subsidiaries, and among its subsidiaries, were as follows:

 

During the fiscal year ended March 31, 2026,

 

  (i) Axonex BVI transferred approximately HK$3,000,000 (US$384,615.38) to Matter International for repayment of intercompany balance; HK$5,000,000 (US$641,025.64) to Axonex Intelligence HK as intercompany loan; and HK$200,000 (US$25,641.03) to Grand Engineering as intercompany loan;

 

  (ii) Matter International transferred approximately HK$20,000 (US$2,564.10) to Axonex BVI for operating expenses;

 

  (iii) Axonex Intelligence HK transferred approximately HK$51,239.44 (US$6,569.16) to Matter International for settlement of expense paid;

 

  (iv) Matter International transferred approximately HK$600,000 (US$76,923.08) to Grand Engineering for initial operating expenses;

 

During the fiscal year ended March 31, 2025,

 

  (i) Axonex BVI transferred approximately HK$24,000,000 (US$3,080,872.91) to Matter International for payment of expenses;

 

  (ii) Matter International transferred approximately HK$790,000 (US$101,412.07) to Axonex BVI for expenses related to our initial public offering.

 

These transfers were made as intercompany loans, for the repayment thereof, or for payment of expenses and not as dividend payments or distributions. Neither Axonex BVI nor its subsidiaries have declared or made any dividend payment or distribution to their respective shareholder(s) for the fiscal years ended March 31, 2026, 2025 and 2024.

 

13

 

 

As of the date of this prospectus, we do not have any plans to declare or pay any dividends on our Ordinary Shares in the foreseeable future. We currently intend to keep all available funds and future earnings, if any, for the operation and expansion of our business. Any future determination related to our dividend policy will be made at the discretion of our board of directors after considering our financial condition, results of operations, capital requirements, contractual requirements, business prospects and other factors the board of directors deems relevant, and subject to the restrictions contained in any future financing instruments.

 

Corporate Information

 

Our principal executive office is located at Unit 506-8, 5/F, Laford Centre, 838 Lai Chi Kok Road, Lai Chi Kok, Kowloon, Hong Kong. The telephone number of our principal executive office is +852 3565-1925. Our registered agent in the BVI is Ogier Global (BVI) Limited. Our registered office and our registered agent’s office in the BVI are both located at the office of Ogier Global (BVI) Limited, Ritter House, Wickhams Cay II, PO Box 3170, Road Town, Tortola VG 1110, British Virgin Islands. Our agent for service of process in the United States is Cogency Global Inc., located at 122 E. 42nd Street, 18th Floor, New York, New York 10168. We maintain a website at https://www.axonex.ai/. We do not incorporate the information on our website into this prospectus, and you should not consider any information on, or that can be accessed through, our website as part of this prospectus.

 

The SEC maintains a website at http://www.sec.gov that contains reports, information statements, and other information regarding issuers that file electronically with the SEC.

 

Implications of Being a Foreign Private Issuer

 

We are a foreign private issuer within the meaning of the rules under the U.S. Securities Exchange Act of 1934, as amended (the “Exchange Act”). As such, we are exempt from certain provisions applicable to United States domestic public companies. For example:

 

●we are not required to provide as many Exchange Act reports, or as frequently, as a domestic public company;

 

●for interim reporting, we are permitted to comply solely with our home country requirements, which are less rigorous than the rules that apply to domestic public companies;

 

●we are not required to provide the same level of disclosure on certain issues, such as executive compensation;

 

●we are exempt from provisions of Regulation FD aimed at preventing issuers from making selective disclosures of material information; and

 

●we are not required to comply with the sections of the Exchange Act regulating the solicitation of proxies, consents or authorizations in respect of a security registered under the Exchange Act.

 

Furthermore, Nasdaq Rule 5615(a)(3) provides that a foreign private issuer, such as us, may rely on our home country corporate governance practices in lieu of certain rules in the Nasdaq Rule 5600 Series and Rule 5250(d), provided that we nevertheless comply with Nasdaq’s Notification of Noncompliance requirement (Rule 5625), the Voting Rights requirement (Rule 5640) and that we have an audit committee that satisfies Rule 5605(c)(3), consisting of committee members that meet the independence requirements of Rule 5605(c)(2)(A)(ii). If we rely on our home country corporate governance practices in lieu of certain rules of Nasdaq, our shareholders may not have the same protections afforded to shareholders of companies that are subject to all of the corporate governance requirements of Nasdaq.

 

We are required to file an annual report on Form 20-F within four months of the end of each financial year. As a foreign private issuer, we are not generally required to provide quarterly financial information to shareholders. However, we are required to file an interim balance sheet and income statement as of the end of our second quarter. These interim financial statements are not required to be reconciled to U.S. GAAP, but they must be provided no later than six months following the end of our second quarter. Press releases relating to financial results and material events will also be furnished to the SEC on Form 6-K. However, the information we are required to file with or furnish to the SEC will be less extensive and less timely than that required to be filed with the SEC by U.S. domestic issuers. A foreign private issuer that follows a home country practice in lieu of one or more of the Nasdaq listing rules is required to disclose in its annual reports filed with the SEC each requirement that it does not follow and describe the home country practice followed by the issuer in lieu of such requirements. If we rely on our home country corporate governance practices in lieu of certain of the rules of Nasdaq, our shareholders may not have the same protections afforded to shareholders of companies that are subject to all of the corporate governance requirements of Nasdaq. If we choose to do so, we may utilize these exemptions for as long as we continue to qualify as a foreign private issuer. Although we are permitted to follow certain corporate governance rules that conform to BVI requirements in lieu of many of the Nasdaq corporate governance rules, we intend to comply with the Nasdaq corporate governance rules applicable to foreign private issuers, except that the Company has elected to follow BVI corporate governance practices in lieu of the requirement for shareholder approval prior to transactions other than public offerings under Nasdaq Listing Rule 5635 in connection with the July 2026 PIPE and the August 2026 PIPE.

 

14

 

 

Because we are a foreign private issuer, our members of our board of directors, executive officers and senior management are not subject to short-swing profit recovery rules and short selling prohibition under Sections 16(b) and (c) of the Exchange Act. They will, however, be subject to the obligations under Section 16(a) of the Exchange Act, including the requirement to file public reports regarding their share ownership and trading activities on Forms 3, 4, and 5, as well as the reporting requirements relating changes in share ownership under Section 13 of the Exchange Act and related SEC rules.

 

Implications of Being an Emerging Growth Company

 

As a company with less than US$1.235 billion in revenue during our last fiscal year, we qualify as an “emerging growth company” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. An “emerging growth company” may take advantage of reduced reporting requirements that are otherwise applicable to larger public companies. In particular, as an emerging growth company, we:

 

●are not required to provide a detailed narrative disclosure discussing our compensation principles, objectives and elements and analyzing how those elements fit with our principles and objectives, which is commonly referred to as “compensation discussion and analysis”;

 

●are not required to obtain an attestation and report from our auditors on our management’s assessment of our internal control over financial reporting pursuant to the Sarbanes-Oxley Act of 2002;

 

●are not required to obtain a non-binding advisory vote from our shareholders on executive compensation or golden parachute arrangements (commonly referred to as the “say-on-pay”, “say-on frequency” and “say-on-golden-parachute” votes);

 

●are exempt from certain executive compensation disclosure provisions requiring a pay-for-performance graph and chief executive officer pay ratio disclosure;

 

●are eligible to claim longer phase-in periods for the adoption of new or revised financial accounting standards under Section 107 of the JOBS Act; and

 

●will not be required to conduct an evaluation of our internal control over financial reporting.

 

We intend to take advantage of all of these reduced reporting requirements and exemptions, including the longer phase-in periods for the adoption of new or revised financial accounting standards under Section 107 of the JOBS Act. Our election to use the phase-in periods may make it difficult to compare our financial statements to those of non-emerging growth companies and other emerging growth companies that have opted out of the phase-in periods under Section 107 of the JOBS Act.

 

We will remain an emerging growth company until the earliest of (i) the last day of the fiscal year during which we have total annual gross revenues of at least US$1.235 billion; (ii) the last day of our fiscal year following the fifth anniversary of the completion of the IPO; (iii) the date on which we have, during the preceding three-year period, issued more than US$1.0 billion in non-convertible debt; or (iv) the date on which we are deemed to be a “large accelerated filer” under the U.S. Securities Exchange Act of 1934, as amended, or the Exchange Act, which would occur if the market value of our Class A Ordinary Shares that are held by non-affiliates exceeds US$700.0 million as of the last business day of our most recently completed second fiscal quarter. Once we cease to be an emerging growth company, we will not be entitled to the exemptions provided in the JOBS Act discussed above.

 

15

 

 

Regulatory Development in the PRC

 

We are a holding company incorporated in the BVI, with substantially all of our operations conducted by our Operating Subsidiaries in Hong Kong. We currently do not have, nor do we currently intend to establish, any subsidiary in Mainland China, nor do we plan to enter into any contractual arrangements to establish a VIE structure with any entity in Mainland China.

 

Hong Kong is a special administrative region of the PRC, and the basic policies of the PRC regarding Hong Kong are reflected in the Basic Law, which serves as Hong Kong’s constitution. The Basic Law provides Hong Kong with a high degree of autonomy and executive, legislative, and independent judicial powers, including that of final adjudication under the principle of “one country, two systems”. According to Article 18 of the Basic Law, Mainland Chinese laws and regulations shall not currently be applied in Hong Kong except for those listed in Annex III of the Basic Law, which is confined to laws relating to national defense, foreign affairs and other matters that are not within the scope of autonomy, such as the laws relating to the national flag, national anthem, and diplomatic privileges and immunities. Accordingly, we believe that the Mainland Chinese laws and regulations on cybersecurity, data security, and the oversight and control over overseas securities offerings do not currently have any material impact on our business, financial condition, or results of operations. However, there is no assurance that there will not be any changes in the economic, political, and legal environment of Hong Kong in the future. If there is a significant change to current political arrangements between Mainland China and Hong Kong, companies operating in Hong Kong may face similar regulatory risks as those operated in Mainland China, including restrictions on their ability to offer securities to investors, list their securities on a U.S. or other foreign exchange, and conduct their business or accept foreign investment. In light of Mainland China’s recent expansion of authority in Hong Kong, there are risks and uncertainties which we cannot foresee for the time being, and rules, regulations and the enforcement of laws in Mainland China can change quickly with little or no advance notice. The Mainland Chinese government may intervene or influence the current and future operations in Hong Kong at any time or may exert more oversight and control over offerings conducted overseas and/or foreign investment in issuers like us.

 

We are aware that, in recent years, the Mainland Chinese government initiated a series of regulatory actions and statements to regulate business operations in certain areas in Mainland China with little advance notice, including cracking down on illegal activities in the securities market, enhancing supervision over Mainland China-based companies listed overseas using a VIE structure, adopting new measures to extend the scope of cybersecurity reviews, and expanding the efforts in anti-monopoly enforcement. This indicated the Mainland Chinese government’s intent to exert more oversight and control over offerings that are conducted by overseas and/or foreign investments in Mainland China-based issuers. Since these statements and regulatory actions are relatively new, and given the uncertainties arising from the legal systems in Mainland China and Hong Kong, including uncertainties regarding the interpretation and enforcement of Mainland Chinese laws and regulations and the authority of the Mainland Chinese government to intervene or influence offshore holding companies headquartered in Hong Kong, there remains significant uncertainty in the interpretation and enforcement of Mainland China laws and regulations. It is also highly uncertain what existing or new laws or regulations or detailed implementations and interpretations will be modified or promulgated by the PRC government, rendering Mainland Chinese law and regulations being applicable to offshore holding companies headquartered in Hong Kong and resulting in an impact on our daily business operation, our ability to accept foreign investments, and the continued listing of our Class A Ordinary Shares on a U.S. or other foreign exchanges. These actions could result in a material change in our operations and/or the value of our Class A Ordinary Shares and could significantly limit or completely hinder our ability to offer or continue to offer our Class A Ordinary Shares to investors.

 

Cybersecurity Review

 

On August 20, 2021, the 30th meeting of the Standing Committee of the 13th National People’s Congress voted and passed the “Personal Information Protection Law of the People’s Republic of China” (the “PIPL”), which became effective on November 1, 2021. The PIPL applies to the processing of personal information of natural persons within the territory of Mainland China that is carried out outside of Mainland China where (i) such processing is for the purpose of providing products or services for natural persons within Mainland China, (ii) such processing is to analyze or evaluate the behavior of natural persons within Mainland China, or (iii) there are any other circumstances stipulated by related laws and administrative regulations.

 

16

 

 

On December 28, 2021, the CAC jointly with the relevant authorities formally published the Measures for Cybersecurity Review (2021), which took effect on February 15, 2022 and replaced the former Measures for Cybersecurity Review (2020) issued on July 10, 2021 (the “Cybersecurity Review Measures”). The Cybersecurity Review Measures provide that operators of critical information infrastructure purchasing network products and services, and online platform operators carrying out data processing activities that affect or may affect national security (together with the operators of critical information infrastructure, the “Operators”), shall conduct a cybersecurity review, and that any online platform operator who controls more than one million users’ personal information must go through a cybersecurity review by the cybersecurity review office if it seeks to be listed in a foreign country. The publication of the Cybersecurity Review Measures expands the application scope of cybersecurity review to cover data processors in Mainland China and indicates greater oversight by the CAC over data security in Mainland China.

 

Our Operating Subsidiaries may collect and store data (including certain personal information) from their customers, some of whom may be individuals in Mainland China, in connection with our business and operations and for “Know Your Customers” purposes (to combat money laundering). Based on our understanding, we do not expect the Cybersecurity Review Measures to have an impact on our business or operations, given that (i) our Hong Kong Operating Subsidiaries are incorporated in Hong Kong; (ii) we have no subsidiary, VIE structure, nor any direct operations in Mainland China; and (iii) pursuant to the Basic Law, which is a national law of the PRC and the constitutional document for Hong Kong, laws and regulations of the Mainland China shall not be applied in Hong Kong except for those listed in Annex III of the Basic Law (which is confined to laws relating to defense and foreign affairs, as well as other matters outside the autonomy of Hong Kong). Moreover, based on our understanding, we believe that our Operating Subsidiaries will not be deemed an “Operator” who is required to file for cybersecurity review before listing in the United States, because as of the date of this prospectus, (i) our Hong Kong Operating Subsidiaries are incorporated and operates in Hong Kong without any subsidiary or VIE structure in Mainland China and each of the PIPL and the Cybersecurity Review Measures does not clearly provide whether it shall be applied to a company based in Hong Kong; (ii) our Operating Subsidiaries have in aggregate collected and stored personal information of less than one million users; (iii) all of the data our Operating Subsidiaries have collected is stored in servers located in Hong Kong; and (iv) neither the Company nor our Operating Subsidiaries have been informed by any PRC governmental authority of any requirement that we should file for a cybersecurity review with the CAC.

 

Data Security Law

 

The “Data Security Law of the People’s Republic of China” (the “DSL”) which was promulgated by the Standing Committee of the National People’s Congress on June 10, 2021 and took effect on September 1, 2021, requires data collection to be conducted in a legitimate and proper manner, and stipulates that, for the purpose of data protection, data processing activities must be conducted based on data classification and hierarchical protection system for data security. According to Article 2 of the DSL, DSL applies to data processing activities within the territory of Mainland China as well as data processing activities conducted outside the territory of Mainland China that jeopardize the national interest or the public interest of the PRC or the rights and interests of any PRC organization and citizens. Any entity failing to perform the obligations provided in the DSL may be subject to orders to correct, warnings and penalties, including ban or suspension of business, revocation of business licenses or other penalties. As of the date of this prospectus, we do not have any operations or maintain any office or personnel in Mainland China, and we have not conducted any data processing activities that may endanger the national interest or the public interest of the PRC or the rights and interests of any PRC organization and citizens. Therefore, based on our understanding, we do not believe that the DSL is applicable to us.

 

CSRC Filing or Approval

 

On August 8, 2006, six Mainland Chinese regulatory agencies jointly adopted the Regulations on Mergers and Acquisitions of Domestic Enterprises by Foreign Investors (the “M&A Rules”), which came into effect on September 8, 2006, and were amended on June 22, 2009. The M&A Rules requires that an offshore special purpose vehicle formed for overseas listing purposes and controlled directly or indirectly by Mainland Chinese citizens shall obtain the approval of the CSRC prior to overseas listing and trading of such special purpose vehicle’s securities on an overseas stock exchange.

 

17

 

 

On July 6, 2021, the General Office of the Central Committee of the Communist Party of China and the General Office of the State Council jointly issued the Opinions on Strictly Cracking Down on Illegal Securities Activities. The Opinions on Strictly Cracking Down on Illegal Securities Activities emphasized the need to strengthen the administration over illegal securities activities, and the need to strengthen the supervision over overseas listings by Mainland China-based companies. Pursuant to the Opinions on Strictly Cracking Down on Illegal Securities Activities, Mainland Chinese regulators are required to accelerate rulemaking related to the overseas issuance and listing of securities, and update the existing laws and regulations related to data security, cross-border data flow, and management of confidential information. Numerous regulations, guidelines and other measures are expected to be adopted under the umbrella of or in addition to the cybersecurity law and data security law. As of the date of this prospectus, no official guidance or related implementation rules have been issued. As a result, the Opinions on Strictly Cracking Down on Illegal Securities Activities remain unclear on how they will be interpreted, amended and implemented by the relevant PRC governmental authorities.

 

On December 24, 2021, the CSRC, together with other relevant government authorities in Mainland China, issued the Provisions of the State Council on the Administration of Overseas Securities Offering and Listing by Domestic Companies (Draft for Comments), and the Measures for the Filing of Overseas Securities Offering and Listing by Domestic Companies (Draft for Comments) (collectively, the “Draft Overseas Listing Regulations”). The Draft Overseas Listing Regulations require that overseas issuance and listing, which shall include direct and indirect issuance and listing, shall complete the filing procedures and submit the relevant information to the CSRC. Where an enterprise whose principal business activities are conducted in Mainland China seeks to issue and list its shares in the name of an overseas issuer on the basis of the equity, assets, income, or other similar rights and interests of the relevant Mainland China domestic enterprise, such activities shall be deemed an indirect overseas issuance and listing under the Draft Overseas Listing Regulations.

 

On February 17, 2023, the CSRC published the Trial Administrative Measures of Overseas Securities Offering and Listing by Domestic Companies and five supporting guidelines, which came into effect on March 31, 2023 (collectively, the “Trial Administrative Measures”). Among others, the Trial Administrative Measures provide that Mainland Chinese domestic companies seeking to offer and list securities (which, for the purposes of the Trial Administrative Measures, are defined thereunder as equity shares, depository receipts, corporate bonds convertible to equity shares, and other equity securities that are offered and listed overseas, either directly or indirectly, by Mainland Chinese domestic companies) in overseas markets, either via direct or indirect means, must file with the CSRC within three working days after their application for an overseas listing is submitted. According to the Trial Administrative Measures, any overseas securities offering and listing made by an issuer that meets both the following conditions will be determined as indirect overseas securities offering and listing by a Mainland Chinese domestic company: (i) 50% or more of the issuer’s operating revenue, total profit, total assets or net assets as documented in its audited consolidated financial statements for the most recent fiscal year is accounted for by domestic companies; and (ii) the main parts of the issuer’s business activities are conducted in Mainland China, or its main places of business are located in Mainland China, or the majority of senior management in charge of its business operations and management are Mainland Chinese citizens or domiciled in Mainland China. In addition, if a company is subject to the filing requirement with the CSRC, such company’s future securities offerings in the same overseas market or subsequent securities offering and listing in other overseas markets shall also be subject to the filing requirement with the CSRC, which shall be completed within three working days after the offering is completed or after the relevant application is submitted to the relevant overseas authorities, respectively.

 

As of the date of this prospectus, we have no operations in Mainland China, and we do not own or control any Mainland Chinese entity, including any subsidiary or VIE structure in Mainland China. Our Hong Kong Operating Subsidiaries are incorporated, located, and operates, in Hong Kong, a special administrative region of the PRC. Based on our understanding of current PRC laws and regulations, as of the date of this prospectus, we and our Hong Kong Operating Subsidiaries are not “domestic companies” as defined under the Trial Administrative Measures, and our Hong Kong Operating Subsidiaries’ operations in Hong Kong and the offering and listing of our securities in the United States are not subject to the review nor prior permission or approval of the PRC authorities, including the CSRC and CAC. Moreover, as of the date of this prospectus, neither the CSRC, the CAC nor any other PRC regulatory agency or administration has contacted the Company in connection with the Group’s operations in Hong Kong and the offering and listing of the Class A Ordinary Shares on Nasdaq. Therefore, we believe that, as of the date of this prospectus, the Mainland Chinese government does not exert direct influence and discretion over the manner in which we conduct our business activities in Hong Kong outside of Mainland China. We do not expect to be materially affected by recent statements by the Mainland Chinese government indicating an intent to exert more oversight and control over overseas and/or foreign investment in Mainland China-based issuers.

 

18

 

 

However, since recent statements, laws and regulatory actions by the Mainland Chinese government are newly published, their interpretation, application, and enforcement are unclear and there also remains significant uncertainty as to the enactment, interpretation and implementation of other regulatory requirements related to overseas securities offerings and other capital markets activities. It remains uncertain whether the Mainland Chinese government will adopt additional requirements or extend the existing requirements to apply to our Operating Subsidiaries located in Hong Kong. It is also uncertain whether the Hong Kong government will be mandated by the Mainland Chinese government, despite the constitutional constraints of the Basic Law, to control offerings conducted overseas and/or foreign investment of entities in Hong Kong, including our Operating Subsidiaries in Hong Kong. In light of Mainland China’s recent expansion of authority in Hong Kong, there are risks and uncertainties which we cannot foresee for the time being, and rules, regulations, and the enforcement of laws in the PRC can change quickly with little or no advance notice. The Mainland Chinese government may intervene or influence the current and future operations in Hong Kong at any time, or may exert more oversight and control over overseas and/or foreign investment in issuers like us. Any actions by the Mainland Chinese government to exert more oversight and control over overseas and/or foreign investments in Hong Kong-based issuers could significantly limit or completely hinder our ability to offer or continue to offer securities to investors. If there is any significant change to current political arrangements between Mainland China and Hong Kong, or the applicable laws, regulations, or interpretations change, and, in such event, if we are required to obtain such approvals in the future, or if we inadvertently conclude that such approvals are not required, and we do not receive such approvals or is denied permission from Mainland China or Hong Kong authorities, we will not be able to maintain our listing on a U.S. exchange, or continue to offer securities to investors, which would materially affect the interests of the investors and cause the value of our Class A Ordinary Shares to significantly decline or become worthless.

 

Permissions required from Hong Kong and Mainland Chinese authorities

 

Based on our understanding of current Hong Kong laws and regulations, as of the date of this prospectus, we and our Hong Kong Operating Subsidiaries are not required to obtain any permissions or approvals from Hong Kong authorities to maintain our listing in the United States and issue our Class A Ordinary Shares to foreign investors. No such permissions or approvals have been applied for by the Company and/or its subsidiaries or denied by any relevant authorities. As of the date of this prospectus, apart from business registration certificates, we and our Hong Kong Operating Subsidiaries are not required to obtain any permission or approval from Hong Kong authorities to operate our business. Our Hong Kong Operating Subsidiaries have received all requisite permissions or approvals from the Hong Kong authorities to operate their business in Hong Kong, including but not limited to their business registration certificates.

 

Based on our understanding of current Mainland Chinese laws and regulations, as of the date of this prospectus, neither the Company nor its subsidiaries are required to obtain permissions or approvals from, or submit filings with, any Mainland Chinese authorities, including the CSRC and CAC, for maintaining our listing in the United States and issuing our Class A Ordinary Shares to foreign investors, or to operate our business as currently conducted, because: (i) the CSRC currently has not issued any definitive rule or interpretation concerning whether listings like ours are subject to the Trial Administrative Measures; (ii) our Hong Kong Operating Subsidiaries were established and operate in Hong Kong, which is not within the definition of a “domestic company” for the purposes of the Trial Administrative Measures; (iii) we do not own or control any Mainland Chinese entity, including any subsidiary or VIE structure in Mainland China, and we do not have any operations in Mainland China; and (iv) businesses conducted by our Hong Kong Operating Subsidiaries are not included in the categories of industries and companies whose foreign securities offerings are subject to review by the CSRC or the CAC. No permissions or approvals have been applied for by us or denied by any relevant Mainland Chinese authority.

 

However, there is no assurance that there will not be any changes in the economic, political, and legal environment in Hong Kong in the future. Uncertainties still exist due to the possibility that laws, regulations, or policies in Hong Kong could change rapidly in the future. In the event that the operation of us or our Operating Subsidiaries in Hong Kong were to become subject to Mainland Chinese laws and regulations, the legal and operational risks associated in Mainland China may also apply to our operations in Hong Kong, and we may face the risks and uncertainties associated with the legal system in Mainland China, its complex and evolving Mainland Chinese laws and regulation, and as to whether and how the recent Mainland Chinese government statements and regulatory developments, such as those relating to data and cyberspace security and anti-monopoly concerns, would be applicable to companies like our Operating Subsidiaries in Hong Kong and us, given the substantial operations of our Operating Subsidiaries in Hong Kong and that the Mainland Chinese government may exercise significant oversight over the conduct of business in Hong Kong.

 

19

 

 

In the event that (i) the Mainland Chinese government expanded the categories of industries and companies whose foreign securities offerings are subject to review by the CSRC or the CAC and that we are required to obtain such permissions or approvals, (ii) we inadvertently concluded that relevant permissions or approvals were not required or that we did not receive or maintain relevant permissions or approvals required, or (iii) applicable laws, regulations, or interpretations change and require us to obtain such permissions or approvals in the future, we may face regulatory risks associated with companies operating in Mainland China, including restrictions on the ability to offer securities to investors, maintain listing on a U.S. or other foreign exchanges, conduct business or accept foreign investment, or sanctions by the CSRC, the CAC, or other Mainland Chinese regulatory agencies. Any action taken by the Mainland Chinese government could significantly limit or completely hinder our operations in Hong Kong and our ability to offer or continue to offer securities to investors and could cause the value of such securities to significantly decline or be worthless.

 

Holding Foreign Companies Accountable Act

 

The Holding Foreign Companies Accountable Act, or the HFCA Act, was enacted on December 18, 2020. The HFCA Act states if the SEC determines that we have filed audit reports issued by a registered public accounting firm that has not been subject to inspection by the PCAOB for three consecutive years beginning in 2021, the SEC shall prohibit our shares from being traded on a national securities exchange or in the over-the-counter trading market in the United States.

 

On March 24, 2021, the SEC adopted interim final rules relating to the implementation of certain disclosure and documentation requirements of the HFCA Act. A company will be required to comply with these rules if the SEC identifies it as having a “non-inspection” year under a process to be subsequently established by the SEC. On June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act (the “AHFCA Act”), which was signed into law on December 29, 2022, amending the HFCA Act and requiring the SEC to prohibit an issuer’s securities from trading on any U.S. stock exchange if its auditor is not subject to PCAOB inspections for two consecutive years instead of three consecutive years. On September 22, 2021, the PCAOB adopted a final rule implementing the HFCA Act, which provides a framework for the PCAOB to use when determining, as contemplated under the HFCA Act, whether the PCAOB is unable to inspect or investigate completely registered public accounting firms located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction. On December 2, 2021, the SEC issued amendments to finalize rules implementing the submission and disclosure requirements in the HFCA Act. The rules apply to registrants that the SEC identifies as having filed an annual report with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that the PCAOB is unable to inspect or investigate completely because of a position taken by an authority in a foreign jurisdiction. On December 16, 2021, the PCAOB issued a Determination Report (the “2021 Determination Report”) which found that the PCAOB is unable to inspect or investigate completely registered public accounting firms headquartered in: (i) Mainland China, and (ii) Hong Kong.

 

On August 26, 2022, the PCAOB announced and signed a Statement of Protocol (the “Protocol”) with the CSRC and the MOF. The Protocol provides the PCAOB with: (1) sole discretion to select the firms, audit engagements and potential violations it inspects and investigates, without any involvement of Chinese authorities; (2) procedures for PCAOB inspectors and investigators to view complete audit work papers with all information included and for the PCAOB to retain information as needed; (3) direct access to interview and take testimony from all personnel associated with the audits the PCAOB inspects or investigates.

 

On December 15, 2022, the PCAOB issued a new Determination Report (the “2022 Determination Report”) which: (1) vacated the 2021 Determination Report; and (2) concluded that the PCAOB had been able to conduct inspections and investigations completely in the PRC in 2022. The 2022 Determination Report cautions, however, that authorities in the PRC might take positions at any time that would prevent the PCAOB from continuing to inspect or investigate completely. As required by the HFCA Act, if in the future the PCAOB determines it can no longer inspect or investigate completely because of a position taken by an authority in the PRC, the PCAOB will act expeditiously to consider whether it should issue a new determination.

 

20

 

 

Our auditor, WWC, P.C., the independent registered public accounting firm that issues the audit report incorporated herein by reference, as a firm headquartered in California and registered with the PCAOB, is subject to laws in the United States pursuant to which the PCAOB conducts regular inspections to assess our auditor’s compliance with the applicable professional standards, with the last inspection having occurred in December 2025. As of the date of this prospectus, our auditor is not subject to, and is not affected by, the 2021 Determination Report (which was vacated by the PCAOB on December 15, 2022) and the trading prohibitions of the HFCA Act.

 

However, in the event it is later determined that the PCAOB is unable to inspect or investigate completely our auditor because of a position taken by an authority in a foreign jurisdiction, such as the PRC authorities, then such lack of inspection could cause trading in the Company’s securities to be prohibited under the HFCA Act, and ultimately result in a determination by a securities exchange to delist the Company’s securities. Furthermore, as more stringent criteria have been imposed by the SEC and the PCAOB, recently, we cannot assure you whether Nasdaq or other regulatory authorities would apply additional and more stringent criteria to us after considering the effectiveness of our auditor’s audit procedures and quality control procedures, adequacy of personnel and training, or sufficiency of resources, geographic reach or experience as it relates to the audit of our financial statements. See “Risk Factors — Risks Relating to our Class A Ordinary Shares and This Resale Offering — Our Class A Ordinary Shares may be delisted or prohibited from being traded on a national exchange under the Holding Foreign Companies Accountable Act if the PCAOB is unable to inspect our auditors” on page 31 of this prospectus.

 

Summary of Risk Factors

 

Investing in our Class A Ordinary Shares involves significant risks. You should carefully consider all of the information in this prospectus before making an investment in our Class A Ordinary Shares. Below please find a summary of the principal risks we face, organized under relevant headings. These risks are discussed more fully under the section titled “Risk Factors” beginning on page 28 of this prospectus and in “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

Risks Relating to Our Business and Operations

 

We face risks and uncertainties relating to our business and operations, including, but not limited to the following:

 

●Our interior design and fit-out business is project-based, and our profitability depends on the terms negotiated under each project agreement and may vary significantly from period to period. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Several of our Operating Subsidiaries have limited operating histories, and their future profitability is subject to greater uncertainty than that of our established interior design and fit-out business. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●The cost of sales of our Operating Subsidiaries has historically fluctuated. If we experience any significant increase in cost of sales, gross profit margin might decrease and our business operations and financial position might be materially and adversely affected. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Inaccurate project cost estimates or cost overruns could adversely affect our results of operations. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●We invest significant time and cost in the design stage of a project and there is a risk that a customer may reject the design proposal. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

21

 

 

●We rely heavily on recurring customers and referrals, our means of obtaining new business is limited, and our number of recurring customers has declined significantly. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●A significant portion of the revenue of our interior design and fit-out segment is derived from a limited number of major customers, and the loss of business from any of them could materially and adversely affect our business and financial performance. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Our ability to retain customers in our interior design and fit-out segment depends on our ability to anticipate and respond to their design preferences and operational requirements, and any failure to do so could materially and adversely affect our business. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●The Group is exposed to liquidity risk and the credit risk of its customers. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Our Operating Subsidiaries are subject to quality, safety, and environmental standards, and any failure to meet these standards could result in remediation costs and reputational harm. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Our business depends on the positive perception of our quality by customers and multiple stakeholders. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Negative publicity could harm our business. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●We may face warranty claims and product liability exposure from customers and end-users. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●We depend on our core management personnel. The concentration of authority in a single individual as both Chairman of the Board and Chief Executive Officer heightens our key-person risk. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Our Operating Subsidiaries’ performance depends on designers, engineers, technology specialists, and other skilled workers. Retaining and recruiting such personnel is challenging. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Our fit-out and construction operations are labor-intensive and reliant on subcontractors. Labor shortages or cost increases could adversely affect our results. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●We depend on materials suppliers and subcontractors. Any disruption to these relationships could adversely affect our business. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Our subcontractors’ failure to comply with applicable laws and regulations could expose us to liability. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Our business depends on seamless communication and cooperation among our staff and across our Operating Subsidiaries. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Disruptions to our supply chains, including for technology hardware, semiconductors, and robotics components, could have a material adverse effect on our operating and financial results. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

22

 

 

●Epidemics, natural disasters, political unrest, or other force majeure events could disrupt our operations and adversely affect our results. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Industrial accidents at work sites could expose us to liability and reputational harm. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Our insurance coverage may be insufficient to cover all losses we may incur. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●We may be unable to protect our intellectual property rights, including technology IP developed through joint ventures. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●We may be subject to intellectual property disputes, including in respect of AI, robotics, and software technologies. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●We are in the process of registering trademarks for multiple brands and, therefore, rely on common law protection until registration is complete. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●We may not be able to implement our business strategies and expansion plans, including our strategic expansion into robotics and AI, effectively to achieve future growth. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●We may face legal disputes and proceedings in the ordinary course of our business. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●We may not be successful in integrating newly established or acquired businesses with our existing operations. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Any disruption to our IT systems and infrastructure could adversely affect our business. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Cybersecurity risks have increased materially as a result of the Group’s expansion into AI, IoT-enabled smart facility management, and connected robotics systems. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●The Group’s robotics, AI, and technology business lines are at an early stage of development and may not achieve commercial viability. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●U.S. export controls, technology restrictions, and geopolitical tensions may adversely affect the Group’s ability to procure technology components and develop its robotics and AI products. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Increased regulatory scrutiny of U.S.-listed companies with operations in Hong Kong and Mainland China, and related legislative and regulatory developments, may create uncertainties for our business, share price, and reputation. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Unfavorable scrutiny or allegations directed at U.S.-listed companies with operations in Hong Kong and Mainland China could affect us even if such scrutiny or allegations are not directed at or applicable to us specifically. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

23

 

 

Risks Relating to Doing Business in the Jurisdictions in which the Operating Subsidiaries Operate

 

We face risks and uncertainties relating to doing business in Hong Kong in general, including, but not limited to the following: 

 

●Substantially all of our operations are in Hong Kong. However, due to the long-arm application of the current Mainland Chinese laws and regulations, the Mainland Chinese government may exercise significant direct oversight and discretion over the conduct of our business and may intervene or influence our operations, which could result in a material change in our operations and/or the value of our Class A Ordinary Shares. Our Operating Subsidiaries in Hong Kong may be subject to certain Mainland Chinese laws and regulations, which may impair our ability to operate profitably and result in a material negative impact on our operations and/or the value of our Class A Ordinary Shares. Furthermore, the changes in the policies, laws, regulations, rules, and the enforcement of laws of Mainland China may also occur quickly with little advance notice and our assertions and beliefs of the risk imposed by the Mainland China legal and regulatory system cannot be certain. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●There remain some uncertainties as to whether we will be required to obtain approvals from the PRC authorities to list on the U.S. exchanges and offer securities in the future, and if required, we cannot assure you that we will be able to obtain such approval. We may become subject to a variety of Mainland Chinese laws and other obligations regarding data security in relation to offerings that are conducted overseas, and any failure to comply with applicable laws and obligations could have a material and adverse effect on our business, financial condition and results of operations and may hinder our ability to offer or continue to offer Class A Ordinary Shares to investors and cause the value of our Class A Ordinary Shares to significantly decline or be worthless. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Compliance with Hong Kong’s Personal Data (Privacy) Ordinance and any such other existing or future data privacy related laws, regulations and governmental orders may entail significant expenses and could materially affect our business. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●If the Mainland Chinese government chooses to extend the oversight and control over offerings that are conducted overseas and/or foreign investment in Mainland China-based issuers to Hong Kong-based issuers, such action may significantly limit or completely hinder our ability to offer or continue to offer Class A Ordinary Shares to investors and cause the value of our Class A Ordinary Shares to significantly decline or be worthless. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●The enactment of the law of the PRC on Safeguarding National Security in the Hong Kong Special Administrative Region (the “Hong Kong National Security Law”) could impact our Hong Kong Operating Subsidiaries, which represent substantially all of our business. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●The enforcement of laws and rules and regulations in the PRC can change quickly with little advance notice. Additionally, the PRC laws and regulations and the enforcement of such that apply or are to be applied to Hong Kong can change quickly with little or no advance notice. As a result, the Hong Kong legal system embodies uncertainties which could limit the availability of legal protections, which could result in a material change in our Operating Subsidiaries’ operations and/or the value of our Class A Ordinary Shares. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●There are political risks associated with conducting business in Hong Kong. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

●Because substantially all of our business is conducted in Hong Kong dollars and the price of our Class A Ordinary Shares is quoted in United States dollars, changes in currency conversion rates may affect the value of your investments. See “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report.

 

24

 

 

Risks Relating to Our Corporate Structure

 

There are risks and uncertainties relating to our corporate structure, including, but not limited to, the following:

 

●We rely on dividends and other distributions on equity paid by our subsidiaries to fund any cash and financing requirements we may have. In the future, to the extent funds or assets in the business are in Hong Kong or a Hong Kong entity, funds or assets may not be available to fund operations or for other uses outside of Hong Kong, due to interventions in, or the imposition of restrictions and limitations on, our or our Operating Subsidiaries’ ability by the Mainland Chinese government to transfer cash or assets. Any limitation on the ability of our subsidiaries to make payments to us could have a material adverse effect on our ability to conduct our business and might materially decrease the value of our Class A Ordinary Shares or cause them to be worthless. See page 28 of this prospectus.

 

●It may be difficult for overseas shareholders and/or regulators to conduct investigations or collect evidence within the territory of the PRC, including Hong Kong. See page 29 of this prospectus.

 

●You may incur additional costs and procedural obstacles in effecting service of legal process, enforcing foreign judgments or bringing actions in Hong Kong against us or our management based on Hong Kong laws. See page 29 of this prospectus.

 

●As the rights of shareholders under BVI law differ from those under U.S. law, you may have fewer protections as a shareholder. See page 29 of this prospectus.

 

●The laws of BVI provide limited protections for minority shareholders, so minority shareholders will not have the same options as to recourse in comparison to the U.S. if the shareholders are dissatisfied with the conduct of our affairs. See page 31 of this prospectus.

 

Risks Relating to Our Class A Ordinary Shares and This Resale Offering

 

There are risks and uncertainties relating to our Class A Ordinary Shares, including, but not limited to, the following:

 

●Our Class A Ordinary Shares may be delisted or prohibited from being traded on a national exchange under the Holding Foreign Companies Accountable Act if the PCAOB is unable to inspect our auditors. See page 31 of this prospectus.

 

●Regulatory developments and market scrutiny relating to companies with operations in Mainland China or Hong Kong may affect investor perception of our Company and the trading price of our Class A Ordinary Shares. See page 32 of this prospectus.

 

●Negative publicity, market commentary, regulatory inquiries or allegations involving us or similarly situated companies could adversely affect our reputation, business and share price. See page 32 of this prospectus.

 

●We may experience extreme stock price volatility unrelated to our actual or expected operating performance, financial condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of our Class A Ordinary Shares, and could result in substantial losses to you. See page 33 of this prospectus.

 

●We have a dual class share structure consisting of Class A Ordinary Shares and Class B Ordinary Shares. Such dual class share structure will limit your ability to influence corporate matters, and allow our directors, officers and principal shareholders have significant voting power and may take actions that may not be in the best interests of our other shareholders, which could severely limit the ability of our other shareholders to influence certain matters requiring shareholder approval and, as a result, we may take actions that our other shareholders do not view as beneficial. See page 34 of this prospectus.

 

●We cannot predict the effect our dual class share structure may have on the market price of our Class A Ordinary Shares. See page 35 of this prospectus.

 

●If we fail to maintain our Nasdaq listing, we may face increased regulatory burdens and reduced investor protections on over-the-counter markets. See page 35 of this prospectus.

 

25

 

 

●In the event that our Class A Ordinary Shares are delisted from Nasdaq, U.S. broker-dealers may be discouraged from effecting transactions in our Class A Ordinary Shares because they may be considered penny stocks and thus be subject to the penny stock rules. See page 35 of this prospectus.

 

●Our Class A Ordinary Shares may be thinly traded and you may be unable to sell at or near ask prices or at all if you need to sell your shares to raise money or otherwise desire to liquidate your shares. See page 36 of this prospectus.

 

●You must rely on price appreciation of our Class A Ordinary Shares for return on your investment because the amount, timing, and whether or not we distribute dividends at all is entirely at the discretion of our board of directors. See page 36 of this prospectus.

 

●The sale or availability for sale of substantial amounts of our Class A Ordinary Shares could adversely affect their market price. See page 37 of this prospectus.

 

●Future issuances of our Class B Ordinary Shares may be dilutive to the voting power of our Class A Ordinary Shareholders. See page 37 of this prospectus.

 

●If securities or industry analysts do not publish research or reports about our business, or if they publish a negative report regarding our Class A Ordinary Shares, the price of our Class A Ordinary Shares and trading volume could decline. See page 37 of this prospectus.

 

●There can be no assurance that we will not be a passive foreign investment company, or PFIC, for United States federal income tax purposes for any taxable year, which could subject United States investors in our Class A Ordinary Shares to significant adverse United States income tax consequences. See page 37 of this prospectus.

 

●If we fail to meet applicable listing requirements, Nasdaq may delist our Class A Ordinary Shares from trading, in which case the liquidity and market price of our Class A Ordinary Shares could decline. See page 38 of this prospectus.

 

●We are an “emerging growth company”, and the reduced disclosure requirements applicable to emerging growth companies may make our Class A Ordinary Shares less attractive to investors. See page 39 of this prospectus.

 

●We will incur increased costs after we cease to qualify as an emerging growth company. See page 39 of this prospectus.

 

●We are a foreign private issuer within the meaning of the rules under the Exchange Act, and as such we are exempt from certain provisions applicable to U.S. domestic public companies. See page 40 of this prospectus.

 

●We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses. See page 40 of this prospectus.

 

●Nasdaq’s newly amended Low Price Requirement may result in immediate suspension and delisting of our Class A ordinary shares without a cure period if our share price falls to $0.10 or less for 10 consecutive business days. See page 40 of this prospectus.

 

●Nasdaq’s proposed $5 million minimum market value continued listing requirement previously approved by SEC now stayed pending further action from the SEC. If affirmed by SEC, such rule could result in immediate suspension and delisting of our Ordinary Shares without any cure period or opportunity to regain compliance. See page 41 of this prospectus.

 

26

 

 

THE OFFERING

 

This prospectus describes the general manner in which the Selling Shareholders may, from time to time, offer and sell up to an aggregate of 4,319,802 Class A Ordinary Shares (the “Resale Shares”). All of the Resale Shares, if and when sold, will be sold by the Selling Shareholders. The Selling Shareholders may sell the Resale Shares, from time to time at prevailing market prices or at privately negotiated prices.

 

Issuer:   Axonex AI Group Limited
   
Shares offered by the Selling Shareholders:   Up to an aggregate of 4,319,802 Class A Ordinary Shares.
   
Shares issued and outstanding as of the date of this prospectus:   6,076,338 Class A Ordinary Shares and 280,752 Class B Ordinary Shares
   
Shares issued and outstanding immediately after this resale offering:   6,076,338 Class A Ordinary Shares and 280,752 Class B Ordinary Shares, assuming no further issuances of Class A Ordinary Shares or Class B Ordinary Shares prior to this resale offering
   
Voting rights:  

Each Class A Ordinary Share shall entitle the holder thereof to one (1) vote on all matters subject to vote at general meetings of our Company and each Class B Ordinary Share shall entitle the holder thereof to twenty (20) votes on all matters subject to vote at general meetings of our Company. Each Class B Ordinary Share is convertible into one (1) Class A Ordinary Share at any time at the option of the holder thereof subject to adjustments provided in the Amended and Restated Memorandum and Articles. Class A Ordinary Shares are not convertible into Class B Ordinary Shares under any circumstances.

 

See the sections titled “Principal Shareholders” beginning on page 44 of this prospectus and “Description of Share Capital” beginning on page 50 of this prospectus.

     
Use of proceeds:   All of the Resale Shares will be sold by the Selling Shareholders for their own account. We will not receive any proceeds from the sales.
   
Nasdaq trading symbol:   AXNX
     
Risk factors:   See the section titled “Risk Factors” beginning on page 28 of this prospectus and “Item 3. Key Information — 3.D. Risk Factors” in our 2026 Annual Report for a discussion of risks you should carefully consider before deciding to invest in our Class A Ordinary Shares.
     
Transfer agent:   Vstock Transfer, LLC.

 

27

 

 

RISK FACTORS

 

Investing in our Class A Ordinary Shares involves a high degree of risk. Before deciding whether to purchase our Class A Ordinary Shares, you should carefully review the risks and uncertainties described in this section and under similar headings in the section titled “Item 3. Key Information — 3.D. Risk Factors” of our 2026 Annual Report filed with the SEC and incorporated by reference into this prospectus. A summary of the risk factors can be found on page 21 of this prospectus. All of these risk factors are incorporated herein in their entirety. Each of these risk factors could adversely affect our business, results of operations, financial condition and cash flows, as well as adversely affect the value of investment in our Class A Ordinary Shares, and the occurrence of any of these risks might cause you to lose all or part of your investment. Additional risks not presently known to us or that we currently believe are immaterial may also significantly impair our business operations.

 

Certain statements in this prospectus, or which are incorporated by reference in this section, are forward-looking statements. The forward-looking statements in this prospectus are also subject to these risks and uncertainties, and our actual results may differ substantially from those discussed in these forward-looking statements. See the section titled “Cautionary Notes Regarding Forward-Looking Statements” on page vi of this prospectus.

 

Risks Relating to Our Corporate Structure

 

We rely on dividends and other distributions on equity paid by our subsidiaries to fund any cash and financing requirements we may have. In the future, to the extent funds or assets in the business are in Hong Kong or a Hong Kong entity, funds or assets may not be available to fund operations or for other uses outside of Hong Kong, due to interventions in, or the imposition of restrictions and limitations on, our or our Hong Kong Operating Subsidiaries’ ability by the Mainland Chinese government to transfer cash or assets. Any limitation on the ability of our subsidiaries to make payments to us could have a material adverse effect on our ability to conduct our business and might materially decrease the value of our Class A Ordinary Shares or cause them to be worthless.

 

Axonex BVI is a holding company incorporated in the BVI, and we rely on dividends and other distributions on equity paid by our subsidiaries for our cash and financing requirements, including the funds necessary to pay dividends and other cash distributions to our shareholders and service any debt we may incur. We do not expect to pay cash dividends in the foreseeable future. If any of our subsidiaries incurs debt on its own behalf in the future, the instruments governing the debt may restrict its ability to pay dividends or make other distributions to us.

 

Under the current practice of the Inland Revenue Department of Hong Kong, no tax is payable in Hong Kong in respect of dividends paid by us. There are no restrictions or limitations under the laws of Hong Kong imposed on the conversion of Hong Kong dollar into foreign currencies and the remittance of currencies out of Hong Kong, nor are there any restrictions on any foreign exchange to transfer cash between Axonex BVI and its subsidiaries, across borders and to U.S. investors, nor are there any restrictions and limitations to distribute earnings from the subsidiaries, to Axonex BVI and U.S. investors and for payments of amounts owed.

 

Currently, the PRC laws and regulations and foreign currency control in Mainland China have no impact on the transfer of cash or assets between Axonex BVI, our Intermediate Holding Companies and our Operating Subsidiaries, or vice versa. However, to the extent that cash and/or assets of the business are in Hong Kong or held by a Hong Kong entity, such cash and/or assets may not be available to fund operations or for other uses outside of Hong Kong in the future due to interventions in or the imposition of restrictions and limitations by the Mainland Chinese government on the ability of Axonex BVI, our Intermediate Holding Companies or our Operating Subsidiaries to transfer cash and/or assets. Any limitation, if imposed in the future, on the ability of our Hong Kong Operating Subsidiaries to make payments to us could have a material adverse effect on our ability to conduct our business and might materially decrease the value of our Class A Ordinary Shares or cause them to be worthless. Such restrictions and limitations, if imposed in the future, may delay or hinder the expansion of our business to outside of Hong Kong and may affect our ability to receive funds from our Operating Subsidiaries in Hong Kong. The promulgation of new laws or regulations, or the new interpretation of existing laws and regulations, in each case, that restrict or otherwise unfavorably impact the ability or way we conduct our business, could require us to change certain aspects of our business to ensure compliance, which could decrease demand for our services, reduce revenues, increase costs, require us to obtain more licenses, permits, approvals or certificates, or subject us to additional liabilities. To the extent any new or more stringent measures are required to be implemented, our business, financial condition and results of operations could be adversely affected and such measures could materially decrease the value of our Class A Ordinary Shares, potentially rendering them worthless. Further, any limitation on the ability of our subsidiaries to pay dividends or make other distributions to us could materially and adversely limit our ability to grow, make investments or acquisitions that could be beneficial to our business, pay dividends, or otherwise fund and conduct our business.

 

28

 

 

It may be difficult for overseas shareholders and/or regulators to conduct investigations or collect evidence within the territory of the PRC, including Hong Kong.

 

Substantially all of our assets are located outside the United States and our principal business operation is conducted in Hong Kong. In addition, our directors and officers reside in Hong Kong. As a result, it may be difficult for investors to effect service of process within the United States upon us or such persons or to enforce judgments obtained in United States courts against them or against us, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state thereof. In the event that the U.S. regulators carry out an investigation on us and there is a need to conduct such investigation, or collect evidence within the territory of the PRC, the U.S. regulators may not be able to carry out such investigation or evidence collection directly in the PRC under the PRC laws.

 

Shareholder claims or regulatory investigations that are common in the United States generally are difficult to pursue as a matter of law or practicality in the PRC. For example, in the PRC, there are significant legal and other obstacles to providing information needed for regulatory investigations or litigation initiated outside the PRC. Although the PRC authorities may establish a regulatory cooperation mechanism with the regulatory authorities of another country or region to implement cross-border supervision and administration, such cooperation with the regulatory authorities in the Unities States may not be efficient in the absence of mutual and practical cooperation mechanism. Furthermore, according to Article 177 of the “Securities Law of the People’s Republic of China”, which became effective in March 2020, no overseas securities regulator is allowed to directly conduct investigations or evidence collection activities within the territory of Mainland China. While detailed interpretation of or implementation rules under the same article have yet to be promulgated, the inability for an overseas securities regulator to directly conduct investigations or evidence collection activities within Mainland China may further increase difficulties faced by you in protecting your interests.

 

You may incur additional costs and procedural obstacles in effecting service of legal process, enforcing foreign judgments or bringing actions in Hong Kong against us or our management based on Hong Kong laws.

 

Currently, our Operating Subsidiaries’ operations are conducted outside the United States, and substantially all of our assets are located outside the United States. All of our directors and officers reside in Hong Kong, and a substantial portion of their assets are located in Hong Kong and outside the United States. You may incur additional costs and procedural obstacles in effecting service of legal process, enforcing foreign judgments or bringing actions in Hong Kong against us or our management, as there are currently no treaties or other arrangements providing for reciprocal enforcement of judgments between Hong Kong and the United States and judgments entered in the United States may be enforced in Hong Kong only at common law as a cause of action in itself and sued upon as a debt between the parties. If you want to enforce a judgment of the United States in Hong Kong, it must, among other things, be a final judgment conclusive upon the merits of the claim, for a liquidated amount in a civil matter and not in respect of taxes, fines, penalties, or similar charges, the proceedings in which the judgment was obtained were not contrary to natural justice, and the enforcement of the judgment is not contrary to public policy of Hong Kong. Such a judgment must be for a fixed sum and must also come from a “competent” court as determined by the private international law rules applied by the Hong Kong courts. The defenses that are available to a defendant in a common law action brought on the basis of a foreign judgment include lack of jurisdiction, breach of natural justice, fraud, and contrary to public policy.

 

As the rights of shareholders under BVI law differ from those under U.S. law, you may have fewer protections as a shareholder.

 

Our Company is a BVI business company with limited liability incorporated under the laws of the BVI. Our corporate affairs are governed by our Amended and Restated Memorandum and Articles of Association, the BVI Act and the common law of the BVI. The rights of shareholders to take action against our directors, actions by our minority shareholders and the fiduciary duties of our directors to us under BVI laws are governed by the BVI Act and the common law of the BVI. The common law of the BVI is derived in part from comparatively limited judicial precedent in the BVI as well as from the common law of England and the wider Commonwealth, the decisions of whose courts are of persuasive authority, but are not binding, on a court in the BVI. The rights of our shareholders and the fiduciary duties of our directors under the BVI law are not as clearly established as they would be under statutes or judicial precedent in some jurisdictions in the United States. In particular, the BVI has a less developed body of securities laws than the United States. Some U.S. states, such as Delaware, have more fully developed and judicially interpreted bodies of corporate law than the BVI.

 

29

 

 

In addition, BVI companies may not have standing to initiate a shareholder derivative action in a federal court of the United States.

 

Shareholders of a BVI company could, however, bring a derivative action in the BVI courts, and there is a clear statutory right to commence such derivative claims under Section 184C of the BVI Act. The circumstances in which any such action may be brought, and the procedures and defenses that may be available in respect to any such action, may result in the rights of shareholders of a BVI company being more limited than those of shareholders of a company organized in the United States. Accordingly, shareholders may have fewer alternatives available to them if they believe that corporate wrongdoing has occurred. The BVI courts are also unlikely to recognize or enforce against us judgments of courts in the United States based on certain liability provisions of U.S. securities law; and to impose liabilities against us, in original actions brought in the BVI, based on certain liability provisions of U.S. securities laws that are penal in nature. There is no statutory recognition in the BVI of judgments obtained in the United States, although the courts of the BVI will generally recognize and enforce the non-penal judgment of a foreign court of competent jurisdiction without retrial on the merits. The BVI Act offers some limited protection of minority shareholders. The principal protection under statutory law is that shareholders may apply to the BVI court for an order directing the company or its director(s) to comply with, or restraining the company or a director from engaging in conduct that contravenes, the BVI Act. Under the BVI Act, the minority shareholders have a statutory right to bring a derivative action in the name of and on behalf of the company in circumstances where a company has a cause of action against its directors. This remedy is available at the discretion of the BVI court. A shareholder may also bring an action against the company for breach of duty owed to him/her as a shareholder. A shareholder who considers that the affairs of the company have been, are being or likely to be, conducted in a manner that is, or any act or acts of the company have been, or are, likely to be oppressive, unfairly discriminatory, or unfairly prejudicial to him/her in that capacity, may apply to the BVI court for an order to remedy the situation.

 

There are common law rights for the protection of shareholders that may be invoked, largely dependent on English common law. Under the general rule pursuant to English common law known as the rule in Foss v. Harbottle, a court will generally refuse to interfere with the management of a company at the insistence of a minority of its shareholders who express dissatisfaction with the conduct of the company’s affairs by the majority or the board of directors. However, every shareholder is entitled to have the affairs of the company conducted properly according to BVI law and the constituent documents of the company. As such, if those who control the company have persistently disregarded the requirements of company law, then the courts may grant relief. Generally, the areas in which the courts will intervene are the following: (1) an act complained of which is outside the scope of the authorized business or is illegal or not capable of ratification by the majority; (2) acts that constitute fraud on the minority where the wrongdoers control the company; (3) acts that infringe or are about to infringe on the personal rights of the shareholders, such as the right to vote; and (4) where the company has not complied with provisions requiring approval of a special or extraordinary majority of shareholders. This means that even if shareholders were to sue us successfully, they may not be able to recover anything to make up for the losses suffered.

 

Certain corporate governance practices in the BVI, where our holding company was incorporated, differ significantly from requirements for companies incorporated in other jurisdictions such as the United States. We can rely on home country practice with respect to our corporate governance, and have elected to rely on BVI corporate governance practices in lieu of the requirement for shareholder approval prior to transactions other than public offerings under Nasdaq Listing Rule 5635 in connection with the July 2026 PIPE and the August 2026 PIPE. If we continue to follow such BVI corporate governance practices or choose to follow additional BVI corporate governance practices in the future, our shareholders may be afforded less protection than they otherwise would under rules and regulations applicable to U.S. domestic issuers. See “Risk Factors — Risks Relating to Our Class A Ordinary Shares and This Resale Offering — We are a foreign private issuer within the meaning of the rules under the Exchange Act, and as such we are exempt from certain provisions applicable to U.S. domestic public companies.” on page 40 of this prospectus.

 

As a result of all of the above, public shareholders may have more difficulties in protecting their interests in the face of actions taken by our management, or members of our board of directors than they would as public shareholders of a company incorporated in the United States.

 

30

 

 

The laws of BVI provide limited protections for minority shareholders, so minority shareholders will not have the same options as to recourse in comparison to the U.S. if the shareholders are dissatisfied with the conduct of our affairs.

 

Under the laws of the BVI, the rights of minority shareholders are protected by provisions of the BVI Act dealing with shareholder remedies and other remedies available under common law (in tort or contractual remedies). The principal protection under statutory law is that shareholders may bring an action to enforce the constitutional documents of the company (i.e. the memorandum and articles of association) as shareholders are entitled to have the affairs of the company conducted in accordance with the BVI Act and the memorandum and articles of association of the company. A shareholder may also bring an action under statute if he/she feels that the affairs of the company have been or will be carried out in a manner that is unfairly prejudicial or discriminating or oppressive to him/her. The BVI Act also provides for certain other protections for minority shareholders, including in respect of investigation of the company and inspection of the company books and records. There are also common law rights for the protection of shareholders that may be invoked, largely dependent on English common law, since the common law of the BVI for business companies is limited.

 

Risks Relating to Our Class A Ordinary Shares and This Resale Offering

 

Our Class A Ordinary Shares may be delisted or prohibited from being traded on a national exchange under the Holding Foreign Companies Accountable Act if the PCAOB is unable to inspect our auditors.

 

The Holding Foreign Companies Accountable Act, or the HFCA Act, was enacted on December 18, 2020. The HFCA Act states if the SEC determines that we have filed audit reports issued by a registered public accounting firm that has not been subject to inspection by the PCAOB for three consecutive years beginning in 2021, the SEC shall prohibit our shares from being traded on a national securities exchange or in the over-the-counter trading market in the United States.

 

On March 24, 2021, the SEC adopted interim final rules relating to the implementation of certain disclosure and documentation requirements of the HFCA Act. A company will be required to comply with these rules if the SEC identifies it as having a “non-inspection” year under a process to be subsequently established by the SEC. On June 22, 2021, the U.S. Senate passed the Accelerating Holding Foreign Companies Accountable Act, or the AHFCA Act, which was signed into law on December 29, 2022, amending the HFCA Act and requiring the SEC to prohibit an issuer’s securities from trading on any U.S. stock exchange if its auditor is not subject to PCAOB inspections for two consecutive years instead of three consecutive years. On September 22, 2021, the PCAOB adopted a final rule implementing the HFCA Act, which provides a framework for the PCAOB to use when determining, as contemplated under the HFCA Act, whether the PCAOB is unable to inspect or investigate completely registered public accounting firms located in a foreign jurisdiction because of a position taken by one or more authorities in that jurisdiction. On December 2, 2021, the SEC issued amendments to finalize rules implementing the submission and disclosure requirements in the HFCA Act. The rules apply to registrants that the SEC identifies as having filed an annual report with an audit report issued by a registered public accounting firm that is located in a foreign jurisdiction and that PCAOB is unable to inspect or investigate completely because of a position taken by an authority in that jurisdiction. On December 16, 2021, the PCAOB issued a Determination Report (the “2021 Determination Report”) which found that the PCAOB is unable to inspect or investigate completely registered public accounting firms headquartered in: (i) Mainland China, and (ii) Hong Kong.

 

On August 26, 2022, the PCAOB announced and signed a Statement of Protocol (the “Protocol”) with the China Securities Regulatory Commission and the Ministry of Finance of the People’s Republic of China. The Protocol provides the PCAOB with: (1) sole discretion to select the firms, audit engagements and potential violations it inspects and investigates, without any involvement of Chinese authorities; (2) procedures for PCAOB inspectors and investigators to view complete audit work papers with all information included and for the PCAOB to retain information as needed; (3) direct access to interview and take testimony from all personnel associated with the audits the PCAOB inspects or investigates.

 

On December 15, 2022, the PCAOB issued a new Determination Report (the “2022 Determination Report”) which: (1) vacated the 2021 Determination Report; and (2) concluded that the PCAOB was able to conduct inspections and investigations completely in the PRC in 2022. The 2022 Determination Report cautions, however, that authorities in the PRC might take positions at any time that would prevent the PCAOB from continuing to inspect or investigate completely. As required by the HFCA Act, if in the future the PCAOB determines it no longer can inspect or investigate completely because of a position taken by an authority in the PRC, the PCAOB will act expeditiously to consider whether it should issue a new determination.

 

31

 

 

Our auditor, WWC, P.C., an independent registered public accounting firm, is headquartered in California and registered with the PCAOB, and thus is subject to laws in the United States pursuant to which the PCAOB conducts regular inspections to assess our auditor’s compliance with the applicable professional standards, with the last inspection having occurred in December 2025. As of the date of this prospectus, our auditor is not subject to and is not affected by the 2021 Determination Report (which was vacated by the PCAOB on December 15, 2022). However, in the event it is later determined that the PCAOB is unable to inspect or investigate completely our auditor because of a position taken by an authority in a foreign jurisdiction, such as the PRC authorities, then such lack of inspection could cause trading in the Company’s securities to be prohibited under the HFCA Act, and ultimately result in a determination by a securities exchange to delist the Company’s securities.

 

The SEC may propose additional rules or guidance that could impact us if our auditor is not subject to PCAOB inspection. For example, on August 6, 2020, the President’s Working Group on Financial Markets, or the PWG, issued the Report on Protecting United States Investors from Significant Risks from Chinese Companies to the then President of the United States. This report recommended that the SEC implement five recommendations to address companies from jurisdictions that do not provide the PCAOB with sufficient access to fulfil its statutory mandate. Some of the concepts of these recommendations were implemented with the enactment of the HFCA Act. However, some of the recommendations were more stringent than the HFCA Act. For example, if a company’s auditor is not subject to PCAOB inspection, the report recommended that the transition period before a company would be delisted would end on January 1, 2022.

 

The SEC has announced that the SEC staff is preparing a consolidated proposal for the rules regarding the implementation of the HFCA Act and to address the recommendations in the PWG. It is unclear when the SEC will complete its rulemaking and when such rules will become effective, and what, if any, of the PWG recommendations will be adopted. The implications of this possible regulation, in addition to the requirements of the HFCA Act, are uncertain. Such uncertainty could cause the market price of our Class A Ordinary Shares to be materially and adversely affected, and our securities could be delisted or prohibited from being traded on the national securities exchange earlier than would be required by the HFCA Act. If our Class A Ordinary Shares are unable to be listed on another securities exchange by then, such a delisting would substantially impair your ability to sell or purchase our Class A Ordinary Shares when you wish to do so, and the risk and uncertainty associated with a potential delisting would have a negative impact on the price of our Class A Ordinary Shares.

 

Regulatory developments and market scrutiny relating to companies with operations in Mainland China or Hong Kong may affect investor perception of our Company and the trading price of our Class A Ordinary Shares.

 

U.S.-listed companies with substantial operations in China, including Hong Kong, have in recent years been subject to increased attention from investors, financial commentators, market participants and regulatory authorities, including the SEC and Nasdaq. This attention has included a focus on, among other things, financial reporting, internal control over financial reporting, corporate governance practices, related party transactions and the adequacy of public disclosures.

 

In addition, U.S. regulators and lawmakers have from time to time considered, proposed or adopted additional rules, guidance and other measures relating to China-based and other emerging market companies listed in the United States, including with respect to disclosure, audit, corporate governance and listing standards. These developments may result in additional compliance obligations, increased regulatory attention or changes in market perception of companies with operations in China, including Hong Kong.

 

Although substantially all of our operations are based in Hong Kong, we also serve corporate clients based in Mainland China. Accordingly, regulatory developments, market commentary or investor concerns relating generally to U.S.-listed companies with operations or business relationships in Mainland China or Hong Kong may affect investor perception of our Company, even if such developments or concerns are not specific to us. Any such effect could result in increased volatility or a decline in the trading price of our Class A Ordinary Shares.

 

Negative publicity, market commentary, regulatory inquiries or allegations involving us or similarly situated companies could adversely affect our reputation, business and share price.

 

Certain U.S.-listed companies with operations in Mainland China or Hong Kong have been the subject of negative publicity, market commentary, short-seller reports, shareholder litigation, regulatory inquiries or investigations. In some cases, the publicly traded securities of these companies have experienced significant volatility or declines in value following such events.

 

If we become the subject of negative publicity, market commentary, regulatory inquiries, investigations, shareholder litigation or unfavorable allegations, whether or not the matters are ultimately determined to have merit, we may need to devote management time and financial resources to reviewing, responding to, or defending against such matters. These matters could be costly and time-consuming, divert management’s attention from our business and adversely affect our reputation, investor confidence and the trading price of our Class A Ordinary Shares.

 

In addition, even where such matters relate to other companies and not to us specifically, market commentary or investor concerns regarding U.S.-listed companies with operations or business relationships in Mainland China or Hong Kong may contribute to broader market volatility or negative investor sentiment. Such developments could adversely affect the market price of our Class A Ordinary Shares.

 

32

 

 

We may experience extreme stock price volatility unrelated to our actual or expected operating performance, financial condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of our Class A Ordinary Shares, and could result in substantial losses to you.

 

The market price of our Class A Ordinary Shares has been volatile and could fluctuate widely due to factors beyond our control. This may happen due to broad market and industry factors, such as performance and fluctuation in the market prices or underperformance or deteriorating financial results of other listed companies based in Hong Kong and Mainland China. The securities of some of these companies have experienced significant volatility since their initial public offerings, including, in some cases, substantial price declines in the trading price of their securities. The trading performances of other Hong Kong and Mainland Chinese companies’ securities after their offerings may affect the attitudes of investors towards Hong Kong-based, U.S.-listed companies, which consequently may affect the trading performance of our Class A Ordinary Shares, regardless of our actual operating performance. In addition, any negative news or perceptions about inadequate corporate governance practices or fraudulent accounting, corporate structure or matters of other Hong Kong and Mainland Chinese companies may also negatively affect the attitudes of investors towards Hong Kong and Mainland Chinese companies in general, including us, regardless of whether we have conducted any inappropriate activities. Furthermore, securities markets may from time to time experience significant price and volume fluctuations that are not related to our operating performance, which may have a material and adverse effect on the trading price of our Class A Ordinary Shares. The market price for our Class A Ordinary Shares may be volatile and subject to wide fluctuations due to factors such as:

 

●the financial projections we may provide to the public, any changes in these projections or our failure to meet these projections;

 

●actual or anticipated fluctuations in our operating results;

 

●changes in financial estimates by securities research analysts;

 

●negative publicity, studies or reports about us, our services, our officers, directors, major shareholders, other beneficial owners, our business partners, or our industry;

 

●our capability to catch up with the technology innovations in the industry, and maintain such technological innovations, once attained;

 

●announcements by us or our competitors of acquisitions, strategic partnerships, joint ventures or capital commitments;

 

●additions or departures of key personnel;

 

●fluctuations of exchange rates between Hong Kong dollar and U.S. dollar;

 

●litigation or regulatory proceedings involving us, our directors, officers or major shareholders;

 

●realization of any of the other risk factors presented in this prospectus;

 

●changes in investors’ perception of our Company and the investment environment generally;

 

●the general market reactions and financial market fluctuations due to the continuous Russo-Ukrainian and Middle Eastern conflicts;

 

●changes in the economic performance or market valuations of companies engaging in the same or similar business as our Company;

 

●economic, social and political conditions in Hong Kong and Mainland China;

 

●the liquidity of the market for our Class A Ordinary Shares;

 

●release or expiry of lock-up or other transfer restrictions on our outstanding Class A Ordinary Shares;

 

●sales and perceived potential sales of additional Class A Ordinary Shares.

 

Any of these factors may result in large and sudden changes in the volume and price at which our Class A Ordinary Shares will trade.

 

33

 

 

Recently, there have been instances of extreme stock price run-ups followed by rapid price declines and strong stock price volatility with a number of recent initial public offerings, especially among companies with relatively smaller public floats. As a relatively small-capitalization company with a relatively small public float, we may experience greater stock price volatility, extreme price run-ups, lower trading volume and less liquidity than large-capitalization companies. In particular, our Class A Ordinary Shares may be subject to rapid and substantial price volatility, low volumes of trades and large spreads in bid and ask prices. Such volatility, including any stock run-up, may be unrelated to our actual or expected operating performance, financial condition or prospects, making it difficult for prospective investors to assess the rapidly changing value of our Class A Ordinary Shares.

 

In addition, if the trading volumes of our Class A Ordinary Shares are low, persons buying or selling in relatively small quantities may easily influence the price of our Class A Ordinary Shares. This low volume of trades could also cause the price of our Class A Ordinary Shares to fluctuate greatly, with large percentage changes in price occurring in any trading day session. Holders of our Class A Ordinary Shares may also not be able to readily liquidate their investment or may be forced to sell at depressed prices due to low volume trading. Broad market fluctuations and general economic and political conditions may also adversely affect the market price of our Class A Ordinary Shares.

 

As a result of this volatility, investors may experience losses on their investment in our Class A Ordinary Shares. A decline in the market price of our Class A Ordinary Shares also could adversely affect our ability to issue additional shares of Class A Ordinary Shares or other securities and our ability to obtain additional financing in the future. No assurance can be given that an active market in our Class A Ordinary Shares will develop or be sustained. If an active market does not develop, holders of our Class A Ordinary Shares may be unable to readily sell the shares they hold or may not be able to sell their shares at all.

 

In the past, shareholders of public companies have often brought securities class action suits against those companies following periods of instability in the market price of their securities. If we were involved in a class action suit, it could divert a significant amount of our management’s attention and other resources from our business and operations and require us to incur significant expenses to defend the suit, which could harm our results of operations. Any such class action suit, whether or not successful, could harm our reputation and restrict our ability to raise capital in the future. In addition, if a claim is successfully made against us, we may be required to pay significant damages, which could have a material adverse effect on our financial condition and results of operations.

 

We have a dual class share structure consisting of Class A Ordinary Shares and Class B Ordinary Shares. Such dual class share structure will limit your ability to influence corporate matters, and allow our directors, officers and principal shareholders have significant voting power and may take actions that may not be in the best interests of our other shareholders, which could severely limit the ability of our other shareholders to influence certain matters requiring shareholder approval and, as a result, we may take actions that our other shareholders do not view as beneficial.

 

We have a dual class share structure consisting of Class A Ordinary Shares and Class B Ordinary Shares. Based on our dual class share structure, each Class A Ordinary Share is entitled to one (1) vote at a meeting of the members of the Company or on any resolution of members, while each Class B Ordinary Share is entitled to twenty (20) votes at a meeting of the members of the Company or on any resolution of members. Due to the disparate voting powers associated with our two classes of ordinary shares, Deep Vision Enterprise Limited, a company controlled by Mr. Hoi Lung CHAN, our Chairman of the Board and Chief Executive Officer, and I Sparks Enterprise Limited, a company controlled by Mr. Cheong Shing KU, our director, beneficially own approximately 1.19% and 1.03% of our issued and outstanding Class A Ordinary Shares, approximately 67.59% and 32.41% of our issued and outstanding Class B Ordinary Shares, and 33.08% and 16.10% of the aggregate voting power of our issued and outstanding Ordinary Shares, respectively; and together, they own 49.18% of the aggregate voting power of our Ordinary Shares. If Mr. Chan and Mr. Ku act together, they will be able to control the management and affairs of our Company and certain matters requiring shareholder approval, including the election of directors and approval of significant corporate transactions.

 

This concentrated control will limit the ability of other shareholders to influence corporate matters and, as a result, we may take actions that our other shareholders do not view as beneficial. The interests of our directors, officers, and principal shareholders, including Mr. Chan and Mr. Ku, may not coincide with your interests, and it may make decisions with which you disagree, including decisions on important topics such as the composition of the board of directors, compensation, management succession, and our business and financial strategy. For example, these shareholders could attempt to delay or prevent a change in control of us, even if such change in control would benefit our other shareholders, which could deprive our shareholders of an opportunity to receive a premium for their shares as part of a sale or other liquidity event, and ultimately affect the prevailing market price of our Class A Ordinary Shares due to investors’ perceptions that conflicts of interest may exist or arise. As a result, this concentration of ownership may not be in the best interests of our other shareholders.

 

34

 

 

We cannot predict the effect our dual class share structure may have on the market price of our Class A Ordinary Shares.

 

We cannot predict whether our dual class share structure will result in a lower or more volatile market price of our Class A Ordinary Shares, adverse publicity or other adverse consequences. For example, certain index providers have announced and implemented restrictions on including companies with multiple class share structures in certain of their indices. In July 2017, FTSE Russell announced that it would require new constituents of its indices to have greater than 5% of the company’s voting rights in the hands of public stockholders, and S&P Dow Jones announced that it would no longer admit companies with multiple class share structures to certain of its indices. Affected indices include the Russell 2000 and the S&P 500, S&P MidCap 400 and S&P SmallCap 600, which together make up the S&P Composite 1500. Also in 2017, MSCI, a leading stock index provider, opened public consultations on its treatment of no-vote and multi-class structures and temporarily barred new multi-class listings from certain of its indices; however, in October 2018, MSCI announced its decision to include equity securities “with unequal voting structures” in its indices and to launch a new index that specifically includes voting rights in its eligibility criteria. Under such announced and implemented policies, the dual class share structure of our Ordinary Shares would make us ineligible for inclusion in certain indices and, as a result, mutual funds, exchange-traded funds and other investment vehicles that attempt to passively track those indices would not invest in our Class A Ordinary Shares. These policies are relatively new, and it is unclear what effect, if any, they will have on the valuations of publicly-traded companies excluded from such indices, but it is possible that they may adversely affect valuations, as compared to similar companies that are included. Due to the dual class share structure of our Ordinary Shares, we will likely be excluded from certain indices, and we cannot assure you that other stock indices will not take similar actions. Given the sustained flow of investment funds into passive strategies that seek to track certain indices, exclusion from certain stock indices would likely preclude investment by many of these funds and could make our Class A Ordinary Shares less attractive to other investors. As a result, the market price of our Class A Ordinary Shares could be adversely affected.

 

If we fail to maintain our Nasdaq listing, we may face increased regulatory burdens and reduced investor protections on over-the-counter markets.

 

Our Class A Ordinary Shares will continue to be listed and traded on the Nasdaq Capital Market, subject to our compliance with the other listing requirements of the Nasdaq Capital Market. We cannot assure you that we will not receive deficiency notifications from Nasdaq in the future. A decline in the closing price of our Class A Ordinary Shares could result in a breach of the requirements for listing on the Nasdaq Capital Market. If we do not maintain compliance, Nasdaq could commence suspension or delisting procedures in respect of our Class A Ordinary Shares. The commencement of suspension or delisting procedures by an exchange remains at the discretion of such exchange and would be publicly announced by the exchange.

 

If our Class A Ordinary Shares are delisted from Nasdaq, they would likely trade, if at all, on over-the-counter markets such as the OTCQX, OTCQB or OTC Pink marketplaces. These alternative markets are generally considered to be less efficient and less liquid than Nasdaq. Trading on the over-the-counter markets could subject Class A Ordinary Shares and our shareholders to additional risks, including limited availability of market quotations, reduced liquidity, decreased market-making activity, reduced analyst coverage, and decreased ability to issue additional Class A Ordinary Shares or obtain additional financing. Additionally, the price of our Class A Ordinary Shares on these markets may be more volatile than on Nasdaq, and shareholders may find it more difficult to dispose of or obtain accurate price information about our Class A Ordinary Shares.

 

In the event that our Class A Ordinary Shares are delisted from Nasdaq, U.S. broker-dealers may be discouraged from effecting transactions in our Class A Ordinary Shares because they may be considered penny stocks and thus be subject to the penny stock rules.

 

The SEC has adopted a number of rules to regulate “penny stock” that restrict transactions involving stock that is deemed to be penny stock. Such rules include Rules 3a51-1, 15g-1, 15g-2, 15g-3, 15g-4, 15g-5, 15g-6, 15g-7, and 15g-9 under the Exchange Act. These rules may have the effect of reducing the liquidity of penny stocks. “Penny stocks” generally are equity securities with a price of less than $5.00 per share (other than securities registered on certain national securities exchanges or quoted on Nasdaq if current price and volume information with respect to transactions in such securities is provided by the exchange or system). Our Class A Ordinary Shares could be considered a “penny stock” within the meaning of the abovementioned rules. The additional sales practice and disclosure requirements imposed upon U.S. broker-dealers may discourage such broker-dealers from effecting transactions in our Class A Ordinary Shares, which could severely limit the market liquidity of our Class A Ordinary Shares and impede their sale in the secondary market.

 

35

 

 

A U.S. broker-dealer selling a penny stock to anyone other than an established customer or “accredited investor” (generally, an individual with a net worth in excess of $1,000,000 or an annual income exceeding $200,000, or $300,000 together with his or her spouse) must make a special suitability determination for the purchaser and must receive the purchaser’s written consent to the transaction prior to sale, unless the broker-dealer or the transaction is otherwise exempt. In addition, the “penny stock” regulations require the U.S. broker-dealer to deliver, prior to any transaction involving a “penny stock”, a disclosure schedule prepared in accordance with SEC standards relating to the “penny stock” market, unless the broker-dealer or the transaction is otherwise exempt. A U.S. broker-dealer is also required to disclose commissions payable to the U.S. broker-dealer and the registered representative and current quotations for the securities. Finally, a U.S. broker-dealer is required to submit monthly statements disclosing recent price information with respect to the “penny stock” held in a customer’s account and information with respect to the limited market in “penny stocks”.

 

The market for “penny stocks” has suffered in recent years from patterns of fraud and abuse. Such patterns include (i) control of the market for the security by one or a few broker-dealers that are often related to the promoter or issuer; (ii) manipulation of prices through prearranged matching of purchases and sales and false and misleading press releases; (iii) “boiler room” practices involving high-pressure sales tactics and unrealistic price projections by inexperienced sales persons; (iv) excessive and undisclosed bid-ask differentials and markups by selling broker-dealers; and (v) the wholesale dumping of the same securities by promoters and broker-dealers after prices have been manipulated to a desired level, resulting in investor losses. Our management is aware of the abuses that have occurred historically in the penny stock market. Although we do not expect to be in a position to dictate the behavior of the market or of broker-dealers who participate in the market, management will strive within the confines of practical limitations to prevent the described patterns from being established with respect to our securities.

 

Our Class A Ordinary Shares may be thinly traded and you may be unable to sell at or near ask prices or at all if you need to sell your shares to raise money or otherwise desire to liquidate your shares.

 

Our Class A Ordinary Shares may be “thinly traded,” meaning that the number of persons interested in purchasing our Class A Ordinary Shares at or near bid prices at any given time may be relatively small or non-existent. This situation may be attributable to a number of factors, including the fact that we are relatively unknown to stock analysts, stockbrokers, institutional investors and others in the investment community that generate or influence sales volume, and that even if we come to the attention of such persons, they tend to be risk-averse and might be reluctant to follow an unproven company such as ours or purchase or recommend the purchase of our shares until such time as we became more seasoned. As a consequence, there may be periods of several days or more when trading activity in our shares is minimal or non-existent, as compared to a seasoned issuer which has a large and steady volume of trading activity that will generally support continuous sales without an adverse effect on share price. A broad or active public trading market for our Class A Ordinary Shares may not develop or be sustained.

 

You must rely on price appreciation of our Class A Ordinary Shares for return on your investment because the amount, timing, and whether or not we distribute dividends at all is entirely at the discretion of our board of directors.

 

Our board of directors has complete discretion as to whether to distribute dividends. Subject to the BVI Act and our Amended and Restated Memorandum and Articles of Association, our board of directors may by resolution, authorize a distribution (which includes a dividend) by our Company to our members if our board of directors are satisfied, on reasonable grounds, that immediately after the distribution satisfy the solvency test, that is: (a) our Company will be able to pay its debts as they fall due; and (b) the value of our assets exceeds its liabilities. In addition, our shareholders may by ordinary resolution declare a dividend, but no dividend may exceed the amount recommended by our board of directors. In either case, all dividends are subject to certain restrictions under BVI law, namely that the Company may only pay dividends out of profits or share premium, and provided that under no circumstances may a dividend be paid if this would result in the Company being unable to pay its debts as they fall due in the ordinary course of business. Any future determination related to our dividend policy will be made at the discretion of our board of directors after considering our financial condition, results of operations, capital requirements, contractual requirements, business prospects and other factors the board of directors deems relevant, and will be subject to the restrictions contained in any future financing instruments. Even if our board of directors decides to declare and pay dividends, the timing, amount and form of future dividends, if any, will depend on, among other things, our future results of operations and cash flow, our capital requirements and surplus, the amount of distributions, if any, received by us from our subsidiaries, our financial conditions, contractual restrictions and other factors deemed relevant by our board of directors. Accordingly, the return on your investment in our Class A Ordinary Shares will likely depend entirely upon any future price appreciation of our Class A Ordinary Shares. You may not realize a return on your investment in our Class A Ordinary Shares and you may even lose your entire investment in our Class A Ordinary Shares.

 

36

 

 

The sale or availability for sale of substantial amounts of our Class A Ordinary Shares could adversely affect their market price.

 

We are registering for resale an aggregate of up to 4,319,802 Class A Ordinary Shares, which represents approximately 71.09% of our outstanding Class A Ordinary Shares. Sales of substantial amounts of our Class A Ordinary Shares in the public market could adversely affect the market price of our Class A Ordinary Shares and could materially impair our ability to raise capital through equity offerings in the future. We cannot predict if and when the Selling Shareholders may sell the Resale Shares in the public markets. The Selling Shareholders acquired 4,255,786 shares of the Resale Shares in the July 2026 PIPE and the August 2026 PIPE at purchase prices of US$0.464 and US$0.316 per share, respectively, or approximately US$1.16 and US$0.79 per share, respectively, after giving effect to the October 2026 Reverse Stock Split, compared to the last reported sale price of our Class A Ordinary Shares of US$0.8930 on November 18, 2026. As a result, the Selling Shareholders may realize a positive rate of return on the sale of their Resale Shares even if the market price of our Class A Ordinary Shares declines below the price at which public investors purchased their shares, and the Selling Shareholders may therefore have an incentive to sell. Moreover, shares held by our other existing shareholders may be sold in the public market in the future, subject to the restrictions in Rule 144 and Rule 701 under the Securities Act and the applicable lock-up agreements, if any. We cannot predict what effect, if any, the market sales of shares held by our Selling Shareholders or any other shareholders or the availability of these securities for future sales will have on the market price of our Class A Ordinary Shares. Furthermore, in the future, we may issue additional Class A Ordinary Shares or other equity or debt securities convertible into Class A Ordinary Shares. Any such issuance could result in substantial dilution to our existing shareholders and could cause the share price of our Class A Ordinary Shares to decline.

 

Future issuances of our Class B Ordinary Shares or increase in the voting rights attached to our Class B Ordinary Shares may be dilutive to the voting power of our Class A Ordinary Shareholders.

 

Future issuances of our Class B Ordinary Shares, which can be approved by our board of directors, could result in dilution to existing holders of our Class A Ordinary Shares. Such issuances, or the perception that such issuances may occur, could depress the market price of our Class A Ordinary Shares.

 

In addition, there might be impact of the conversion of Class B Ordinary Shares on holders of Class A Ordinary Shares, including dilution and the reduction in aggregate voting power, as well as the potential increase in the relative voting power if any holder of our Class B Ordinary Shares retains their shares.

 

If securities or industry analysts do not publish research or reports about our business, or if they publish a negative report regarding our Class A Ordinary Shares, the price of our Class A Ordinary Shares and trading volume could decline.

 

The trading market for our Class A Ordinary Shares may depend in part on the research and reports that industry or securities analysts publish about us or our business. We do not have any control over these analysts. If one or more of the analysts who cover us downgrade us, the price of our Class A Ordinary Shares would likely decline. If one or more of these analysts cease coverage of our Company or fail to regularly publish reports on us, we could lose visibility in the financial markets, which could cause the price of our Class A Ordinary Shares and the trading volume to decline.

 

There can be no assurance that we will not be a passive foreign investment company, or PFIC, for United States federal income tax purposes for any taxable year, which could subject United States investors in our Class A Ordinary Shares to significant adverse United States income tax consequences.

 

We will be classified as a passive foreign investment company, or PFIC, for any taxable year if either (i) 75% or more of our gross income for such year consists of certain types of “passive” income, or (ii) 50% or more of the value of our assets (determined on the basis of a quarterly average) during such year produce or are held for the production of passive income (the “asset test”). Based upon our current and expected income and assets, including goodwill and the value of the assets held by our strategic investment business, as well as estimations as to the market price of our Class A Ordinary Shares, we do not presently expect to be classified as a PFIC for the current taxable year or the foreseeable future.

 

While we do not expect to be a PFIC, because the value of our assets, for purposes of the asset test, may be determined by reference to the market price of our Class A Ordinary Shares, fluctuations in the market price of our Class A Ordinary Shares may cause us to become classified as a PFIC for the current or subsequent taxable years. The determination of whether we will be or become a PFIC will also depend, in part, on the composition and classification of our income, including the relative amounts of income generated by and the value of assets of our strategic investment business as compared to our other businesses. Because there are uncertainties in the application of the relevant rules, it is possible that the U.S. Internal Revenue Service, or the IRS, may challenge our classification of certain income and assets as non-passive which may result in our being or becoming a PFIC in the current or subsequent years. In addition, the composition of our income and assets will also be affected by how, and how quickly, we use our liquid assets and the cash raised in our follow-on offerings. If we determine not to deploy significant amounts of cash for active purposes, our risk of being a PFIC may substantially increase. Because there are uncertainties in the application of the relevant rules and PFIC status is a factual determination made annually after the close of each taxable year, there can be no assurance that we will not be a PFIC for the current taxable year or any future taxable year.

 

37

 

 

If we are a PFIC in any taxable year, a U.S. Holder (as defined under the heading “Taxation - Material United States Federal Income Tax Considerations - General” in our 2026 Annual Report) may incur significantly increased United States income tax on gain recognized on the sale or other disposition of our Class A Ordinary Shares and on the receipt of distributions on our Class A Ordinary Shares to the extent such gain or distribution is treated as an “excess distribution” under the United States federal income tax rules, and such holder may be subject to burdensome reporting requirements. Further, if we are a PFIC for any year during which a U.S. Holder holds our Class A Ordinary Shares, we will generally continue to be treated as a PFIC for all succeeding years during which such U.S. Holder holds our Class A Ordinary Shares. For more information, see “Taxation - Material United States Federal Income Tax Considerations - Passive Foreign Investment Company Considerations” in our 2026 Annual Report.

 

If we fail to meet applicable listing requirements, Nasdaq may delist our Class A Ordinary Shares from trading, in which case the liquidity and market price of our Class A Ordinary Shares could decline.

 

Our securities are listed on the Nasdaq Capital Market. We cannot assure you that we will be able to meet the continued listing standards of Nasdaq in the future. If we fail to comply with the applicable listing standards and Nasdaq delists our Class A Ordinary Shares, we and our shareholders could face significant material adverse consequences, including:

 

●a limited availability for market quotations for our Class A Ordinary Shares;

 

●reduced liquidity with respect to our Class A Ordinary Shares;

 

●a determination that our Class A Ordinary Share is a “penny stock” which will require brokers trading in our Class A Ordinary Shares to adhere to more stringent rules and possibly result in a reduced level of trading activity in the secondary trading market for our Class A Ordinary Shares;

 

●limited amount of news and analyst coverage; and

 

●a decreased ability to issue additional securities or obtain additional financing in the future.

 

We received a written notification on December 19, 2025 from the Listing Qualifications Department of Nasdaq stating that the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum bid price of US$1.00 per share for at least 30 consecutive business days (the “Minimum Bid Price Requirement”). The Company was granted a 180-day compliance period, through June 17, 2026, to regain compliance with the Minimum Bid Price Requirement. If, at any time before June 17, 2026, the closing bid price for its Class A Ordinary Shares was at least US$1.00 for a minimum of 10 consecutive business days, Nasdaq would provide us with written confirmation of compliance with the Minimum Bid Price Requirement. On March 31, 2026, the Board of Directors of the Company approved a reverse stock split of all of the Company’s issued and unissued shares, including the Class A Ordinary Shares with no par value and Class B Ordinary Shares with no par value, at an exchange ratio of one (1) share for ten (10) shares (the “May 2026 Reverse Stock Split”). The May 2026 Reverse Stock Split primarily served as a mechanism to regain compliance with the Minimum Bid Price Requirement. On May 6, 2026, our Class A Ordinary Shares began trading on Nasdaq on a post-May 2026 Reverse Stock Split basis under the then existing symbol “MIMI”. On May 20, 2026, we received formal notification from Nasdaq indicating that the Company has regained compliance with the Minimum Bid Price Requirement. Furthermore, pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iv), if the Company’s Class A Ordinary Shares fail to meet the continued listing requirement for minimum bid price of US$1.00 per share and the Company has effected a reverse stock split over the prior one-year period; or has effected one or more reverse stock splits over the prior two-year period with a cumulative ratio of 250 shares or more to one, then the Company shall not be eligible for any compliance period specified in Rule 5810(c)(3)(A) and the Listing Qualifications Department shall issue a Staff Delisting Determination under Rule 5810 with respect to the Company’s security. The Company effected the May 2026 Reverse Stock Split, which took effect under BVI law on April 8, 2026, with our Class A Ordinary Shares beginning to trade on Nasdaq on a post-May 2026 Reverse Stock Split basis on May 6, 2026, and the October 2026 Reverse Stock Split, which took effect under BVI law on October 9, 2026, with our Class A Ordinary Shares beginning to trade on Nasdaq on a post-October 2026 Reverse Stock Split basis on October 22, 2026. Accordingly, until at least October 22, 2027, the Company will not be provided any compliance period to regain compliance with the Minimum Bid Price Requirement and will receive a Staff Delisting Determination if the closing bid price of our Class A Ordinary Shares is below US$1.00 for 30 consecutive business days, upon which the Company would be entitled to appeal Nasdaq’s determination to a Nasdaq Hearings Panel and request a hearing. There can be no assurance that we will maintain compliance with the continued listing requirements of Nasdaq.

 

Our Class A Ordinary Shares will continue to be listed and traded on the Nasdaq Capital Market, subject to our compliance with the other listing requirements of the Nasdaq Capital Market. We cannot assure you that we will not receive other deficiency notifications from Nasdaq in the future. A decline in the closing price of our Class A Ordinary Shares could result in a breach of the requirements for listing on the Nasdaq Capital Market. If we do not maintain compliance, Nasdaq could commence suspension or delisting procedures in respect of our Class A Ordinary Shares. The commencement of suspension or delisting procedures by an exchange remains at the discretion of such exchange and would be publicly announced by the exchange. If a suspension or delisting were to occur, there would be significantly less liquidity in the suspended or delisted securities. In addition, our ability to raise additional necessary capital through equity or debt financing would be greatly impaired. Furthermore, with respect to any suspended or delisted Class A Ordinary Shares, we would expect decreases in institutional and other investor demand, analyst coverage, market making activity and information available concerning share prices and volume, and fewer broker-dealers would be willing to execute trades with respect to such Class A Ordinary Shares. A suspension or delisting would likely decrease the attractiveness of our Class A Ordinary Shares to investors and cause the sales volume of our Class A Ordinary Shares to decline, which could result in a further decline in the market price of our Class A Ordinary Shares.

 

38

 

 

We are an “emerging growth company”, and the reduced disclosure requirements applicable to emerging growth companies may make our Class A Ordinary Shares less attractive to investors.

 

We are an “emerging growth company,” as defined in the Jumpstart Our Business Startups Act of 2012, or the JOBS Act. For so long as we remain an emerging growth company, we are permitted and intend to rely on exemptions from certain disclosure requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include:

 

●being permitted to provide only two years of audited financial statements, in addition to any required unaudited interim financial statements, with correspondingly reduced “Management’s Discussion and Analysis of Financial Condition and Results of Operations” disclosure;

 

●not being required to comply with the auditor attestation requirements in the assessment of our internal control over financial reporting of Section 404(b) of the Sarbanes-Oxley Act;

 

●not being required to comply with any requirement that may be adopted by the Public Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements;

 

●reduced disclosure obligations regarding executive compensation; and

 

●exemptions from the requirements of holding a non-binding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved.

 

We have taken advantage of reduced reporting burdens in preparing our financial statements incorporated by reference in this prospectus. For example, our auditor is not required to attest to the effectiveness of our internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act, we have elected to use the extended transition period for complying with new or revised accounting standards, and our auditor is not required to communicate critical audit matters in its report on our financial statements.

 

We cannot predict whether investors will find our Class A Ordinary Shares less attractive if we rely on these exemptions. If some investors find our Class A Ordinary Shares less attractive as a result, there may be a less active trading market for our Class A Ordinary Shares and our share price may be more volatile.

 

We will remain an emerging growth company until the earliest of (i) the date on which we are deemed to be a “large accelerated filer” under the Securities Exchange Act of 1934, as amended, or the Exchange Act, which would occur if the market value of our Class A Ordinary Shares that are held by non-affiliates exceeds $700 million as of the last business day of our most recently completed second fiscal quarter; (ii) the end of the fiscal year during which we have total annual gross revenues of $1.235 billion or more; (iii) the date on which we have, during the preceding three-year period, issued more than $1.0 billion in non-convertible debt; or (iv) the last day of our fiscal year following the fifth anniversary of the completion of the IPO.

 

We will incur increased costs after we cease to qualify as an emerging growth company.

 

We are a public company and expect to incur significant legal, accounting and other expenses that we did not incur as a private company. The Sarbanes-Oxley Act of 2002 and the rules subsequently implemented by the SEC and Nasdaq detailed requirements concerning corporate governance practices of public companies. Compliance with these rules increases our legal and financial compliance costs and may make some corporate activities more time-consuming and costly. As a company with less than $1.235 billion in net revenue for our last fiscal year, we qualify as an “emerging growth company” pursuant to the JOBS Act. An emerging growth company may take advantage of specified reduced reporting and other requirements that are otherwise applicable generally to public companies. These provisions include exemption from the auditor attestation requirement under Section 404 of the Sarbanes-Oxley Act of 2012 relating to internal controls over financial reporting.

 

After we cease to qualify as an “emerging growth company,” we expect to incur significant expenses and devote substantial management effort toward ensuring compliance with the requirements of Section 404 of the Sarbanes-Oxley Act of 2002 and our other public company reporting obligations and compliance matters. We are currently evaluating and monitoring developments with respect to these rules and regulations, and we cannot predict or estimate with any degree of certainty the amount of additional costs we may incur or the timing of such costs.

 

39

 

 

We are a foreign private issuer within the meaning of the rules under the Exchange Act, and as such we are exempt from certain provisions applicable to U.S. domestic public companies.

 

Because we qualify as a foreign private issuer under the Exchange Act, we are exempt from certain provisions of the securities rules and regulations in the United States that are applicable to U.S. domestic issuers, including:

 

●the rules under the Exchange Act requiring the filing with the SEC of quarterly reports on Form 10-Q or current reports on Form 8-K;

 

●the sections of the Exchange Act regulating the solicitation of proxies, consents, or authorizations in respect of a security registered under the Exchange Act; and

 

●the selective disclosure rules by issuers of material non-public information under Regulation FD.

 

We are required to file an annual report on Form 20-F within four months of the end of each fiscal year. Press releases relating to financial results and material events will also be furnished to the SEC on Form 6-K. Beginning March 18, 2026, members of our board of directors and senior management are subject to insider trading reporting obligations under Section 16(a) of the Exchange Act. They are also subject to the obligations to report changes in share ownership under Section 13 of the Exchange Act and related SEC rules. However, the information we are required to file with or furnish to the SEC will be less extensive and less timely compared to that required to be filed with the SEC by U.S. domestic issuers. As a result, you may not be afforded the same protections or information that would be made available to you were you investing in a U.S. domestic issuer.

 

We may lose our foreign private issuer status in the future, which could result in significant additional costs and expenses.

 

We are a foreign private issuer, and therefore, we are not required to comply with all of the periodic disclosure and current reporting requirements of the Exchange Act. The determination of foreign private issuer status is made annually on the last business day of an issuer’s most recently completed second fiscal quarter. We would lose our foreign private issuer status if, for example, more than 50% of our shares are directly or indirectly held by residents of the United States and we fail to meet additional requirements necessary to maintain our foreign private issuer status. If we lose our foreign private issuer status on this date, we will be required to file with the SEC periodic reports and registration statements on U.S. domestic issuer forms, which are more detailed and extensive than the forms available to a foreign private issuer. We will also have to mandatorily comply with U.S. federal proxy requirements, and all of our directors, officers and principal shareholders will become subject to short-swing profit recovery rules and reporting obligations under Section 16 of the Exchange Act. On December 18, 2025, U.S. President Donald Trump signed into law the Holding Foreign Insiders Accountable Act (the “HFIA Act”), which eliminates the exemption for directors and officers of foreign private issuers to comply with Section 16(a) of the Exchange Act. The new law took effect on March 18, 2026. Directors and officers of foreign private issuers will be required to publicly report their ownership in, and transactions involving, the applicable foreign private issuer’s securities to the SEC on Forms 3, 4, and 5.

 

In addition, we will lose our ability to rely upon exemptions from certain corporate governance requirements under the Nasdaq rules. As a U.S. listed public company that is not a foreign private issuer, we will incur significant additional legal, accounting and other expenses that we will not incur as a foreign private issuer, and accounting, reporting and other expenses in order to maintain a listing on a U.S. securities exchange.

 

Nasdaq’s newly amended Low Price Requirement may result in immediate suspension and delisting of our Class A ordinary shares without a cure period if our share price falls to $0.10 or less for 10 consecutive business days.

 

On August 22, 2025, Nasdaq filed a proposed rule change to raise the consequences of failing to satisfy the Low Price Requirement, which was approved by the SEC on an accelerated basis and became operative on January 19, 2026. Under the amended Low Price Requirement, a failure to meet the continued listing requirement for minimum bid price shall be determined to exist if a company’s security has a closing bid price of $0.10 or less for 10 consecutive business days, regardless of whether the company is under any compliance period specified in Nasdaq Rule 5810(c)(3)(A), and upon such failure, a delisting determination will be issued under Nasdaq Rule 5810, the security shall be immediately suspended from trading, and the company shall be ineligible for any compliance period otherwise described in Nasdaq Rule 5810(c)(3)(A). In addition, a request for a hearings panel review will not stay the trading suspension.

 

40

 

 

If the price of our Class A Ordinary Shares deteriorates further and falls to $0.10 or less for 10 consecutive business days, we would be immediately suspended from trading and delisted without any opportunity to cure the deficiency or stay the suspension pending a hearing. Nasdaq has observed deep financial or operational distress from companies whose security’s price drops to $0.10 or less for 10 consecutive business days, and these financial or operational issues are generally not temporary. This accelerated delisting mechanism creates significant uncertainty for our shareholders and could result in the sudden and complete loss of a public trading market for our Class A Ordinary Shares.

 

Nasdaq’s proposed $5 million minimum market value continued listing requirement previously approved by SEC now stayed pending further action from the SEC. If affirmed by SEC, such rule could result in immediate suspension and delisting of our Ordinary Shares without any cure period or opportunity to regain compliance.

 

On January 13, 2026, Nasdaq proposed a new listing rule requiring companies on the Nasdaq Global and Capital Markets to maintain a minimum market value of listed securities of $5 million (the “MVLS Rule”). Under the MVLS Rule, if our market value falls below $5 million for 30 consecutive business days, our Class A Ordinary Shares would be immediately suspended from trading and delisted from Nasdaq, with no cure period, no compliance period, and no stay of suspension during any appeal. On July 22, 2026, such rule was approved by the SEC and became effective.

 

On July 29, 2026, however, the SEC notified Nasdaq that it had received notices of intention to petition for review the SEC’s July 22, 2026 order approving the MVLS Rule. Pursuant to Rule 431(e) of the SEC’s Rules of Practice, the approval order has been stayed pending further action from the SEC. Accordingly, the MVLS Rule is currently not effective. As there is no prescribed timeline for SEC’s action, there is uncertainty as to whether and when such rule will become effective.

 

If affirmed by the SEC, the MVLS Rule would represent a fundamental departure from Nasdaq’s traditional approach to listing deficiencies. Unlike other continued listing requirements that provide companies with 180 days or more to regain compliance, the market value requirement would result in immediate and irreversible consequences. While we could request a hearing before a Nasdaq Listing Qualifications Hearings Panel to appeal a delisting determination, such a request would not prevent the immediate suspension of our Class A Ordinary Shares from trading. Furthermore, the Nasdaq Listing Qualifications Hearings Panel would have extremely limited discretion and could only reverse the delisting decision if it determines that the initial determination was in error, and could not consider evidence that we had subsequently regained compliance or grant us additional time to do so.

 

Nasdaq’s proposal reflects its belief that once a company’s market value falls below $5 million, the challenges facing that company are generally not temporary and are so severe that the company is unlikely to regain and sustain compliance for the long term. Nasdaq further believes it is difficult to maintain fair and orderly markets for such low-value companies. This proposal is part of a broader trend of Nasdaq tightening listing standards for small issuers, including recent rules granting Nasdaq discretion to deny initial listings based on susceptibility to manipulative trading and other market value-based requirements. This increasingly stringent regulatory environment creates greater challenges for microcap companies like us to maintain public listings.

 

While our current market value of listed securities is above $5 million, there is no assurance that our market value would not fall below $5 million in the future. Our market value is calculated as our consolidated closing bid price multiplied by our total number of listed securities. Factors that could cause our market value to fall below the $5 million threshold include continued share price decline, lack of investor interest, adverse market conditions, negative developments in our business operations, dilutive financing transactions, or broader market volatility affecting microcap companies. If the MVLS Rule becomes effective and we are simultaneously addressing our existing minimum bid price deficiency when our market value falls or faces the threat of falling below $5 million, we could face multiple overlapping delisting threats that compound the risk of delisting.

 

If the MVLS Rule becomes effective and we fail to maintain the required market value for 30 consecutive business days, our Ordinary Shares would be immediately suspended from trading and delisted from Nasdaq with no opportunity to cure the deficiency, which would have severe adverse consequences for our business, our ability to raise capital, and the liquidity and value of our shareholders’ investments.

 

41

 

 

USE OF PROCEEDS

 

All of the Resale Shares will be sold by the Selling Shareholders for their own account. We will not receive any proceeds from the sales.

 

We will bear the out-of-pocket costs, expenses and fees incurred in connection with the registration of the Resale Shares offered for sale by the Selling Shareholders under this prospectus. The Selling Shareholders will bear their own broker or similar commissions payable with respect to any sales of the Resale Shares.

 

42

 

 

DIVIDEND POLICY

 

Axonex BVI, our BVI holding company, since its incorporation on October 18, 2023, has not declared or made any dividend payment or distribution to its shareholders, including U.S. investors, in the past, nor has any dividend payment or distribution been made by our subsidiaries to the BVI holding company. For the fiscal years ended March 31, 2026, 2025 and 2024, neither Axonex BVI nor its subsidiaries has declared or made any dividend payment or distribution to their respective shareholder(s).

 

We anticipate that we will retain any earnings to support operations and to finance the growth and development of our business. Therefore, we currently have no plans to declare or pay any dividends on our shares in the near future. Any future determination related to our dividend policy will be made at the discretion of our board of directors after considering our financial condition, results of operations, capital requirements, contractual requirements, business prospects and other factors the board of directors deems relevant, and subject to the restrictions contained in any future financing instruments.

 

The declaration, amount and payment of any future dividends will be at the sole discretion of our board of directors, subject to compliance with applicable BVI laws regarding solvency. Our board of directors will take into account general economic and business conditions, our financial condition and results of operations, our available cash and current and anticipated cash needs, capital requirements, contractual, legal, tax and regulatory restrictions and other implications on the payment of dividends by us to our shareholders or by our subsidiaries to us, and such other factors as our board of directors may deem relevant. In addition, our shareholders may by ordinary resolution declare a dividend, but no dividend may exceed the amount recommended by our board of directors.

 

Subject to the BVI Act and our Amended and Restated Memorandum and Articles of Association, our board of directors may, by resolution of directors, declare and authorize a distribution (which includes a dividend) to our shareholders from time to time and of an amount they think fit if they are satisfied, on reasonable grounds, that immediately after the distribution (a) the Company will be able to pay its debts as they fall due; and (b) the value of our assets exceeds our liabilities.

 

Our Company relies on dividends paid by our subsidiaries for its cash requirements, including funds to pay any dividends and other cash distributions to its shareholders, service any debt it may incur and pay its operating expenses. Our Company’s ability to pay dividends to its shareholders will depend on, among other things, the availability of dividends from our subsidiaries.

 

Under the current practice of the Inland Revenue Department of Hong Kong, no tax is payable in Hong Kong in respect of dividends paid by us.

 

Cash dividends, if any, on our Class A Ordinary Shares will be paid in U.S. dollars.

 

43

 

 

principal shareholders

 

The following table sets forth information regarding the beneficial ownership of our Class A Ordinary Shares and Class B Ordinary Shares as of the date of this prospectus by (i) each of our directors and executive officers; and (ii) each person or group known to us to beneficially own 5% or more of our outstanding Class A Ordinary Shares and Class B Ordinary Shares. Except as set forth below, we are not aware of any other person or group that beneficially owns 5% or more of our outstanding Class A Ordinary Shares and Class B Ordinary Shares.

 

We have determined beneficial ownership in accordance with the rules of the SEC. These rules generally attribute beneficial ownership of securities to persons who possess sole or shared voting power or investment power with respect to those securities. The person is also deemed to be a beneficial owner of any security of which that person has a right to acquire beneficial ownership within 60 days of the date of this prospectus. Unless otherwise indicated, the persons identified in this table have sole voting and investment power with respect to all shares shown as beneficially owned by them, subject to applicable community property laws.

 

Other than as disclosed herein, none of our shareholders has informed us that it is affiliated with a registered broker-dealer or is in the business of underwriting securities. The number of individual holders of record is based exclusively upon our share register and does not address whether a share or shares may be held by the holder of record on behalf of more than one person or institution who may be deemed to be the beneficial owner of a share or shares in our Company.

 

As of the date of this prospectus, we have 6,076,338 Class A Ordinary Shares and 280,752 Class B Ordinary Shares issued and outstanding. Each Class A Ordinary Share shall entitle the holder thereof to one (1) vote on all matters subject to vote at general meetings of our Company and each Class B Ordinary Share shall entitle the holder thereof to twenty (20) votes on all matters subject to vote at general meetings of our Company.

 

44

 

 

The table below has reflected (i) the 1-for-10 May 2026 Reverse Stock Split effective April 8, 2026 (with trading on Nasdaq on a post-split basis commencing May 6, 2026) and the 2-for-5 October 2026 Reverse Stock Split effective October 9, 2026 (with trading on Nasdaq on a post-split basis commencing October 22, 2026); (ii) the conversion by AL Holding Group Limited of 2,100,000 Class B Ordinary Shares into 2,100,000 Class A Ordinary Shares on December 11, 2025; (iii) the issuance of 211,879 Class B Ordinary Shares to Deep Vision Enterprise Limited on May 26, 2026; (iv) the appointment of Mr. Xunze (Tyler) Xiu and the resignation of Ms. Lo Chanii Kam; (v) the July 2026 PIPE and the August 2026 PIPE; and (vi) the August 2026 Offering.

 

   Class A
Ordinary Shares
Beneficially Owned
   Class B
Ordinary Shares
Beneficially Owned
   Aggregate
Voting
Power (1)
 
Name of Beneficial Owner  Number   %   Number   %   % 
Directors and Executive Officers (2):                         
Hoi Lung Chan(3)   72,184    1.19%   189,752    67.59%   33.08%
Cheong Shing Ku(4)   62,552    1.03%   91,000    32.41%   16.10%
Sze Ki Cheng   -    -    -    -    - 
Ka Wai (Taniel) Wong   -    -    -    -    - 
Chun Pong Raymond Siu   -    -    -    -    - 
Xunze (Tyler) Xiu   -    -    -    -    - 
Directors and Executive Officers as a Group:   134,736    2.22%   280,752    100%   49.18%
5% or Greater Shareholders:                         
Deep Vision Enterprise Limited(3)   72,184    1.19%   189,752    67.59%   33.08%
I Sparks Enterprise Limited(4)   62,552    1.03%   91,000    32.41%   16.10%
Chun Yin Dai   505,330    8.32%   -    -    4.32%
Ka Kin Law   505,119    8.31%   -    -    4.32%
Chun Kit Lau   505,119    8.31%   -    -    4.32%
Tao Liu   499,761    8.22%   -    -    4.27%

 

(1)Aggregate voting power represents voting power with respect to all of our Class A Ordinary Shares and Class B Ordinary Shares as a single class. Each Class A Ordinary Share shall entitle the holder thereof to one (1) vote per share and each Class B Ordinary Share shall entitle the holder thereof to twenty (20) votes per share on all matters submitted to our shareholders for a vote. Holders of our Class A Ordinary Shares and Class B Ordinary Shares shall vote together as a single class on all matters submitted to a vote of our shareholders, except as may otherwise be required by the BVI Act or the Amended and Restated Memorandum and Articles of Association. Each Class B Ordinary Share is convertible into one (1) Class A Ordinary Share at any time at the option of the holder thereof but in no event shall Class A Ordinary Shares be convertible into Class B Ordinary Shares.

 

(2)

Unless otherwise indicated, the business address of our directors and executive officers is Unit 506-8, 5/F, Laford Centre, 838 Lai Chi Kok Road, Lai Chi Kok, Kowloon, Hong Kong.

 

(3) Deep Vision Enterprise Limited is a BVI business company with limited liability incorporated under the laws of the BVI, which is wholly owned by Mr. Hoi Lung CHAN, the Chairman of the Board and Chief Executive Officer of the Company. Mr. Chan holds the voting and dispositive power over the Class A Ordinary Shares and Class B Ordinary Shares held by Deep Vision Enterprise Limited. The registered address of Deep Vision Enterprise Limited is at the office of Ogier Global (BVI) Limited, Ritter House, Wickhams Cay II, PO Box 3170, Road Town, Tortola VG1110, British Virgin Islands.

 

(4)I Sparks Enterprise Limited is a BVI business company with limited liability incorporated under the laws of the BVI, which is wholly owned by Mr. Cheong Shing KU, a director of the Company. Mr. Ku holds the voting and dispositive power over the Class A Ordinary Shares and Class B Ordinary Shares held by I Sparks Enterprise Limited. The registered address of I Sparks Enterprise Limited is at the office of Ogier Global (BVI) Limited, Ritter House, Wickhams Cay II, PO Box 3170, Road Town, Tortola VG1110, British Virgin Islands.

 

45

 

 

SELLING SHAREHOLDERS

 

Each of the Selling Shareholders is not a broker-dealer nor an affiliate of a broker-dealer. The Selling Shareholders may, from time to time, offer and sell any or all of the Resale Shares being registered for resale under the registration statement of which this prospectus forms a part. However, we cannot advise you as to whether the Selling Shareholders will, in fact, sell any or all of such Resale Shares. In addition, the Selling Shareholders named below may have sold, transferred or otherwise disposed of, or may sell, transfer or otherwise dispose of, at any time and from time to time, some or all of our securities in transactions exempt from or not subject to the registration requirements of the Securities Act after the date on which the information in the table is presented. See the section titled “Plan of Distribution” beginning on page 48 of this prospectus.

 

When we refer to “Selling Shareholders” in this prospectus, we refer to the persons listed in the table below, and their pledgees, donees, transferees, assignees, successors, and others who later come to hold any of the Selling Shareholders’ interest in the Resale Shares after the date of this prospectus.

 

The table below sets forth, as of the date of this prospectus, information regarding the beneficial ownership of the Class A Ordinary Shares of the Selling Shareholders and the number of Class A Ordinary Shares that may be sold by the Selling Shareholders pursuant to this prospectus. The percentage of beneficial ownership of each listed Selling Shareholder is based on 6,076,338 Class A Ordinary Shares, including 4,319,802 Resale Shares, issued and outstanding as of the date of this prospectus and immediately after this resale offering, giving effect to the October 2026 Reverse Stock Split and assuming no further issuances of Class A Ordinary Shares during this resale offering. Information with respect to our Class A Ordinary Shares owned beneficially after this resale offering assumes the sale of all of the Resale Shares held by the Selling Shareholders. The Selling Shareholders may offer and sell some, all or none of their Resale Shares.

 

The Class A Ordinary Shares being registered for resale pursuant to this prospectus will constitute a considerable percentage of our “public float” (defined as the number of our issued and outstanding Class A Ordinary Shares held by non-affiliates). The Selling Shareholders named below beneficially own an aggregate of 4,319,802 Resale Shares, which is equal to approximately 71.09% of our total issued and outstanding Class A Ordinary Shares as of the date of the prospectus. The Selling Shareholders will be able to sell their Resale Shares for so long as the registration statement of which this prospectus forms a part is available for use.

 

46

 

 

Because the Selling Shareholders may dispose of all, none or some portion of their Resale Shares, we cannot advise you as to whether the Selling Shareholders will in fact sell any or all of such Resale Shares. No estimate can be given as to the number of Class A Ordinary Shares that will be beneficially owned by the Selling Shareholders upon completion or termination of this resale offering. For purposes of the table below, however, we have assumed that, upon completion of this resale offering, none of the Resale Shares covered by the registration statement of which this prospectus forms a part will be beneficially owned by the Selling Shareholders and further assumed that the Selling Shareholders will not acquire or dispose of beneficial ownership of any other securities during this resale offering.

 

   Class A
Ordinary Shares
Beneficially Owned
Prior to Resale
Offering
   Maximum Number of
Class A Ordinary
Shares
   Class A
Ordinary Shares
Beneficially Owned
After Resale
Offering
 
Name of Selling Shareholder  Number   %   Offered (1)   Number   % 
Chun Yin Dai(2)   505,330    8.32%   505,330          -        - 
Ka Kin Law(2)   505,119    8.31%   505,119    -    - 
Chun Kit Lau(2)   505,119    8.31%   505,119    -    - 
Tao Liu(2)   499,761    8.22%   499,761    -    - 
Pik Man Soo(2)   252,817    4.16%   252,817    -    - 
Man Yip Pun(2)   252,817    4.16%   252,817    -    - 
Yau Sing Lee(2)   252,817    4.16%   252,817    -    - 
Ya Hui Chen(2)   252,817    4.16%   252,817    -    - 
Pui Li Bailie Kan(2)   252,817    4.16%   252,817    -    - 
Lee Cheung(2)   249,026    4.10%   249,026    -    - 
Kwok Hung Lee(2)   230,032    3.79%   230,032    -    - 
Jingyu Zhao(2)   210,226    3.46%   210,226    -    - 
Xiaoxue Ai(2)   191,511    3.15%   191,511    -    - 
Lai Sze Ng(2)   159,593    2.63%   159,593    -    - 

 

(1)Assumes that the Selling Shareholders sell all of their Resale Shares offered for sale pursuant to this prospectus.

 

(2)

Except as described in the following sentence, each of the Selling Shareholders acquired the Resale Shares pursuant to the July 2026 PIPE (as defined below) and the August 2026 PIPE (as defined below). In addition, 38,000 of the Resale Shares held by Dai Chun Yin and 26,000 of the Resale Shares held by Cheung Lee (in each case after giving effect to the October 2026 Reverse Stock Split) were acquired from an existing shareholder of the Company in private transactions on January 16, 2026. We were not a party to, and did not receive any proceeds from, those transactions.

 

On July 2, 2026, the Company entered into a securities purchase agreement with each of the Selling Shareholders, pursuant to which the Company agreed to issue and sell to the Selling Shareholders an aggregate of 4,310,350 Class A Ordinary Shares (the “July 2026 PIPE Shares”) at a purchase price of US$ 0.464 per share, representing 20% of the closing price of the Class A Ordinary Shares on the Nasdaq Capital Market on July 1, 2026, for an aggregate purchase price of US$2,000,000 (the “July 2026 PIPE”). On July 8, 2026, the Company issued the July 2026 PIPE Shares to the Selling Shareholders.

 

On July 30, 2026, the Company entered into another securities purchase agreement with each of the Selling Shareholders, pursuant to which the Company agreed to issue and sell to the Selling Shareholders an aggregate of 6,329,115 Class A Ordinary Shares (the “August 2026 PIPE Shares”) at a purchase price of US$0.316 per share, representing 20% of the closing price of the Class A Ordinary Shares on the Nasdaq Capital Market on July 29, 2026, for an aggregate purchase price of US$2,000,000 (the “August 2026 PIPE”). On August 11, 2026, the Company issued the August 2026 PIPE Shares to the Selling Shareholders.

 

On October 9, 2026, the Company effected a reverse stock split of all of the Company’s issued and unissued shares, including the Resale Shares, at an exchange ratio of two (2) shares for five (5) shares (the “October 2026 Reverse Stock Split”). Our Class A Ordinary Shares began trading on Nasdaq on a post-October 2026 Reverse Stock Split basis on October 22, 2026. The number of Resale Shares held by each Selling Shareholder gives effect to the October 2026 Reverse Stock Split.

 

For more information, please refer to “Prospectus Summary – Recent Developments – Private Placement of Class A Ordinary Shares, July 2026”, “Prospectus Summary – Recent Developments – Private Placement of Class A Ordinary Shares, August 2026” and “Prospectus Summary – Recent Developments – Reverse Stock Split, October 2026” on pages 8 and 10 of this prospectus, respectively.

 

47

 

 

PLAN OF DISTRIBUTION

 

The Resale Shares held by the Selling Shareholders may be sold or distributed from time to time by the Selling Shareholders directly to one or more purchasers or through brokers, dealers, or underwriters who may act solely as agents at market prices prevailing at the time of sale, at prices related to the prevailing market prices, at negotiated prices, or at fixed prices, which may be carried out on any stock exchange, market or trading facility on which the shares are traded or in private transactions. The sale of the Selling Shareholders’ Resale Shares offered by this prospectus may be effected in one or more of the following methods:

 

●on any national securities exchange or quotation service on which the securities may be listed or quoted at the time of sale;

 

●in the over-the-counter market;

 

●in transactions otherwise than on these exchanges or systems or in the over-the-counter market;

 

●ordinary brokerage transactions and transactions in which the broker-dealer solicits purchasers;

 

●transactions involving cross or block trades;

 

●purchases by a broker-dealer as principal and resale by the broker-dealer for its account;

 

●an exchange distribution in accordance with the rules of the applicable exchange;

 

●in privately negotiated transactions;

 

●short sales made after the date the registration statement of which this prospectus forms a part is declared effective by the SEC;

 

●broker-dealers may agree with a Selling Shareholder to sell a specified number of such Resale Shares at a stipulated price per share;

 

●“at the market” into an existing market for securities;

 

●through the writing or settlement of options on the shares;

 

●a combination of any such methods of sale; and

 

●any other method permitted pursuant to applicable law.

 

In order to comply with the securities laws of certain states, if applicable, the Resale Shares of the Selling Shareholders may be sold only through registered or licensed brokers or dealers. In addition, in certain states, such Resale Shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from the registration or qualification requirement is available and complied with.

 

The Selling Shareholders may also sell the Resale Shares under Rule 144 promulgated under the Securities Act, if available, or any other exemption available under the Securities Act rather than under this prospectus. In addition, the Selling Shareholders may transfer the Class A Ordinary Shares by other means not described in this prospectus.

 

48

 

 

The Selling Shareholders may also sell the Resale Shares directly to market makers acting as principals and/or broker-dealers acting as agents for themselves or their customers. Such broker-dealers may receive compensation in the form of discounts, concessions or commissions from the Selling Shareholders and/or the purchasers of shares for whom such broker-dealers may act as agents or to whom they sell as principal or both, which compensation as to a particular broker-dealer might be in excess of customary commissions. The Selling Shareholders may agree to indemnify any agent, dealer or broker-dealer that participates in transactions involving sales of the Resale Shares if liabilities are imposed on that person under the Securities Act. It is possible that the Selling Shareholders will attempt to sell the Resale Shares in block transactions to market makers or other purchasers at a price per share which may be below the then market price. Market makers and block purchasers purchasing the shares will do so for their own account and at their own risk. The Selling Shareholders cannot assure that all or any of the securities offered in this prospectus will be sold by them. In connection with sales of securities or otherwise, the Selling Shareholders may enter into hedging transactions with broker-dealers, which may in turn engage in short sales of the securities in the course of hedging in positions they assume. The Selling Shareholders may also sell securities short and deliver securities covered by this prospectus to close out short positions and to return borrowed shares in connection with such short sales. The Selling Shareholders may also loan or pledge securities to broker-dealers that in turn may sell such securities. The Selling Shareholders and any broker-dealers or agents that participate in the distribution of the Resale Shares may be deemed to be “underwriters” within the meaning of Section 2(a)(11) of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers or agents and any profit on the resale of the Resale Shares purchased by them may be deemed to be underwriting commissions or discounts under the Securities Act.

 

The Selling Shareholders may pledge or grant a security interest in some or all of their securities offered in this prospectus and, if they default in the performance of their secured obligations, the pledgees or secured parties may offer and sell the securities from time to time pursuant to this prospectus or any amendment to this prospectus under Rule 424(b)(3) or other applicable provision of the Securities Act amending, if necessary, the list of Selling Shareholders to include the pledgee, transferee or other successors in interest as Selling Shareholders under this prospectus. The Selling Shareholders may also transfer and donate the securities in other circumstances in which case the transferees, donees, pledgees or other successors in interest will be the selling beneficial owners for purposes of this prospectus.

  

With respect to a particular offering of the securities held by the Selling Shareholders, to the extent required, we will file a supplement to this prospectus. If any sales of the Resale Shares offered under this prospectus are made to broker-dealers as principals and subsequent resales by broker-dealers for their own account, the Company would be required to file a post-effective amendment to the registration statement of which this prospectus forms a part. In the post-effective amendment, the Company would be required to disclose the names of any participating broker-dealers and the compensation arrangements relating to such sales.

 

To the extent applicable, we will make copies of this prospectus (as it may be supplemented or amended from time to time) available to the Selling Shareholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act.

 

The Selling Shareholders will pay any fees and expenses incurred by the Selling Shareholders for brokerage, accounting, tax, or legal services or any other expenses incurred by the Selling Shareholders in disposing of the Resale Shares. We will bear all costs, fees, and expenses in effecting the registration of the securities covered by this prospectus, including, without limitation, all SEC filing fees and expenses of compliance with state securities or “blue sky” laws and other registration and filing fees and fees and expenses of our counsel and our independent registered public accountants.

 

Regulation M

 

The anti-manipulation rules of Regulation M under the Exchange Act may apply to sales of our Class A Ordinary Shares and activities of the Selling Shareholders.

 

We have advised the Selling Shareholders that while they are engaged in a distribution of the securities included in this prospectus, they are required to comply with Regulation M promulgated under the Exchange Act. With certain exceptions, Regulation M precludes the selling shareholders, any affiliated purchasers, and any broker-dealer or other person who participates in the distribution from bidding for or purchasing, or attempting to induce any person to bid for or purchase, any security which is the subject of the distribution until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in order to stabilize the price of a security in connection with the distribution of that security. All of the foregoing may affect the marketability of the securities offered for sale in this prospectus.

 

49

 

 

DESCRIPTION OF SHARE CAPITAL

 

We are incorporated as a BVI business company under the laws of the BVI on October 18, 2023, under the name “Mint Incorporation Limited”, company no. 2134287, and changed our name to “Axonex AI Group Limited” on September 28, 2026. As of the date of this prospectus, we are authorized to issue an unlimited number of shares of no par value each divided into unlimited class A ordinary shares of no par value each and unlimited class B ordinary shares of no par value each.

 

The following are summaries of the material provisions of our Amended and Restated Memorandum and Articles of Association and the BVI Act, insofar as they relate to the material terms of our Ordinary Shares. Our Amended and Restated Memorandum and Articles of Association are filed as exhibits to the registration statement of which this prospectus forms a part.

 

Ordinary Shares

 

Class A Ordinary Shares

 

Each Class A Ordinary Share in the Company confers upon the shareholder the right to one (1) vote per share at a meeting of the shareholders of the Company or on any resolution of shareholders. Unless otherwise required by the BVI Act, and our Amended and Restated Memorandum and Articles of Association, holders of our Class A Ordinary Shares will vote together with holders of our Class B Ordinary Shares as a single class on all matters presented to our shareholders for their vote approval.

 

Each Class A Ordinary Share in the Company confers upon the shareholder the right to an equal share in any dividend paid by the Company.

 

Each Class A Ordinary Share in the Company confers upon the shareholder the right to an equal share in the distribution of the surplus assets of the Company on its liquidation.

 

Class A Ordinary Shares are not convertible into Class B Ordinary Shares at any time.

 

All of our issued Class A Ordinary Shares are fully paid and non-assessable. Certificates representing the Class A Ordinary Shares are issued in registered form. Our shareholders who are non-residents of the BVI may freely hold and vote their Class A Ordinary Shares.

 

As of the date of this prospectus, there are 6,076,338 Class A Ordinary Shares issued and outstanding.

 

Class B Ordinary Shares

 

Each Class B Ordinary Share in the Company confers upon the shareholder the right to twenty (20) votes at a meeting of the shareholders of the Company or on any resolution of shareholders. Unless otherwise required by the BVI Act, and our Amended and Restated Memorandum and Articles of Association, holders of our Class B Ordinary Shares will vote together with holders of our Class A Ordinary Shares as a single class on all matters presented to our shareholders for their vote approval.

 

Each Class B Ordinary Share in the Company confers upon the shareholder the right to an equal share in any dividend paid by the Company.

 

Each Class B Ordinary Share in the Company confers upon the shareholder the right to an equal share in the distribution of the surplus assets of the Company on its liquidation.

 

Each Class B Ordinary Share shall be converted at the option of the holder, at any time after issue and without the payment of any additional sum, into such number of Class A Ordinary Shares, as may be issued at the rate of conversion from Class B Ordinary Shares to Class A Ordinary Shares on a 1:1 basis, subject to adjustments to account for any subdivision, combination or similar reclassification or recapitalization of outstanding Class A Ordinary Shares without a proportionate and corresponding subdivision, combination or similar reclassification or recapitalization of outstanding Class B Ordinary Shares provided in the Amended and Restated Memorandum and Articles of Association (the “Conversion Rate”), of fully paid Class A Ordinary Shares calculated at the Conversion Rate. Any and all taxes and stamp, issue and registration duties (if any) arising on conversion shall be borne by the holder of Class B Ordinary Shares requesting conversion.

 

As of the date of this prospectus, there are 280,752 Class B Ordinary Shares issued and outstanding.

 

50

 

 

Dividends

 

The holders of our Ordinary Shares are entitled to such dividends as may be declared by our board of directors subject to the BVI Act. Our Amended and Restated Memorandum and Articles of Association provide that our directors may, by resolution of directors, authorize and declare a distribution at a time and of an amount they think fit if they are satisfied, on reasonable grounds, that, immediately after the distribution, the value of the Company’s assets will exceed its liabilities and the Company will be able to satisfy its debts as they fall due in the ordinary course of business.

 

Unclaimed Dividends

 

A dividend that remains unclaimed for a period of three (3) years after it became due for payment may, by resolution of directors, be forfeited, for the benefit of the Company, and shall cease to remain owing by the Company.

 

Shareholders’ Voting Rights

 

Pursuant to our Amended and Restated Memorandum and Articles of Association, at each meeting of the shareholders of our Company, on a poll, each shareholder who is present in person or by proxy (or, in the case of a shareholder being a corporation, by its duly authorized representative) shall have one (1) vote for each Class A Ordinary Share and twenty (20) votes for each Class B Ordinary Share which such shareholder holds. Unless otherwise required by the BVI Act, and our Amended and Restated Memorandum and Articles of Association, holders of Class A Ordinary Shares and Class B Ordinary Shares shall at all times vote together as one class on all resolutions of the shareholders. At any meeting of the shareholders, the chairman of the meeting is responsible for deciding in such manner as he considers appropriate whether any resolution proposed has been carried or not and the result of his decision shall be announced to the meeting and recorded in the minutes of the meeting. If the chairman has any doubt as to the outcome of the vote on a proposed resolution, he shall cause a poll to be taken of all votes cast upon such resolution. If the chairman fails to take a poll, then any shareholder present in person or by proxy who disputes the announcement by the chairman of the result of any vote may immediately following such announcement demand that a poll be taken and the chairman shall cause a poll to be taken. If a poll is taken at any meeting, the result shall be announced to the meeting and recorded in the minutes of the meeting. There are no prohibitions to cumulative voting under the laws of the BVI, but our Amended and Restated Memorandum and Articles of Association do not provide for cumulative voting.

 

Variation of Rights of Shares

 

The rights attached to any class of shares may only, whether or not the Company is being wound up, be varied by a resolution of shareholders, provided that only the holders of the relevant class of shares shall be entitled to vote thereon, unless otherwise provided by the terms of issue of such class.

 

Meetings of Shareholders

 

Any of our directors may convene a meeting of shareholders at any time and in any manner and place the director considers necessary or desirable. The director convening a meeting must not give less than seven (7) clear calendar days’ notice of the meeting to those shareholders whose names appear as shareholders in the register of shareholders on the date of the notice and are entitled to vote at the meeting, and the other directors. Our board of directors must convene a meeting of shareholders upon the written request of shareholders entitled to exercise thirty per cent (30%) or more of the voting rights in respect of the matter for which the meeting is requested. A meeting of shareholders held in contravention of the requirement to give notice is valid if shareholders holding at least ninety per cent (90%) of the total voting rights on all the matters to be considered at the meeting have waived notice of the meeting and, for this purpose, the presence of a shareholder at the meeting shall constitute waiver in relation to all the shares which that shareholder holds.

 

The quorum for a meeting of shareholders is duly constituted if, at the commencement of the meeting, there are present in person or by proxy not less than 50 per cent (50%) of the votes of the shares (or class or series of shares) entitled to vote on the resolutions to be considered at the meeting. A quorum may comprise a single shareholder or proxy. If within two hours from the time appointed for the meeting a quorum is not present, the meeting, if convened upon the requisition of shareholders, will be dissolved. In any other case, it will stand adjourned to the next business day in the jurisdiction in which the meeting was to have been held at the same time and place or to such other time and place as the directors may determine, and if at the adjourned meeting there are present within one hour from the time appointed for the meeting in person or by proxy not less than one third of the votes of the shares (or each class or series of shares) entitled to vote on the matter to be considered by the meeting, those present will constitute a quorum but otherwise the meeting will either be dissolved or stand further adjourned at the discretion of the chairman of the board of directors or, if different, the chairman of the meeting.

 

Any shareholder who is not an individual may by resolution of its directors or other governing body authorize any individual as it thinks fit to act as its representative at any meeting of shareholders. The duly authorized representative shall be entitled to exercise the same rights on behalf of the shareholder which he represents as that shareholder could exercise if it were an individual.

 

51

 

 

Directors

 

Under our Amended and Restated Memorandum and Articles of Association, we are required to have a minimum of one director, and the maximum number of directors shall be unlimited. For as long as our Class A Ordinary Shares are listed or quoted on any Designated Stock Exchange (as defined in our Amended and Restated Memorandum and Articles of Association), the board of directors shall include at least such number of independent directors as applicable law, rules or regulations of the Designated Stock Exchange require as determined by the directors.

 

A director may be appointed by ordinary resolution or by the directors for such term as the shareholders or the directors determine. Any appointment may be to fill a vacancy or as an addition to the existing directors.

 

The directors or, for as long as our Class A Ordinary Shares (or depository receipts therefor) are listed or quoted on any Designated Stock Exchange and if required by the rules of such Designated Stock Exchange, any committee thereof, may, by a resolution of directors, fix the emoluments of directors with respect to services to be rendered in any capacity to the Company.

 

Under our Amended and Restated Memorandum and Articles of Association, there is no shareholding qualification required for directors.

 

Pursuant to our Amended and Restated Memorandum and Articles of Association, each of our directors holds office for the term, if any, fixed by the resolution of shareholders or resolution of directors appointing him/her, or until his/her earlier death, resignation or removal. If no term is fixed on the appointment of a director, the director serves indefinitely until his earlier death, resignation or removal.

 

A director may be removed from office with or without cause by, (a) a resolution of shareholders passed at a meeting of the shareholders called for the purposes of removing the director or for purposes including the removal of the director or by a written resolution passed by a least seventy-five per cent (75%) of the shareholders of the Company entitled to vote; or (b) a resolution of directors.

 

A director may at any time resign or retire from office by giving the Company notice in writing. Unless the notice specifies a later date, the director shall be deemed to have resigned on the date the notice is received by the Company.

 

A director shall resign forthwith as a director of the Company if he/she is, or becomes, disqualified from acting as a director under the BVI Act.

 

Each of the compensation committee and the nominating and corporate governance committee shall consist of at least three (3) directors and the majority of the committee members shall be independent within the meaning of the Nasdaq corporate governance rules. The audit committee shall consist of at least three (3) directors, all of whom shall be independent within the meaning of the Nasdaq corporate governance rules and will meet the criteria for independence set forth in Rule 10A-3 or Rule 10C-1 of the Exchange Act.

 

Meetings of Directors

 

Our business and affairs are managed by our board of directors, who will make decisions by voting on resolutions of directors. Our directors are free to meet at such times and in such manner and places within or outside the BVI as the directors determine to be necessary or desirable. A director must be given not less than three (3) calendar days’ notice of a meeting of directors. At any meeting of directors, a quorum will be present if not less than one half of the total number of directors is present, unless there are only two (2) directors in which case the quorum is two (2). An action that may be taken by the directors at a meeting may also be taken by a resolution of directors consented to in writing by all directors.

 

Any director which is a body corporate may appoint any individual as its duly authorised representative for the purpose of representing it at meetings of directors, with respect to the signing of consents or otherwise.

 

52

 

 

Protection of Minority Shareholders

 

In certain limited circumstances, a shareholder has the right to seek various remedies against the company in the event the directors are in breach of their duties under the BVI Act. Pursuant to Section 184B of the BVI Act, if a company or director of a company engages in, proposes to engage in or has engaged in, conduct that contravenes the provisions of the BVI Act or the memorandum or articles of association of the company, the courts of the BVI may, on application of a shareholder or director of the company, make an order directing the company or director to comply with, or restraining the company or director from engaging in conduct that contravenes the BVI Act or the memorandum or articles of association. Furthermore, pursuant to Section 184I(1) of the BVI Act, a shareholder of a company who considers that the affairs of the company have been, are being or likely to be, conducted in a manner that is, or any acts of the company have been, or are likely to be oppressive, unfairly discriminatory, or unfairly prejudicial to him/her in that capacity, may apply to the courts of the BVI for an order which, inter alia, can require the company or any other person to pay compensation to the shareholders.

 

If we are deemed insolvent for the purposes of the BVI Insolvency Act (Revised 2020) (the “BVI Insolvency Act”) (i.e., (1) it fails to comply with the requirements of a statutory demand that has not been set aside under Section 157 of the BVI Insolvency Act; (2) the execution or other process issued on a judgment, decree or order of a BVI court in favor of a creditor of the company is returned wholly or partly unsatisfied; or (3) either the value of the company’s liabilities exceeds its assets, or the company is unable to pay its debts as they fall due), there are very limited circumstances where prior payments made to shareholders or other parties may be deemed to be a “voidable transaction” for the purposes of the BVI Insolvency Act. A voidable transaction would include, for these purposes, payments made as “unfair preferences” or “transactions at an undervalue.” A liquidator appointed over an insolvent company who considers that a particular transaction or payment is a voidable transaction under the BVI Insolvency Act could apply to the BVI courts for an order setting aside that payment or transaction in whole or in part.

 

Pre-emptive Rights

 

There are no pre-emptive rights applicable to the issue by us of new Class A Ordinary Shares under either BVI law or our Amended and Restated Memorandum and Articles of Association.

 

Transfer of Class A Ordinary Shares

 

Subject to the restrictions in our Memorandum and Articles of Association and applicable securities laws, any of our shareholders may transfer all or any of his/her Class A Ordinary Shares by written instrument of transfer signed by the transferor and containing the name and address of the transferee. Our board of directors may not resolve to refuse or delay the transfer of any Ordinary Shares unless the shareholder has failed to pay an amount due in respect of it.

 

Forfeiture of Ordinary Shares

 

Our Ordinary Shares that are not fully paid on issue are subject to the forfeiture provisions set forth in our Amended and Restated Memorandum and Articles of Association. For this purpose, Ordinary Shares issued for a promissory note or a contract for future services are deemed to be not fully paid.

 

If a shareholder fails to pay any call, the directors may give to such shareholder not less than fourteen (14) days’ written notice requiring payment and specifying the amount unpaid including any interest which may have accrued, any expenses which have been incurred by us due to that person’s default and the place where payment is to be made. The written notice shall also contain a warning that if the notice is not complied with, the Ordinary Shares in respect of which the call is made will be liable to be forfeited.

 

If such notice is not complied with, the directors may, before the payment required by the notice has been received, resolve that any Ordinary Share the subject of that notice be forfeited (which forfeiture shall include all dividends or other monies payable in respect of the forfeited Ordinary Share and not paid before such forfeiture).

 

A forfeited Ordinary Share may be sold, re-allotted or otherwise disposed of on such terms and in such manner as the directors determine and at any time before a sale, re-allotment or disposition the forfeiture may be cancelled on such terms as the directors think fit.

 

A person whose Ordinary Shares have been forfeited shall cease to be a shareholder in respect of the forfeited Ordinary Shares, and that shareholder shall be discharged from any further obligation to the Company.

 

53

 

 

Redemption and Purchase of Ordinary Shares

 

We may purchase, redeem or otherwise acquire and hold our own Ordinary Shares save that we may not purchase, redeem or otherwise acquire our own Ordinary Shares without the consent of the shareholders whose Ordinary Shares are to be purchased, redeemed or otherwise acquired unless we are permitted or required by the BVI Act or any other provision in our Amended and Restated Memorandum and Articles of Association to purchase, redeem or otherwise acquire the Ordinary Shares without such consent.

 

Issuance of Ordinary Shares

 

Subject to the BVI Act and our Amended and Restated Memorandum and Articles of Association, shares in our Company may be issued, and options to acquire shares in our Company granted, at such times, to such persons, for such consideration and on such terms as the directors may determine.

 

Liquidation Rights

 

As permitted by BVI law and our Amended and Restated Memorandum and Articles of Association, the Company may be voluntarily liquidated by a resolution of members or, if permitted under section 199(2) of the BVI Act, by a resolution of directors if we have no liabilities or we are able to pay our debts as they fall due and the value of our assets equals or exceeds our liabilities. On a liquidation, on winding up or other return of assets of the Company to shareholders (other than on conversion, redemption or purchase of Ordinary Shares), assets available for distribution among the holders of Ordinary Shares shall be distributed among the holders of the Ordinary Shares on a pro rata basis.

 

Inspection of Books and Records

 

Under the BVI Act, holders of our Ordinary Shares are entitled, upon giving written notice to us, to inspect (i) our memorandum and articles of association, as amended and restated from time to time; (ii) the register of members, (iii) the register of directors and (iv) minutes of meetings and resolutions of members, and to make copies and take extracts from the documents and records. However, our directors can refuse access if they are satisfied that to allow such access would be contrary to our interests.

 

Differences in Corporate Law

 

The BVI Act and the laws of the BVI affecting BVI companies like us and our shareholders differ from laws applicable to U.S. corporations and their shareholders. Set forth below is a summary of the significant differences between the provisions of the laws of the BVI applicable to us and, for illustrative purposes only, the Delaware General Corporation Law (the “DGCL”), which governs companies incorporated in the state of Delaware.

 

Mergers and Similar Arrangements

 

Under the BVI Act, two or more companies, each a “constituent company”, may merge or consolidate in accordance with Section 170 of the BVI Act. A merger means the merging of two or more constituent companies into one of the constituent companies and a consolidation means the uniting of two or more constituent companies into a new company. In order to merge or consolidate, the directors of each constituent company must approve a written plan of merger or consolidation, which must be authorized by a resolution of shareholders. While a director may vote on the plan of merger or consolidation even if he has a financial interest in the plan, the interested director must disclose the interest to all other directors of the company promptly upon becoming aware of the fact that he is interested in a transaction entered into or to be entered into by the company.

 

A transaction entered into by our Company in respect of which a director is interested (including a merger or consolidation) is voidable by us unless the director’s interest was (a) disclosed to the board of directors prior to the transaction or (b) the transaction or proposed transaction is (i) between the director and the Company and (ii) the transaction or proposed transaction is or is to be entered into in the ordinary course of the Company’s business and on usual terms and conditions.

 

Notwithstanding the above, a transaction entered into by the Company is not voidable if (a) the material facts of the interest of the director in the transaction are known by the shareholders entitled to vote at a meeting of shareholders and the transaction is approved or ratified by a resolution of shareholders; or (b) the Company received fair value for the transaction.

 

54

 

 

Shareholders not otherwise entitled to vote on the merger or consolidation may still acquire the right to vote if the plan of merger or consolidation contains any provision that, if proposed as an amendment to the memorandum and articles of association of the company, would entitle them to vote as a class or series on the proposed amendment. In any event, all shareholders must be given a copy of the plan of merger or consolidation irrespective of whether they are entitled to vote at the meeting to approve the plan of merger or consolidation. The shareholders of the constituent companies are not required to receive shares of the surviving or consolidated company but may receive debt obligations or other securities of the surviving or consolidated company, other assets, or a combination thereof. Further, some or all of the shares of a class or series may be converted into a kind of asset while the other shares of the same class or series may receive a different kind of asset. As such, not all the shares of a class or series must receive the same kind of consideration. After the plan of merger or consolidation has been approved by the directors and authorized by a resolution of the shareholders, articles of merger or consolidation are executed by each company and filed with the Registrar of Corporate Affairs in the BVI. A shareholder may dissent from a mandatory redemption of his shares pursuant to an arrangement (if permitted by the court), a merger (unless the shareholder was a shareholder of the surviving company prior to the merger and continues to hold the same or similar shares after the merger) or a consolidation. A shareholder properly exercising his dissent rights is entitled to a cash payment equal to the fair value of his shares.

 

A shareholder dissenting from a merger or consolidation must object in writing to the merger or consolidation before the vote by the shareholders on the merger or consolidation, unless notice of the meeting was not given to the shareholder. If the merger or consolidation is approved by the shareholders, the company must give notice of this fact to each shareholder who gave written objection within twenty (20) days immediately following the date of the shareholders’ approval. These shareholders then have twenty (20) days from the date of such notice to give to the company their written election in the form specified by the BVI Act to dissent from the merger or consolidation, provided that in the case of a merger, the twenty (20) days starts when the plan of merger is delivered to the shareholder. Upon giving notice of his/her election to dissent, a shareholder ceases to have any shareholder rights except the right to be paid the fair value of his/her shares. As such, the merger or consolidation may proceed in the ordinary course notwithstanding his/her dissent. Within seven (7) days of the later of the delivery of the notice of election to dissent and the effective date of the merger or consolidation, the company must make a written offer to each dissenting shareholder to purchase his/her shares at a specified price per share that the company determines to be the fair value of the shares. The company and the shareholder then have thirty (30) days to agree upon the price. If the company and a shareholder fail to agree on the price within the thirty (30) days, then the company and the shareholder shall, within twenty (20) days immediately following the expiration of the thirty (30)-day period, each designate an appraiser and these two appraisers shall designate a third appraiser. These three appraisers shall fix the fair value of the shares as of the close of business on the day prior to the shareholders’ approval of the transaction without taking into account any change in value as a result of the transaction.

 

Under Delaware law, each corporation’s board of directors must approve a merger agreement. The merger agreement must state, among other terms, the terms of the merger and method of carrying out the merger. This agreement must then be approved by the majority vote of the outstanding stock entitled to vote at an annual or special meeting of each corporation, and no class vote is required unless provided in the certificate of incorporation.

 

Delaware permits an agreement of merger to contain a provision allowing the agreement to be terminated by the board of directors of either corporation, notwithstanding approval of the agreement by the stockholders of all or any of the corporations (1) at any time prior to the filing of the agreement with the Secretary of State or (2) after filing if the agreement contains a post-filing effective time and an appropriate filing is made with the Secretary of State to terminate the agreement before the effective time. In lieu of filing an agreement of merger, the surviving corporation may file a certificate of merger, executed in accordance with Section 103 of the DGCL. The surviving corporation is also permitted to amend and restate its certification of incorporation in its entirety. The agreement of merger may also provide that it may be amended by the board of directors of either corporation prior to the time that the agreement filed with the Secretary of State becomes effective, even after approval by stockholders, so long as any amendment made after such approval does not adversely affect the rights of the stockholders of either corporation and does not change any term in the certificate of incorporation of the surviving corporation. If the agreement is amended after filing but before becoming effective, an appropriate amendment must be filed with the Secretary of State. If the surviving corporation is not a Delaware corporation, it must consent to service of process for enforcement of any obligation of the corporation arising as a result of the merger; such obligations include any suit by a stockholder of the disappearing Delaware corporation to enforce appraisal rights under Delaware law.

 

If a proposed merger or consolidation for which appraisal rights are provided is to be submitted for approval at a shareholder meeting, the subject company must give notice of the availability of appraisal rights to its shareholders at least twenty (20) days prior to the meeting.

 

55

 

 

A dissenting shareholder who desires to exercise appraisal rights must (a) not vote in favor of the merger or consolidation; and (b) continuously hold the shares of record from the date of making the demand through the effective date of the applicable merger or consolidation. Further, the dissenting shareholder must deliver a written demand for appraisal to the company before the vote is taken. The Delaware Court of Chancery will determine the fair value of the shares exclusive of any element of value arising from the accomplishment or expectation of the merger, together with interest, if any, to be paid upon the amount determined to be the fair value. In determining such fair value, the court will take into account “all relevant factors”. Unless the Delaware Court of Chancery in its discretion determines otherwise, interest from the effective date of the merger through the date of payment of the judgment will be compounded quarterly and accrue at five per cent (5%) over the Federal Reserve discount rate.

 

Indemnification of Directors and Officers

 

BVI law does not limit the extent to which a company’s memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any provision providing indemnification may be held by the BVI courts to be contrary to public policy (e.g. for purporting to provide indemnification against civil fraud or the consequences of committing a crime).

 

Under our Amended and Restated Memorandum and Articles of Association, we may indemnify against all expenses, including legal fees, and against all judgments, fines and amounts paid in settlement and reasonably incurred in connection with legal, administrative or investigative proceedings for any person who:

 

●is or was a party or is threatened to be made a party to any threatened, pending or completed proceedings, whether civil, criminal, administrative or investigative, by reason of the fact that the person is or was our director; or

 

●is or was, at our request, serving as a director of, or in any other capacity is or was acting for, another company or a partnership, joint venture, trust or other enterprise.

 

These indemnities only apply if the person acted honestly and in good faith with a view to our best interests and, in the case of criminal proceedings, the person had no reasonable cause to believe that his/her conduct was unlawful.

 

This standard of conduct is generally the same as permitted under the DGCL for a Delaware corporation.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have been advised that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable.

 

Directors’ Fiduciary Duties

 

Under BVI law, the directors owe the company certain statutory and fiduciary duties including, among others, a duty to act honestly, in good faith, for a proper purpose and with a view to what the directors believe to be in the best interests of the company. When exercising powers or performing duties as a director, the director is required to exercise the care, diligence and skill that a reasonable director would exercise in the circumstances taking into account, without limitation, the nature of the company, the nature of the decision and the position of the director and the nature of the responsibilities undertaken. In exercising the powers of a director, the directors ensure neither they nor the company acts in a manner which contravenes the BVI Act or its memorandum and articles of association, as amended and restated from time to time. A shareholder has the right to seek damages for breaches of duties owed to us by our directors.

 

Under Delaware corporate law, a director of a Delaware corporation has a fiduciary duty to the corporation and its shareholders. This duty has two components: the duty of care and the duty of loyalty. The duty of care requires that a director act in good faith, with the care that an ordinarily prudent person would exercise under similar circumstances. Under this duty, a director must inform himself/herself of, and disclose to shareholders, all material information reasonably available regarding a significant transaction. The duty of loyalty requires that a director act in a manner he/she reasonably believes to be in the best interests of the corporation. He/She must not use his/her corporate position for personal gain or advantage. This duty prohibits self-dealing by a director and mandates that the best interest of the corporation and its shareholders take precedence over any interest possessed by a director, officer or controlling shareholder and not shared by the shareholders generally. In general, actions of a director are presumed to have been made on an informed basis, in good faith and in the honest belief that the action taken was in the best interests of the corporation. However, this presumption may be rebutted by evidence of a breach of one of the fiduciary duties. Should such evidence be presented concerning a transaction by a director, a director must prove the procedural fairness of the transaction and that the transaction was of fair value to the corporation.

 

56

 

 

Shareholder Actions by Written Consent

 

BVI law provides that shareholders may approve corporate matters by way of a written resolution without a meeting signed by or on behalf of shareholders sufficient to constitute the requisite majority of shareholders who would have been entitled to vote on such matter at a general meeting, provided that if the consent is less than unanimous, notice must be given to all non-consenting shareholders. Pursuant to our Amended and Restated Memorandum and Articles of Association, an action that may be taken by the shareholders of our Company at a meeting may also be taken by a resolution of shareholders of our Company consented to in writing, without the need for any notice, but if any resolution of shareholders of our Company is adopted otherwise than by the unanimous written consent of all shareholders of our Company, a copy of such resolution shall forthwith be sent to all shareholders of our Company not consenting to such resolution. The consent may be in the form of counterparts, each counterpart being signed by one or more shareholders of our Company. If the consent is in one or more counterparts, and the counterparts bear different dates, then the resolution shall take effect on the earliest date upon which eligible persons holding a sufficient number of votes of shares to constitute a resolution of shareholders of our Company have consented to the resolution by signed counterparts. Under the DGCL, a corporation may eliminate the right of shareholders to act by written consent by amendment to its certificate of incorporation.

 

Shareholder Proposals

 

BVI law and our Amended and Restated Memorandum and Articles of Association provide that shareholders holding thirty per cent (30%) or more of the voting rights entitled to vote on any matter for which a meeting is to be requested may request that the directors shall requisition a meeting of shareholders. Under the DGCL, a shareholder has the right to put any proposal before the annual meeting of shareholders, provided it complies with the notice provisions in the governing documents. A special meeting may be called by the board of directors or any other person authorized to do so in the governing documents, but shareholders may be precluded from calling special meetings.

 

As a BVI company, we are not obliged by law to call annual general meetings of shareholders, but our Amended and Restated Memorandum and Articles of Association do permit the directors to call such a meeting. The location of any meeting of shareholders can be determined by the board of directors and can be held anywhere in the world.

 

Cumulative Voting

 

There are no prohibitions in relation to cumulative voting under the laws of the BVI but our Amended and Restated Memorandum and Articles of Association do not provide for cumulative voting. Under the DGCL, cumulative voting for elections of directors is not permitted unless the corporation’s certificate of incorporation specifically provides for it. As a result, our shareholders are not afforded any less protections or rights on this issue than shareholders of a Delaware corporation.

 

Removal of Directors

 

Under our Amended and Restated Memorandum and Articles of Association, a director of our Company may be removed from office, with or without cause, by a resolution of shareholders passed at a meeting of shareholders of our Company called for the purposes of removing the director or for purposes including the removal of the director or by written resolution passed by at least seventy-five per cent (75%) of the shareholders of our Company entitled to vote, or by a resolution of directors of our Company. Under the DGCL, a director of a corporation with a classified board may be removed only for cause with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise.

 

Transactions with Interested Shareholders

 

The DGCL contains a business combination statute applicable to Delaware public corporations whereby, unless the corporation has specifically elected not to be governed by such statute by amendment to its certificate of incorporation, it is prohibited from engaging in certain business combinations with an “interested shareholder” for three (3) years following the date that such person becomes an interested shareholder. An interested shareholder generally is a person or group who or which owns or owned fifteen per cent (15%) or more of the target’s outstanding voting shares within the past three (3) years. This has the effect of limiting the ability of a potential acquirer to make a two-tiered bid for the target in which all shareholders would not be treated equally. The statute does not apply if, among other things, prior to the date on which such shareholder becomes an interested shareholder, the board of directors approves either the business combination or the transaction which resulted in the person becoming an interested shareholder. This encourages any potential acquirer of a Delaware public corporation to negotiate the terms of any acquisition transaction with the target’s board of directors.

 

57

 

 

Dissolution and Winding Up

 

Under our Amended and Restated Memorandum and Articles of Association, we may appoint a voluntary liquidator by a resolution of the shareholders of our Company or by resolution of directors of our Company. Under the DGCL, unless the board of directors approves the proposal to dissolve, dissolution must be approved by shareholders holding hundred per cent (100%) of the total voting power of the corporation. Only if the dissolution is initiated by the board of directors may it be approved by a simple majority of the corporation’s outstanding shares. Delaware law allows a Delaware corporation to include in its certificate of incorporation a supermajority voting requirement in connection with dissolutions initiated by the board of directors.

 

Variation of Rights of Shares

 

Under the DGCL, a corporation may vary the rights of a class of shares with the approval of a majority of the outstanding shares of such class, unless the certificate of incorporation provides otherwise. Under BVI law and our Amended and Restated Memorandum and Articles of Association, if at any time our shares are divided into different classes of shares, the rights attached to any class may only be varied, whether or not our company is in liquidation, with the consent in writing of or by a resolution passed at a meeting by a majority of the votes cast by those entitled to vote at a meeting of the holders of the issued shares in that class.

 

Amendment of Governing Documents

 

As permitted by BVI law, our Amended and Restated Memorandum and Articles of Association may be amended with a resolution of our shareholders or, subject to certain exceptions, by resolution of directors. An amendment is effective from the date it is registered at the Registrar of Corporate Affairs in the BVI. Under the DGCL, a corporation’s governing documents may be amended with the approval of a majority of the outstanding shares entitled to vote, unless the certificate of incorporation provides otherwise.

 

Anti-Money Laundering — BVI

 

In order to comply with legislation or regulations aimed at the prevention of money laundering, we are required to adopt and maintain anti-money laundering procedures, and may require subscribers to provide evidence to verify their identity and source of funds. Where permitted, and subject to certain conditions, we may also delegate the maintenance of our anti-money laundering procedures (including the acquisition of due diligence information) to a suitable person.

 

We reserve the right to request such information as is necessary to verify the identity of a subscriber. In some cases, the directors may be satisfied that no further information is required since an exception applies under the Anti-Money Laundering Regulations (as revised) of the BVI, as amended and revised from time to time or any other applicable law. In the event of delay or failure on the part of the subscriber in producing any information required for verification purposes, we may refuse to accept the application, in which case any funds received will be returned without interest to the account from which they were originally debited.

 

If any person resident in the BVI knows or suspects that another person is engaged in money laundering or terrorist financing and the information for that knowledge or suspicion came to their attention in the course of their business the person will be required to report his belief or suspicion to the Financial Investigation Agency of the BVI, pursuant to the BVI Proceeds of Criminal Conduct Act (as revised). Such a report shall not be treated as a breach of confidence or of any restriction upon the disclosure of information imposed by any enactment or otherwise.

 

58

 

 

TAXATION

 

The following sets forth the material BVI, Hong Kong and U.S. federal income tax consequences related to an investment in our Class A Ordinary Shares. It is directed to U.S. Holders (as defined below) of our Class A Ordinary Shares and is based upon laws and relevant interpretations thereof in effect as of the date of this prospectus, all of which are subject to change. This description does not deal with all possible tax consequences relating to an investment in our Class A Ordinary Shares, such as the tax consequences under state, local and other tax laws.

 

The following brief description applies only to U.S. Holders (as defined below) that hold Class A Ordinary Shares as capital assets and that have the U.S. dollar as their functional currency. This brief description is based on the tax laws of the United States in effect as of the date of this prospectus and on U.S. Treasury regulations in effect or, in some cases, proposed, as of the date of this prospectus, as well as judicial and administrative interpretations thereof available on or before such date. All of the foregoing authorities are subject to change, which change could apply retroactively and could affect the tax consequences described below.

 

The brief description below of the U.S. federal income tax consequences to “U.S. Holders” will apply to you if you are a beneficial owner of shares and you are, for U.S. federal income tax purposes:

 

●an individual who is a citizen or resident of the United States;

 

●a corporation (or other entity taxable as a corporation for U.S. federal income tax purposes) organized under the laws of the United States, any state thereof or the District of Columbia;

 

●an estate whose income is subject to U.S. federal income taxation regardless of its source; or

 

●a trust that (1) is subject to the primary supervision of a court within the United States and the control of one or more U.S. persons for all substantial decisions or (2) has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person.

 

WE URGE POTENTIAL PURCHASERS OF OUR SHARES TO CONSULT THEIR OWN TAX ADVISORS CONCERNING THE U.S. FEDERAL, STATE, LOCAL AND NON-U.S. TAX CONSEQUENCES OF PURCHASING, OWNING AND DISPOSING OF OUR SHARES.

 

Material United States Federal Income Tax Considerations

 

The following discussion is a summary of United States federal income tax considerations relating to the ownership and disposition of our Class A Ordinary Shares by a U.S. holder (as defined below) that holds our Class A Ordinary Shares as “capital assets” (generally, property held for investment) under the United States Internal Revenue Code of 1986, as amended (the “Code”). This discussion is based upon existing United States federal income tax law, which is subject to differing interpretations and may be changed, possibly with retroactive effect. No ruling has been sought from the Internal Revenue Service (the “IRS”) with respect to any United States federal income tax consequences described below, and there can be no assurance that the IRS or a court will not take a contrary position. This discussion does not address all aspects of United States federal income taxation that may be important to particular investors in light of their individual circumstances, including investors subject to special tax rules (for example, banks or other financial institutions, insurance companies, broker-dealers, pension plans, cooperatives, traders in securities that have elected the mark-to-market method of accounting for their securities, partnerships and their partners, regulated investment companies, real estate investment trusts, and tax-exempt organizations (including private foundations)), holders who are not U.S. holders, holders who own (directly, indirectly, or constructively) 10% or more of our voting shares, holders who will hold their Class A Ordinary Shares as part of a straddle, hedge, conversion, constructive sale, or other integrated transaction for United States federal income tax purposes, or investors that have a functional currency other than the United States dollar, all of whom may be subject to tax rules that differ significantly from those summarized below. In addition, this discussion does not discuss any non-United States, alternative minimum tax, state, or local tax considerations, or the Medicare tax on net investment income. Each U.S. holder is urged to consult its tax advisors regarding the United States federal, state, local, and non-United States income and other tax considerations with respect to the ownership and disposition of our Class A Ordinary Shares.

 

59

 

 

General

 

For purposes of this discussion, a “U.S. holder” is a beneficial owner of our Class A Ordinary Shares that is, for United States federal income tax purposes, (i) an individual who is a citizen or resident of the United States, (ii) a corporation (or other entity treated as a corporation for United States federal income tax purposes) created in, or organized under the laws of, the United States or any state thereof or the District of Columbia, (iii) an estate the income of which is subject to United States federal income taxation regardless of its source, or (iv) a trust (A) the administration of which is subject to the primary supervision of a United States court and which has one or more United States persons who have the authority to control all substantial decisions of the trust or (B) that has otherwise elected to be treated as a United States person under applicable United States Treasury regulations.

 

If a partnership (or other entity treated as a partnership for United States federal income tax purposes) is a beneficial owner of our Class A Ordinary Shares, the tax treatment of a partner in the partnership will generally depend upon the status of the partner and the activities of the partnership. Partnerships holding our Class A Ordinary Shares and partners in such partnerships are urged to consult their tax advisors as to the particular United States federal income tax consequences of an investment in our Class A Ordinary Shares.

 

Passive Foreign Investment Company Considerations

 

A non-United States corporation, such as our company, will be a “passive foreign investment company,” or “PFIC,” for United States federal income tax purposes, if, in any particular taxable year, either (i) 75% or more of its gross income for such year consists of certain types of “passive” income or (ii) 50% or more of the average quarterly value of its assets (as determined on the basis of fair market value) during such year produce or are held for the production of passive income. For this purpose, cash is categorized as a passive asset and the company’s unbooked intangibles associated with active business activities may generally be classified as active assets. Passive income generally includes, among other things, dividends, interest, rents, royalties, and gains from the disposition of passive assets. We will be treated as owning a proportionate share of the assets and earning a proportionate share of the income of any other corporation in which we own, directly or indirectly, at least 25% (by value) of the stock.

 

The discussion below under “Dividends” and “Sale or Other Disposition of Class A Ordinary Shares” is written on the basis that we will not be or become a PFIC for United States federal income tax purposes. The United States federal income tax rules that apply if we are a PFIC for the current taxable year or any subsequent taxable year are generally discussed below under “Passive Foreign Investment Company Rules”.

 

Dividends

 

Subject to the PFIC rules discussed below, any cash distributions (including the amount of any tax withheld) paid on our Class A Ordinary Shares out of our current or accumulated earnings and profits, as determined under United States federal income tax principles, will generally be includible in the gross income of a U.S. holder as dividend income on the day actually or constructively received by the U.S. holder. Because we do not intend to determine our earnings and profits on the basis of United States federal income tax principles, any distribution paid will generally be reported as a “dividend” for United States federal income tax purposes. A non-corporate recipient of dividend income will generally be subject to tax on dividend income from a “qualified foreign corporation” at a reduced United States federal tax rate rather than the marginal tax rates generally applicable to ordinary income provided that certain holding period requirements are met.

 

A non-United States corporation (other than a corporation that is a PFIC for the taxable year in which the dividend is paid or the preceding taxable year) will generally be considered to be a qualified foreign corporation (a) if it is eligible for the benefits of a comprehensive tax treaty with the United States which the Secretary of Treasury of the United States determines is satisfactory for purposes of this provision and which includes an exchange of information program, or (b) with respect to any dividend it pays on stock which is readily tradable on an established securities market in the United States. In the event we are deemed to be a resident enterprise under the Mainland Chinese Enterprise Income Tax Law, we may be eligible for the benefits of the United States-PRC income tax treaty (which the U.S. Treasury Department has determined is satisfactory for this purpose) and in that case we would be treated as a qualified foreign corporation with respect to dividends paid on our Class A Ordinary Shares. Each non-corporate U.S. holder is advised to consult its tax advisors regarding the availability of the reduced tax rate applicable to qualified dividend income for any dividends we pay with respect to our Class A Ordinary Shares. Dividends received on the Class A Ordinary Shares will not be eligible for the dividends received deduction allowed to corporations.

 

60

 

 

Dividends will generally be treated as income from foreign sources for United States foreign tax credit purposes and will generally constitute passive category income. In the event that we are deemed to be a Mainland Chinese “resident enterprise” under the Enterprise Income Tax Law, a U.S. holder may be subject to Mainland Chinese withholding taxes on dividends paid on our Class A Ordinary Shares. In that case, a U.S. holder may be eligible, subject to a number of complex limitations, to claim a foreign tax credit in respect of any foreign withholding taxes imposed on dividends received on Class A Ordinary Shares. A U.S. holder who does not elect to claim a foreign tax credit for foreign tax withheld may instead claim a deduction, for United States federal income tax purposes, in respect of such withholdings, but only for a year in which such U.S. holder elects to do so for all creditable foreign income taxes. The rules governing the foreign tax credit are complex. U.S. holders are advised to consult their tax advisors regarding the availability of the foreign tax credit under their particular circumstances.

 

Sale or Other Disposition of Class A Ordinary Shares

 

Subject to the Passive Foreign Investment Company (PFIC) rules discussed below, you will recognize taxable gain or loss on any sale, exchange or other taxable disposition of a share equal to the difference between the amount realized (in U.S. dollars) for the share and your tax basis (in U.S. dollars) in the Class A Ordinary Shares. The gain or loss will be treated as a capital gain or loss. If you are a non-corporate U.S. Holder, including an individual U.S. Holder, who has held the Class A Ordinary Shares for more than one year, you will be eligible for reduced tax rates. The deductibility of capital losses is subject to limitations. Any such gain or loss that you recognize will generally be treated as United States source income or loss for foreign tax credit limitation purposes.

 

Passive Foreign Investment Company Rules

 

Based on our current and anticipated operations and the composition of our assets, we were not PFIC for U.S. federal income tax purposes. Depending on the assets held by us for the production of passive income, it is possible that, for our taxable year or for any subsequent year, more than 50% of our assets may be assets which produce passive income, in which case we would be deemed a PFIC, which could have adverse U.S. federal income tax consequences for U.S. taxpayers who are shareholders. We will make this determination following the end of any particular tax year. PFIC status is a factual determination for each taxable year which cannot be made until the close of the taxable year. A non-U.S. corporation is considered a PFIC, as defined in Section 1297(a) of the U.S. Internal Revenue Code (“IRC”), for any taxable year if either:

 

●at least 75% of its gross income is passive income; or

 

●at least 50% of the value of its assets (based on an average of the quarterly values of the assets during a taxable year) is attributable to assets that produce or are held for the production of passive income (the “asset test”).

 

We will be treated as owning our proportionate share of the assets and earning our proportionate share of income of any other corporation in which we own, directly or indirectly, at least 25% (by value) of the stock.

 

There can be no assurance with respect to our status as a PFIC for our current taxable year or any future taxable year. In addition, because the value of our assets for purposes of the asset test will generally be determined based on the market price of our Class A Ordinary Shares and because cash is generally considered to be an asset held for the production of passive income, our PFIC status will depend in large part on the market price of our Class A Ordinary Shares and the amount of cash we raise in any follow-on offerings. Accordingly, fluctuations in the market price of the Class A Ordinary Shares may cause us to become a PFIC. In addition, the application of the PFIC rules is subject to uncertainty in several respects and the composition of our income and assets will be affected by how, and how quickly, we spend the cash we raise in any follow-on offerings. We are under no obligation to take steps to reduce the risk of our being classified as a PFIC, and as stated above, the determination of the value of our assets will depend upon material facts (including the market price of our Class A Ordinary Shares from time to time and the amount of cash we raise in any follow-on offerings) that may not be within our control. If we are a PFIC for any year during which you hold Class A Ordinary Shares, we will continue to be treated as a PFIC for all succeeding years during which you hold Class A Ordinary Shares. If we cease to be a PFIC and you did not previously make a timely “mark-to-market” election as described below, you will continue to be treated as a PFIC, however, you may avoid some of the adverse effects of the PFIC regime by making a “purging election” (as described below) with respect to the Class A Ordinary Shares.

 

61

 

 

If we are a PFIC for any taxable year during which you hold Class A Ordinary Shares, you will be subject to special tax rules with respect to any “excess distribution” that you receive and any gain you realize from a sale or other disposition (including a pledge) of the Class A Ordinary Shares, unless you make a “mark-to-market” election as discussed below. Distributions you receive in a taxable year that are greater than 125% of the average annual distributions you received during the shorter of the three preceding taxable years or your holding period for the Class A Ordinary Shares will be treated as an excess distribution. Under these special tax rules:

 

●the excess distribution or gain will be allocated ratably over your holding period for the Class A Ordinary Shares;

 

●the amount allocated to the current taxable year, and any taxable year prior to the first taxable year in which we were a PFIC, will be treated as ordinary income;

 

●the amount allocated to each other year will be subject to the highest tax rate in effect for that year and the interest charge generally applicable to underpayments of tax will be imposed on the resulting tax attributable to each such year, and

 

●an additional tax equal to the interest charge generally applicable to underpayments of tax will be imposed on the tax attributable to each prior taxable year, other than a pre-PFIC year.

 

The tax liability for amounts allocated to years prior to the year of disposition or “excess distribution” cannot be offset by any net operating losses for such years, and gains (but not losses) realized on the sale of the Class A Ordinary Shares cannot be treated as capital, even if you hold the Class A Ordinary Shares as capital assets.

 

A U.S. Holder of “marketable stock” (as defined below) in a PFIC may make a mark-to-market election for such stock to elect out of the tax treatment discussed above. If you make a mark-to-market election for the Class A Ordinary Shares, you will include in income each year an amount equal to the excess, if any, of the fair market value of the Class A Ordinary Shares as of the close of your taxable year over your adjusted basis in such Class A Ordinary Shares. You are allowed a deduction for the excess, if any, of the adjusted basis of the Class A Ordinary Shares over their fair market value as of the close of the taxable year. However, deductions are allowable only to the extent of any net mark-to-market gains on the Class A Ordinary Shares included in your income for prior taxable years. Amounts included in your income under a mark-to-market election, as well as gain on the actual sale or other disposition of the Class A Ordinary Shares, are treated as ordinary income. Ordinary loss treatment also applies to the deductible portion of any mark-to-market loss on the Class A Ordinary Shares, as well as to any loss realized on the actual sale or disposition of the Class A Ordinary Shares, to the extent that the amount of such loss does not exceed the net mark-to-market gains previously included for such Class A Ordinary Shares. Your basis in the Class A Ordinary Shares will be adjusted to reflect any such income or loss amounts. If you make a valid mark-to-market election, the tax rules that apply to distributions by corporations which are not PFICs would apply to distributions by us, except that the lower applicable capital gains rate for qualified dividend income discussed above under “Dividends” above generally would not apply.

 

The mark-to-market election is available only for “marketable stock”, which is stock that is traded in other than de minimis quantities on at least 15 days during each calendar quarter (“regularly traded”) on a qualified exchange or other market (as defined in applicable U.S. Treasury regulations), including the Nasdaq Capital Market. If the Class A Ordinary Shares are regularly traded on the Nasdaq Capital Market and if you are a holder of Class A Ordinary Shares, the mark-to-market election would be available to you were we to be or become a PFIC.

 

Alternatively, a U.S. Holder of stock in a PFIC may make a “qualified electing fund” election with respect to such PFIC to elect out of the tax treatment discussed above. A U.S. Holder who makes a valid qualified electing fund election with respect to a PFIC will generally include in gross income for a taxable year such holder’s pro rata share of the corporation’s earnings and profits for the taxable year. However, the qualified electing fund election is available only if such PFIC provides such U.S. Holder with certain information regarding its earnings and profits as required under applicable U.S. Treasury regulations. We do not currently intend to prepare or provide the information that would enable you to make a qualified electing fund election. If you hold Class A Ordinary Shares in any year in which we are a PFIC, you will be required to file U.S. Internal Revenue Service Form 8621 regarding distributions received on the Class A Ordinary Shares and any gain realized on the disposition of the Class A Ordinary Shares. If you do not make a timely “mark-to-market” election (as described above), and if we were a PFIC at any time during the period you hold our Class A Ordinary Shares, then such Class A Ordinary Shares will continue to be treated as stock of a PFIC with respect to you even if we cease to be a PFIC in a future year, unless you make a “purging election” for the year we cease to be a PFIC. A “purging election” creates a deemed sale of such Class A Ordinary Shares at their fair market value on the last day of the last year in which we are treated as a PFIC. The gain recognized by the purging election will be subject to the special tax and interest charge rules treating the gain as an excess distribution, as described above. As a result of the purging election, you will have a new basis (equal to the fair market value of the Class A Ordinary Shares on the last day of the last year in which we are treated as a PFIC) and holding period (which new holding period will begin the day after such last day) in your Class A Ordinary Shares for tax purposes.

 

62

 

 

IRC Section 1014(a) provides for a step-up in basis to the fair market value for our Class A Ordinary Shares when inherited from a decedent that was previously a holder of our Class A Ordinary Shares. However, if we are determined to be a PFIC and a decedent that was a U.S. Holder did not make either a timely qualified electing fund election for our first taxable year as a PFIC in which the U.S. Holder held (or was deemed to hold) our Class A Ordinary Shares, or a mark-to-market election and ownership of those Class A Ordinary Shares are inherited, a special provision in IRC Section 1291(e) provides that the new U.S. Holder’s basis should be reduced by an amount equal to the IRC Section 1014 basis minus the decedent’s adjusted basis just before death. As such if we are determined to be a PFIC at any time prior to a decedent’s passing, the PFIC rules will cause any new U.S. Holder that inherits our Class A Ordinary Shares from a U.S. Holder to not get a step-up in basis under IRC Section 1014 and instead will receive a carryover basis in those Class A Ordinary Shares.

 

You are urged to consult your tax advisors regarding the application of the PFIC rules to your investment in our Class A Ordinary Shares and the elections discussed above.

 

Information Reporting

 

Dividend payments with respect to our Class A Ordinary Shares and proceeds from the sale, exchange or redemption of our Class A Ordinary Shares may be subject to information reporting to the U.S. Internal Revenue Service and possible U.S. backup withholding at a current rate of 24%. Backup withholding will not apply, however, to a U.S. Holder who furnishes a correct taxpayer identification number and makes any other required certification on U.S. Internal Revenue Service Form W-9 or who is otherwise exempt from backup withholding. U.S. Holders who are required to establish their exempt status generally must provide such certification on U.S. Internal Revenue Service Form W-9. U.S. Holders are urged to consult their tax advisors regarding the application of the U.S. information reporting and backup withholding rules.

 

Backup withholding is not an additional tax. Amounts withheld as backup withholding may be credited against your U.S. federal income tax liability, and you may obtain a refund of any excess amounts withheld under the backup withholding rules by filing the appropriate claim for refund with the U.S. Internal Revenue Service and furnishing any required information. We do not intend to withhold taxes for individual shareholders. However, transactions effected through certain brokers or other intermediaries may be subject to withholding taxes (including backup withholding), and such brokers or intermediaries may be required by law to withhold such taxes.

 

Under the Hiring Incentives to Restore Employment Act of 2010, certain U.S. Holders are required to report information relating to our Class A Ordinary Shares, subject to certain exceptions (including an exception for Class A Ordinary Shares held in accounts maintained by certain financial institutions), by attaching a complete Internal Revenue Service Form 8938, Statement of Specified Foreign Financial Assets, with their tax return for each year in which they hold Class A Ordinary Shares. Failure to report the information could result in substantial penalties. You should consult your own tax advisor regarding your obligation to file Form 8938.

 

Hong Kong Taxation

 

The taxation of income and capital gains of holders of Class A Ordinary Shares is subject to the laws and practices of Hong Kong and of jurisdictions in which holders of Class A Ordinary Shares are resident or otherwise subject to tax. The following summary of certain relevant taxation provisions under Hong Kong law is based on current law and practice, is subject to changes therein and does not constitute legal or tax advice. The discussion does not deal with all possible tax consequences relating to an investment in the Class A Ordinary Shares. Accordingly, each prospective investor (particularly those subject to special tax rules, such as banks, dealers, insurance companies, tax-exempt entities and holders of 10% or more of our voting capital stock) should consult its own tax advisor regarding the tax consequences of an investment in the Class A Ordinary Shares. The discussion is based upon laws and relevant interpretations thereof in effect as of the date of this prospectus, all of which are subject to change. There is no reciprocal tax treaty in effect between Hong Kong and the United States.

 

Tax on Dividends

 

Under the current practices of the Hong Kong Inland Revenue Department, no tax is payable in Hong Kong in respect of dividends paid by us as a company incorporated in the BVI.

 

63

 

 

Profits Tax

 

On March 21, 2018, the Hong Kong Legislative Council passed The Inland Revenue (Amendment) (No. 7) Bill 2017 (the “Bill”) which introduces the two-tiered profits tax rates regime. The Bill was signed into law on March 21, 2018 and was gazetted on the following day. Under the two-tiered profits tax rates regime, the first HK$2 million of profits of the qualifying group entity will be taxed at 8.25%, and profits above HK$2 million will be taxed at 16.5%. The profits of group entities not qualifying for the two-tiered profits tax rates regime will continue to be taxed at a flat rate of 16.5%.

 

Accordingly, the Hong Kong profits tax is calculated at 8.25% on the first HK$2 million of the estimated assessable profits and at 16.5% on the estimated assessable profits above HK$2 million.

 

Under Hong Kong tax law, our subsidiaries in Hong Kong are exempted from income tax on their qualified foreign-derived income and there is no withholding tax in Hong Kong on remittance of dividends.

 

Stamp Duty

 

Hong Kong stamp duty, currently charged at the rate of 0.13% of the amount of the consideration or of its value on every sold note and every bought note for sale or purchase of any Hong Kong stock (i.e., a total of HK$2.6 (US$0.3) per HK$1,000.0 (US$128.2)). In addition, a fixed duty of HK$5.0 (US$0.6) is currently payable on any instrument of transfer of any Hong Kong stock. If one of the parties to the sale is a non-Hong Kong resident and does not pay the required stamp duty, the duty not paid will be assessed on the instrument of transfer (if any) and the transferee will be liable for payment of such duty. No Hong Kong stamp duty is payable upon the transfer of our Class A Ordinary Shares outside Hong Kong.

 

Estate Duty

 

The Revenue (Abolition of Estate Duty) Ordinance 2005 came into effect on February 11, 2006 in Hong Kong. No Hong Kong estate duty is payable and no estate duty clearance papers are needed for an application for a grant of representation in respect of holders of our Class A Ordinary Shares whose death occurs on or after February 11, 2006.

 

Certain Mainland Chinese Tax Laws and Regulations Consideration

 

The Arrangement between Mainland China and Hong Kong for the Avoidance of Double Taxation and Prevention of Fiscal Evasion with Respect to Taxes on Income (the “Double Tax Avoidance Arrangement”)

 

The National People’s Congress of the People’s Republic of China enacted the Enterprise Income Tax Law, which became effective on January 1, 2008 and was last amended on December 29, 2018. According to the Enterprise Income Tax Law and the Regulation on the Implementation of the Enterprise Income Tax Law, or the Implementing Rules, which became effective on January 1, 2008 and was further amended on April 23, 2019, dividends generated after January 1, 2008 and payable by a foreign-invested enterprise in Mainland China to its foreign enterprise investors are subject to a 10% withholding tax, unless any such foreign enterprise investor’s jurisdiction of incorporation has a tax treaty with Mainland China that provides for a preferential withholding arrangement. According to the Notice of the State Administration of Taxation (the “SAT”) on Negotiated Reduction of Dividends and Interest Rates issued on January 29, 2008, revised on February 29, 2008, and the Arrangement between Mainland China and Hong Kong for the Avoidance of Double Taxation and Prevention of Fiscal Evasion with Respect to Taxes on Income, or Double Tax Avoidance Arrangement, the withholding tax rate in respect of the payment of dividends by a Mainland Chinese enterprise to a Hong Kong enterprise may be reduced to 5% from a standard rate of 10% if the Hong Kong enterprise directly holds at least 25% of the Mainland Chinese enterprise and certain other conditions are met, including: (i) the Hong Kong enterprise must directly own the required percentage of equity interests and voting rights in the Mainland China-resident enterprise; and (ii) the Hong Kong enterprise must have directly owned such required percentage in the Mainland China-resident enterprise throughout the 12 months prior to receiving the dividends. However, based on the Circular on Certain Issues with Respect to the Enforcement of Dividend Provisions in Tax Treaties issued on February 20, 2009 by the SAT, if the relevant Mainland Chinese tax authorities determine, in their discretion, that a company benefits from such reduced income tax rate due to a structure or arrangement that is primarily tax-driven, such Mainland Chinese tax authorities may adjust the preferential tax treatment; and based on the Announcement on Certain Issues with Respect to the “Beneficial Owner” in Tax Treaties issued by the SAT on February 3, 2018 and effective from April 1, 2018, if an applicant’s business activities do not constitute substantive business activities, it could result in the negative determination of the applicant’s status as a “beneficial owner”, and consequently, the applicant could be precluded from enjoying the above-mentioned reduced income tax rate of 5% under the Double Tax Avoidance Arrangement.

 

64

 

 

Enterprise Income Tax Law

 

The Enterprise Income Tax Law and the Implementing Rules impose a uniform 25% enterprise income tax rate to both foreign invested enterprises and domestic enterprises in Mainland China, except where tax incentives are granted to special industries and projects. Under the Enterprise Income Tax Law, an enterprise established outside Mainland China with “de facto management bodies” within Mainland China is considered a “resident enterprise” for Mainland Chinese enterprise income tax purposes and is generally subject to a uniform 25% enterprise income tax rate on its worldwide income. The Notice Regarding the Determination of Chinese-Controlled Offshore Incorporated Enterprises as PRC Tax Resident Enterprises on the Basis of De Facto Management Bodies promulgated by the SAT and last amended on December 29, 2017 and the Announcement of the State Administration of Taxation on Issues concerning the Determination of Resident Enterprises Based on the Standards of Actual Management Institutions promulgated by the SAT on January 29, 2014 set out the standards used to classify certain Mainland Chinese invested enterprises controlled by Mainland Chinese enterprises or Mainland Chinese enterprise groups and established outside of Mainland China as “resident enterprises”, which also clarified that dividends and other income paid by such Mainland Chinese “resident enterprises” will be considered Mainland Chinese source income and will be subject to Mainland Chinese withholding tax, currently at a rate of 10%, when paid to non-Mainland Chinese enterprise shareholders. This notice also subjects such Mainland Chinese “resident enterprises” to various reporting requirements with the Mainland Chinese tax authorities. Under the Implementing Rules, a “de facto management body” is defined as a body that has material and overall management and control over the manufacturing and business operations, personnel and human resources, finances and properties of an enterprise.

 

On October 17, 2017, the SAT issued the Bulletin on Issues Concerning the Withholding of Non-PRC Resident Enterprise Income Tax at Source, or Bulletin 37, which replaced the Notice on Strengthening Administration of Enterprise Income Tax for Share Transfers by Non-PRC Resident Enterprises, issued by the SAT, on December 10, 2009, and partially replaced and supplemented by the rules under the Bulletin on Issues of Enterprise Income Tax on Indirect Transfers of Assets by Non-PRC Resident Enterprises, or Bulletin 7, issued by the SAT, on February 3, 2015. Under Bulletin 7, an “indirect transfer” of assets, including equity interests in a Mainland China resident enterprise, by non-Mainland China resident enterprises may be re-characterized and treated as a direct transfer of Mainland Chinese taxable assets, if such arrangement does not have a reasonable commercial purpose and was established for the purpose of avoiding payment of Mainland Chinese enterprise income tax. As a result, gains derived from such indirect transfer may be subject to Mainland Chinese enterprise income tax. In respect of an indirect offshore transfer of assets of a Mainland Chinese establishment, the relevant gain is to be regarded as effectively connected with the Mainland Chinese establishment and therefore included in its enterprise income tax filing, and would consequently be subject to enterprise income tax at a rate of 25%. Where the underlying transfer relates to the immoveable properties in Mainland China or to equity investments in a Mainland Chinese resident enterprise, which is not effectively connected to a Mainland Chinese establishment of a non-resident enterprise, a Mainland Chinese enterprise income tax at 10% would apply, subject to available preferential tax treatment under applicable tax treaties or similar arrangements, and the party who is obligated to make the transfer payments bears the withholding obligation. Pursuant to Bulletin 37, the withholding party shall declare and pay the withheld tax to the competent tax authority in the place where such withholding party is located within 7 days from the date of occurrence of the withholding obligation. Both Bulletin 37 and Bulletin 7 do not apply to transactions of sale of shares by investors through a public stock exchange where such shares were acquired from a transaction through a public stock exchange.

 

We are a holding company incorporated in the BVI with substantially all our operations conducted, and substantially all our revenue generated, by our subsidiaries in Hong Kong. We do not have, nor do we currently intend to establish, any subsidiary in Mainland China or set up any establishment in Mainland China. We do not plan to enter into any contractual arrangements to establish a VIE structure with any entity in Mainland China, and none of our subsidiaries directly or indirectly holds any interests in any enterprises in Mainland China. Based on our understanding of the current PRC laws and regulations, neither the Company nor its subsidiaries are subject to the Enterprise Income Tax Law, the Double Tax Avoidance Arrangement or any Mainland Chinese taxation laws and regulations, nor do these laws and regulations have any impact on our business or operations.

 

BVI Taxation

 

The Company and all distributions, interest and other amounts paid by the Company in respect of the Class A Ordinary Shares of the Company to persons who are not resident in the BVI are exempt from all provisions of the Income Tax Ordinance in the BVI.

 

No estate, inheritance, succession or gift tax is payable with respect to any shares, debt obligations or other securities of a BVI company.

 

All instruments relating to transactions in respect of the shares, debt obligations or other securities of the Company and all instruments relating to other transactions relating to the business of the Company are exempt from payment of stamp duty in the BVI, provided that they do not relate to real estate in the BVI.

 

There are currently no withholding taxes or exchange control regulations in the BVI applicable to our Company.

 

65

 

 

ENFORCEABILITY OF CIVIL LIABILITIES

 

We are incorporated under the laws of the BVI as a BVI business company with limited liability. We are incorporated in the BVI because of certain benefits associated with being a BVI business company, such as (i) political and economic stability; (ii) an effective and sophisticated judicial system with a dedicated commercial court; (iii) tax neutral treatment, with no tax levied against companies incorporated in the BVI by the local tax authorities; (iv) the absence of foreign exchange control or currency restrictions; and (v) the availability of professional and support services.

 

However, certain disadvantages accompany incorporation in the BVI: (a) the BVI has a less developed body of securities laws as compared to the United States and these securities laws provide significantly less protection to investors as compared to the United States; and (b) BVI companies do not have standing to sue before the federal courts of the United States.

 

We believe the disadvantages of incorporating in the BVI are outweighed by the benefits to us and our investors of such incorporation.

 

Our Amended and Restated Memorandum and Articles of Association do not contain provisions requiring that disputes, including those arising under the securities laws of the United States, between us, our officers, directors and shareholders, be arbitrated.

 

Substantially all of our assets are located outside the United States. All our directors and officers reside outside of the United States. As a result, it may be difficult or impossible for investors to effect service of process within the United States upon us or such persons or to enforce judgments obtained in United States courts against them or against us, including judgments predicated upon the civil liability provisions of the securities laws of the United States or any state thereof.

 

We have appointed Cogency Global Inc. as our agent to receive service of process upon whom process may be served in any action brought against us under the securities laws of the United States.

 

Hong Kong

 

There is uncertainty as to whether the courts of Hong Kong would (i) recognize or enforce judgments of United States courts obtained against us or our directors or officers predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States, or (ii) entertain original actions brought in Hong Kong against us or our directors or officers predicated upon the securities laws of the United States or any state in the United States.

 

Judgments of United States courts will not be directly enforced in Hong Kong. There are currently no treaties or other arrangements providing for reciprocal enforcement of foreign judgments between Hong Kong and the United States. However, the common law permits an action to be brought upon a foreign judgment. That is to say, a foreign judgment itself may form the basis of a cause of action since the judgment may be regarded as creating a debt between the parties to it. In a common law action for enforcement of a foreign judgment in Hong Kong, the enforcement is subject to various conditions, including but not limited to, that the foreign judgment is a final judgment conclusive upon the merits of the claim, the judgment is for a liquidated amount in a civil matter and not in respect of taxes, fines, penalties, or similar charges, the proceedings in which the judgment was obtained were not contrary to natural justice, and the enforcement of the judgment is not contrary to public policy of Hong Kong. Such a judgment must be for a fixed sum and must also come from a “competent” court as determined by the private international law rules applied by the Hong Kong courts. The defenses that are available to a defendant in a common law action brought on the basis of a foreign judgment include lack of jurisdiction, breach of natural justice, fraud, and contrary to public policy. However, a separate legal action for debt must be commenced in Hong Kong in order to recover such debt from the judgment debtor.

 

British Virgin Islands

 

We have been advised by Ogier, our counsel as to the laws of the BVI that the BVI do not have a treaty providing for reciprocal recognition and enforcement of judgments of courts of the United States in civil and commercial matters and that a final judgment for the payment of money rendered by any general or state court in the United States based on civil liability, whether or not predicated solely upon the U.S. federal securities laws, would not be enforceable in the BVI. We have also been advised that a final and conclusive judgment obtained in U.S. federal or state courts under which a sum of money is payable as compensatory damages (i.e., not being a sum claimed by a revenue authority for taxes or other charges of a similar nature by a governmental authority, or in respect of a fine or penalty or multiple or punitive damages) may be the subject of an action on a debt in the court of the BVI under the common law doctrine of obligation.

 

Ogier has further advised us that there is uncertainty as to whether the BVI would:

 

●recognize or enforce judgments of United States courts obtained against us or our directors or officers predicated upon the civil liability provisions of the securities laws of the United States or any state in the United States; or

 

●entertain original actions brought in the BVI against us or our directors or officers predicated upon the securities laws of the United States or any state in the United States.

 

For a detailed description of risks related to enforceability of civil liabilities, please refer to “Risk Factors – Risks Relating to Our Corporate Structure – You may incur additional costs and procedural obstacles in effecting service of legal process, enforcing foreign judgments or bringing actions in Hong Kong against us or our management based on Hong Kong laws” on page 29 of this prospectus.

 

66

 

 

LEGAL MATTERS

 

We are being represented by Ortoli Rosenstadt LLP with respect to certain legal matters as to United States federal securities and New York State law. The legality and validity of the Class A Ordinary Shares offered from time to time under this prospectus under the laws of the British Virgin Islands will be passed upon for us by Ogier. Ortoli Rosenstadt LLP may rely upon Ogier with respect to matters governed by the laws of the British Virgin Islands.

 

EXPERTS

 

The consolidated financial statements as of March 31, 2026, 2025 and 2024 and for each of the three fiscal years ended March 31, 2026, 2025 and 2024 appearing in our 2026 Annual Report and incorporated by reference in this prospectus, have been so included in reliance on the report of WWC, P.C., an independent registered public accounting firm, given on their authority as experts in accounting and auditing. The current address of WWC, P.C. is 2010 Pioneer Court, San Mateo, CA 94403. 

 

WHERE YOU CAN FIND ADDITIONAL INFORMATION

 

We have filed with the SEC a registration statement on Form F-1 (including amendments and exhibits to the registration statement) under the Securities Act with respect to the Class A Ordinary Shares offered hereby. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth in the registration statement or the exhibits filed therewith. For further information about us and the Class A Ordinary Shares offered hereby, reference is made to the registration statement and the exhibits filed therewith. This prospectus summarizes material provisions of contracts and other documents that we refer you to. However, statements contained in this prospectus regarding the contents of any contract or any other document that is filed as an exhibit to the registration statement are not necessarily complete, and in each instance, we refer you to the copy of such contract or other document filed as an exhibit to the registration statement. Since this prospectus may not contain all the information that you may find important, you should review the full text of these documents.

 

We are subject to periodic reporting and other informational requirements of the Exchange Act, as applicable to foreign private issuers. Accordingly, we are required to file reports, including annual reports on Form 20-F, and other information with the SEC. As a foreign private issuer, we are exempt from the rules of the Exchange Act prescribing the furnishing and content of proxy statements to shareholders under the federal proxy rules contained in Sections 14(a), (b) and (c) of the Exchange Act. Beginning March 18, 2026, members of our board of directors and senior management are subject to insider trading reporting obligations under Section 16(a) of the Exchange Act. They are also subject to the obligations to report changes in share ownership under Section 13 of the Exchange Act and related SEC rules. However, the information we are required to file with or furnish to the SEC will be less extensive and less timely compared to that required to be filed with the SEC by U.S. domestic issuers.

 

You can request copies of these documents upon payment of a duplicating fee, by writing to the SEC. The SEC also maintains public reference facilities at 100 F Street, N.E., Washington, D.C. 20549 and a website at http://www.sec.gov that contains reports, proxy statements and other information about issuers, such as us, who file electronically with the SEC. The information on SEC’s website is not a part of this prospectus.

 

67

 

 

INCORPORATION OF CERTAIN INFORMATION BY REFERENCE

 

The SEC allows us to “incorporate by reference” into this prospectus the documents we file with, or furnish to, it, which means that we can disclose important information to you by referring you to these documents.  Each document incorporated by reference is current only as of the date of such document, and the incorporation by reference of such documents should not create any implication that there has been no change in our affairs since such date. The information that we incorporate by reference into this prospectus forms a part of this prospectus, except for any information superseded by information contained directly in this prospectus, and should be read with the same care.

 

We incorporate by reference into this prospectus the documents listed below:

 

  ● our Annual Report on Form 20-F for the fiscal year ended March 31, 2026, filed with the SEC on August 14, 2026 (including any exhibits, except where otherwise noted); and

 

  ● our reports of foreign private issuer on Form 6-K, furnished to the SEC on September 15, 2025, October 2, 2025, November 3, 2025, November 14, 2025, December 11, 2025, December 18, 2025, December 23, 2025, December 29, 2025, January 28, 2026, February 9, 2026, February 25, 2026, March 11, 2026, March 31, 2026, April 14, 2026, May 4, 2026, May 20, 2026, May 27, 2026, May 28, 2026, June 1, 2026, June 25, 2026, June 30, 2026, July 13, 2026, August 11, 2026, August 24, 2026, August 26, 2026, August 28, 2026, August 31, 2026, September 3, 2026, September 9, 2026, September 10, 2026, September 15, 2026, October 7, 2026, October 9, 2026, October 13, 2026, October 15, 2026, October 20, 2026 (as amended by the Form 6-K/A furnished on October 27, 2026), and November 5, 2026.

 

The information relating to us contained in this prospectus does not purport to be comprehensive and should be read together with the information contained in the documents incorporated or deemed to be incorporated by reference into this prospectus.

 

As you read the above documents, you may find inconsistencies in information from one document to another. If you find inconsistencies between the documents and this prospectus, you should rely on the statements made in this prospectus. All information appearing in this prospectus is qualified in its entirety by the information and financial statements, including the notes thereto, contained in the documents incorporated by reference herein.

 

Copies of all documents incorporated by reference into this prospectus, other than exhibits to those document unless such exhibits are specifically incorporated by reference into this prospectus, will be provided at no cost to each person, including any beneficial owner, who receives a copy of this prospectus on the written or oral request of that person made to: 

 

Axonex AI Group Limited

Unit 506-8, 5/F, Laford Centre

838 Lai Chi Kok Road

Lai Chi Kok, Kowloon, Hong Kong

 

You should rely only on the information contained or incorporated by reference in this prospectus. We have not authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume that the information appearing in this prospectus is accurate only as of the date on the front cover of this prospectus, or such earlier date, that is indicated in this prospectus. Our business, financial condition, results of operations and prospects may have changed since that date.

 

68

 

 

PART II

 

INFORMATION NOT REQUIRED IN PROSPECTUS

 

ITEM 6. INDEMNIFICATION OF DIRECTORS AND OFFICERS.

 

British Virgin Islands law does not limit the extent to which a company’s amended and restated memorandum and articles of association may provide for indemnification of officers and directors, except to the extent any such provision may be held by the British Virgin Islands courts to be contrary to public policy, such as to provide indemnification against civil fraud or the consequences of committing a crime. Our Amended and Restated Memorandum and Articles of Association provide for the indemnification of directors for losses, damages, costs, and expenses incurred in their capacities as such unless such losses or damages arise from their own wilful neglect or default.

 

Insofar as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers or persons controlling us under the foregoing provisions, we have been informed that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable as a matter of United States law.

 

We have maintained insurance in relation to any of our directors or officers against any liability asserted against the directors or officers and incurred by the directors or officers in that capacity.

  

ITEM 7. RECENT SALES OF UNREGISTERED SECURITIES.

 

Issuance of Class B Ordinary Shares, May 2026 (References to share and per share data described in this subsection have not been adjusted to give effect to the October 2026 Reverse Stock Split)

 

On May 18, 2026, the Company entered into a share purchase agreement (the “May 2026 Share Purchase Agreement”) with Deep Vision Enterprise Limited (“Deep Vision”), a principal shareholder of the Company and wholly owned by Mr. Hoi Lung CHAN (Chairman of the Board and Chief Executive Officer of the Company), pursuant to which the Company issued and sold to Deep Vision 211,879 Class B Ordinary Shares (the “May 2026 Class B Shares”) at a purchase price of US$3.01 per share for an aggregate gross proceeds of HK$5,000,000 (equivalent to US$637,755.10 based on the exchange rate of HK$7.84 to US$1.00 agreed by the parties in the May 2026 Share Purchase Agreement) (the “May 2026 Class B Share Issuance”). On May 26, 2026, the Company issued the May 2026 Class B Shares to Deep Vision.

 

No placement agents were involved in the May 2026 Class B Share Issuance. The May 2026 Class B Shares issued in the May 2026 Class B Share Issuance were exempt from the registration requirements of the Securities Act pursuant to Regulation S promulgated thereunder or Section 4(a)(2) thereof.

 

Private Placement of Class A Ordinary Shares, July 2026 (References to share and per share data described in this subsection have not been adjusted to give effect to the October 2026 Reverse Stock Split)

 

On July 2, 2026, the Company entered into a securities purchase agreement with certain new investors and existing shareholders of the Company (each a “PIPE Investor”, and collectively, the “PIPE Investors”), pursuant to which the Company agreed to issue and sell to the PIPE Investors an aggregate of 4,310,350 Class A Ordinary Shares (the “July 2026 PIPE Shares”) at a purchase price of US$ 0.464 per share, representing 20% of the closing price of the Class A Ordinary Shares on the Nasdaq Capital Market on July 1, 2026, for an aggregate purchase price of US$2,000,000 (the “July 2026 PIPE”). On July 8, 2026, the Company issued the July 2026 PIPE Shares to the PIPE Investors.

 

No placement agents were involved in the July 2026 PIPE. The July 2026 PIPE Shares issued in the July 2026 PIPE were exempt from the registration requirements of the Securities Act pursuant to Regulation S promulgated thereunder or Section 4(a)(2) thereof.

 

Private Placement of Class A Ordinary Shares, August 2026 (References to share and per share data described in this subsection have not been adjusted to give effect to the October 2026 Reverse Stock Split)

 

On July 30, 2026, the Company entered into securities purchase agreements with the PIPE Investors, all being existing shareholders of the Company at the time, pursuant to which the Company agreed to issue and sell to the PIPE Investors an aggregate of 6,329,115 Class A Ordinary Shares (the “August 2026 PIPE Shares”) at a purchase price of US$0.316 per share, representing 20% of the closing price of the Class A Ordinary Shares on the Nasdaq Capital Market on July 29, 2026, for an aggregate purchase price of US$2,000,000 (the “August 2026 PIPE”). On August 11, 2026, the Company issued the August 2026 PIPE Shares to the PIPE Investors.

 

No placement agents were involved in the August 2026 PIPE. The August 2026 PIPE Shares issued in the August 2026 PIPE were exempt from the registration requirements of the Securities Act pursuant to Regulation S promulgated thereunder or Section 4(a)(2) thereof.

 

II-1

 

 

ITEM 8. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES.

 

(a)Exhibits

 

See Exhibit Index beginning on page II-4 of this registration statement.

 

(b)Financial Statement Schedules

 

Schedules have been omitted because the information required to be set forth therein is not applicable or is shown in the Consolidated Financial Statements or the notes thereto.

 

ITEM 9. UNDERTAKINGS.

 

(a)The undersigned Registrant hereby undertakes:

 

(1)To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

 

(i)To include any prospectus required by section 10(a)(3) of the Securities Act of 1933;

 

(ii)To reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective registration statement;

 

(iii)To include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any material change to such information in the registration statement; provided, however, that paragraphs (a)(1)(i), (ii), and (iii) of this section do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the registrant pursuant to section 13 or section 15(d) of the Securities Exchange Act of 1934 (15 U.S.C. 78m or 78o(d)) that are incorporated by reference in the registration statement, or, as to a registration statement.

 

(2)That, for the purpose of determining any liability under the Securities Act of 1933, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

(3)To remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

 

(4)To file a post-effective amendment to the registration statement to include any financial statements required by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information otherwise required by Section 10(a)(3) of the Act need not be furnished, provided that the registrant includes in the prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements.

 

(5)That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser:

 

(i)If the registrant is relying on Rule 430B:

 

(A)Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of the date the filed prospectus was deemed part of and included in the registration statement; and

 

II-2

 

 

(B)Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such effective date; or

 

(ii)If the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness. Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately prior to such date of first use.

 

(6)That, for the purpose of determining liability of the registrant under the Securities Act of 1933 to any purchaser in the initial distribution of the securities the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the purchaser and will be considered to offer or sell such securities to such purchaser:

 

(i)Any preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;

 

(ii)Any free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the undersigned registrant;

 

(iii)The portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant or its securities provided by or on behalf of the undersigned registrant; and

 

(iv)Any other communication that is an offer in the offering made by the undersigned registrant to the purchaser.

 

(b) Insofar as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers and controlling persons of the registrant pursuant to the provisions described in Item 6 hereof, or otherwise, the registrant has been advised that in the opinion of the SEC such indemnification is against public policy as expressed in the Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Act and will be governed by the final adjudication of such issue.

 

(c) The undersigned registrant hereby undertakes that:

 

(1)That for purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant pursuant to Rule 424(b)(1) or (4), or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of the time it was declared effective.

 

(2)That for the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

 

II-3

 

 

EXHIBIT INDEX

 

Exhibit No.   Description
3.1   Sixth Amended and Restated Memorandum and Articles of Association (incorporated herein by reference to Exhibit 3.1 to the Registrant’s Form 6-K initially filed with the U.S. Securities and Exchange Commission on November 5, 2026)
5.1*   Opinion of Ogier regarding the validity of the Class A Ordinary Shares being registered
8.1*   Opinion of Ogier regarding certain British Virgin Islands tax matters (included in Exhibit 5.1)
10.1   Employment Agreement by and between the Registrant and Cheong Shing KU, dated October 20, 2025 (incorporated herein by reference to Exhibit 4.1 to the Registrant’s Form 20-F filed with the U.S. Securities and Exchange Commission on August 14, 2026)
10.2   Employment Agreement by and between the Registrant and Hoi Lung CHAN, dated October 20, 2025 (incorporated herein by reference to Exhibit 4.2 to the Registrant’s Form 20-F filed with the U.S. Securities and Exchange Commission on August 14, 2026)
10.3   Employment Agreement by and between the Registrant and Sze Ki Cheng, dated March 21, 2026 (incorporated herein by reference to Exhibit 4.3 to the Registrant’s Form 20-F filed with the U.S. Securities and Exchange Commission on August 14, 2026)
10.4   Tenancy Agreement by and between Wing Kwok Enterprises Limited and Matter Interiors Limited, dated February 11, 2025 (incorporated herein by reference to Exhibit 4.4 to the Registrant’s Form 20-F filed with the U.S. Securities and Exchange Commission on August 14, 2026)
10.5   Tenancy Agreement by and between Online Holdings Limited and Axonex Intelligence Limited, dated May 16, 2026 (incorporated herein by reference to Exhibit 4.5 to the Registrant’s Form 20-F filed with the U.S. Securities and Exchange Commission on August 14, 2026)
10.6   Form of Director Offer Letter by and between the Registrant and Independent Director Nominee (incorporated herein by reference to Exhibit 4.6 to the Registrant’s Form 20-F filed with the U.S. Securities and Exchange Commission on August 14, 2026)
10.7   Tenancy Agreement by and between Online Holdings Limited and Rice Robotics (Hong Kong) Limited, dated June 22, 2026 (incorporated herein by reference to Exhibit 4.7 to the Registrant’s Form 20-F filed with the U.S. Securities and Exchange Commission on August 14, 2026)
10.8   Share Purchase Agreement by and between the Registrant and Deep Vision Enterprise Limited, dated May 18, 2026 (incorporated herein by reference to Exhibit 99.1 to the Registrant’s Form 6-K filed with the U.S. Securities and Exchange Commission on May 27, 2026)
10.9   Form of Securities Purchase Agreement (New Investors) by and between the Registrant and the investors named therein, dated July 2, 2026 (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Form 6-K filed with the U.S. Securities and Exchange Commission on July 13, 2026)
10.10   Form of Securities Purchase Agreement (Existing Shareholders) by and between the Registrant and the investors named therein (incorporated herein by reference to Exhibit 10.2 to the Registrant’s Form 6-K filed with the U.S. Securities and Exchange Commission on July 13, 2026)
10.11   Form of Securities Purchase Agreement by and between the Registrant and the investors named therein (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Form 6-K filed with the U.S. Securities and Exchange Commission on August 11, 2026)
10.12   Form of Amendment No. 1 to Securities Purchase Agreement, dated August 26, 2026, by and between the Registrant and the investors named therein (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Form 6-K furnished to the U.S. Securities and Exchange Commission on August 31, 2026)
10.13   Form of Amendment No. 2 to Securities Purchase Agreement, dated October 7, 2026, by and between the Registrant and the investors named therein (incorporated herein by reference to Exhibit 10.1 to the Registrant’s Form 6-K furnished to the U.S. Securities and Exchange Commission on October 13, 2026)
14.1   Code of Business Conduct and Ethics (incorporated herein by reference to Exhibit 11.1 to the Registrant’s Form 20-F filed with the U.S. Securities and Exchange Commission on August 14, 2026)
14.2   Insider Trading Policy (incorporated herein by reference to Exhibit 11.2 to the Registrant’s Form 20-F filed with the U.S. Securities and Exchange Commission on August 14, 2026)
21.1   List of Subsidiaries (incorporated herein by reference to Exhibit 8.1 to the Registrant’s Form 20-F filed with the U.S. Securities and Exchange Commission on August 14, 2026)
23.1*   Consent of WWC, P.C.
23.2*   Consent of Ogier (included in Exhibit 5.1)
97.1   Executive Compensation Recovery Policy (incorporated herein by reference to Exhibit 97.1 to the Registrant’s Form 20-F filed with the U.S. Securities and Exchange Commission on August 14, 2026)
107*   Filing Fee table

 

*Filed herewith

** To be filed by amendment

 

II-4

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form F-1 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in Hong Kong, on November 20, 2026.

 

  Axonex AI Group Limited
     
  By: /s/ Hoi Lung CHAN
    Name:  Hoi Lung CHAN
    Title: Chief Executive Officer and Chairman of the Board
      (Principal Executive Officer)

 

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

 

Signature   Title   Date
         
/s/ Hoi Lung CHAN   Chief Executive Officer and Chairman of the Board of Director   November 20, 2026
Name: Hoi Lung CHAN   (Principal Executive Officer)    
         
/s/ Sze Ki CHENG   Chief Financial Officer   November 20, 2026
Name: Sze Ki CHENG   (Principal Financial and Accounting Officer)    
         
/s/ Cheong Shing KU   Director   November 20, 2026
Name: Cheong Shing KU        
         
/s/ Ka Wai WONG   Independent Director   November 20, 2026
Name: Ka Wai WONG        
         
/s/ Chun Pong Raymond SIU   Independent Director   November 20, 2026
Name: Chun Pong Raymond SIU        
         
/s/ Xunze XIU   Independent Director   November 20, 2026
Name: Xunze XIU        

 

II-5

 

 

SIGNATURE OF AUTHORIZED REPRESENTATIVE IN THE UNITED STATES

 

Pursuant to the Securities Act of 1933 as amended, the undersigned, the duly authorized representative in the United States of America, has signed this registration statement thereto in New York, NY on November 20, 2026.

 

  COGENCY GLOBAL INC.
   
  By: /s/ Colleen A. De Vries
  Name:  Colleen A. De Vries
  Title: Senior Vice-President on behalf of Cogency Global Inc.

 

II-6

 


ATTACHMENTS / EXHIBITS

ATTACHMENTS / EXHIBITS

OPINION OF OGIER REGARDING THE VALIDITY OF THE CLASS A ORDINARY SHARES BEING REGISTERED

CONSENT OF WWC, P.C

FILING FEE TABLE

IDEA: R1.htm

IDEA: R2.htm

IDEA: R3.htm

IDEA: FilingSummary.xml

IDEA: MetaLinks.json

IDEA: ea031276101ex-fee_htm.xml